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 1 
1 INTRODUCTION 
1.1  Natural Products as a Source for New Lead Structures 
Since the beginning of human civilization, the structurally diverse metabolites of 
plants and microorganisms have bean a main source for medicals, pigments, 
dyes, flavors and even poisons. Many of the currently known lead structures for 
therapeutic agents and pesticides are natural products or their derivatives. 
Recently discovered marine environment and symbiont microorganisms 
constitute exciting new sources of pharmacologically active natural products1 
Novel structures observed in all these sources allowed scientists to gain new 
insight into the structural and functional relationships of active compounds.  
For several natural products, efficient synthetic methods were developed for 
therapeutical and industrial applications. However, in general, the structural 
complexities of many compounds represent a challenge for long term synthetic 
supply. Usually many synthetic reaction steps are necessary and the final yield 
is unsatisfactory. Therefore many promising drug candidates can not be 
produced on industrial scale using this method. Using the natural source can 
often be problematic too, since the amount of the metabolite produced is 
insufficient and the source organisms cannot be cultured to increase 
production. 2 
 Recent developments in the biosynthesis of natural products, combined with 
advanced techniques in molecular biology, analytical chemistry and genetic 
engineering, provide promising approaches to overcome these problems and 
open new possibilities to use Nature’s biochemical machineries as tools of 
discovery and production. These methods and techniques are used to derivatize 
compounds, investigate the function of genes and construct candidate substance 
libraries for front line drugs.3 Metagenomic analysis of species is used to 
identify and isolate biosynthetic gene clusters of these novel compounds.4 Then 
molecular biological methods are employed for the expression of these gene 
clusters in culturable host species to obtain sufficient amounts of compounds 
and enzymes in a laboratory environment. Finally, biotechnollogy provides an 
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opportunity to manipulate gene clusters and to investigate derivatives of the 
original compound. 5,6 
The focus of this study is polyketide natural products of bacterial origin and 
their biosynthetic pathways. In the remainder of this Chapter 1, the necessary 
background to the origin and the biosynthesis of bacterial polyketides is 
presented. 
 
                                                                                                                        1 INTRODUCTION 
____________________________________________________________________________________________ 
 3 
1.2 Polyketides 
Thousands of polyketide metabolites, exhibiting remarkable structural and 
functional diversity, are reported from various sources such as bacteria, fungi, 
plants, insects, dinoflagullates, mollusks and sponges.7 Their wide clinical and 
industrial applicability makes them one of the most demanded classes of 
substances. The antibiotic antitumor agent doxorubicin (1),8,9 the 
immunosuppressant rapamycin (2),8,10 the antimalarial ionophore monensin 
(3), and the erythromycin A (4)11,12 are examples of commercially available 
polyketide drugs of microbial origin. Figure 1.1 shows the structures of these 
polyketides having useful pharmacological activities. 
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Figure 1.1 Representative structures of commercially used polyketides.12 
 
Polyketides are loosely categorized based on their structure as complex or 
aromatic, and based on their biosynthesis as reduced or non-reduced. The 
biosyntheses of these two classes of polyketides differ significantly. 
1 INTRODUCTION 
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Polyketides like the polyaromatic compound doxorubicin (1) in Figure 1.1 are 
usually derived from an unreduced form of a poly--keto-chain biosynthetic 
precursor. Hence they are classified as non-reduced. In the case of reduced 
polyketides, the carbonyl functions of the poly--keto-chain have been reduced 
similar as in fatty acid biosynthesis. The two main classes of reduced polyketides 
are macrolides, such as erythromycin (4) and rapamycin (2), and polyethers, 
such as monensin A (3).13, 11  
In this thesis, the compound griseorhodin A (5), a rare bacterial aromatic 
polyketide with a highly complex aromatic spiro ketal structure, is investigated. 
It was isolated from Streptomyces californicus JA264014 and Streptomyces sp. 
JP95.15  Figure 1.2 shows the structure of the polyketide. 
Figure 1.2 Structure of griseorhodin A (5). 
1.3 Biosynthesis of Polyketides and Different Types of 
Polyketide Synthases 
The biosynthesis of polyketides involves the stepwise formation of a 
functionalized chain derived from simple carbon building blocks via 
decarboxylative Claisen condensation analogous to classical fatty acid 
biosynthesis. This chain synthesis requires CoA (6) activated starter unit and 
extender units. In addition, enzymes catalyzing and directing the polyketide 
biosynthesis called polyketide synthases (PKSs), which are functioning with an 
activated acyl carrier protein (ACP) unit, are required.16,17 The inactive form of 
ACP, which is called apo-ACP, needs to be transformed into the holo-ACP form 
by a phosphopantetheinyl transferase (PPTase) as shown in Figure 1.3. During 
the chain elongation steps of the polyketide synthesis, the growing chain stays 
attached to the holo-ACP arm. The phosphopantetheine (7) residue functions as 
O O
O
MeO
O
O
OH
OH OH O
HO
O
Griseorhodin A (5)
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an arm reaching the polyketide intermediate to the catalytic centers of the PKS 
complexes.16,18 
 
Figure 1.3 Phosphopantetheinyl transferase catalyzed posttranslational modification of 
apo-ACP into holo-ACP. 18 
After each condensation step, either the resulting poly--keto chain 
intermediate is elongated further or the keto groups of the chain intermediate 
are modified and reduced prior to the next elongation. In classical fatty acid 
biosynthesis, each successive chain elongation step is followed by a fixed 
sequence of keto reduction, dehydration and enoyl reduction. However, the 
individual chain elongation intermediates of modular polyketide biosynthesis 
may undergo all, some or none of these functional group modifications. In 
addition, usage of tailoring enzymes for further processing results in highly 
chemically complex products. Schematics of the biosynthetic pathways showing 
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the difference between fatty acid, aromatic polyketide, and reduced polyketide 
syntheses are shown in Figure 1.4.2,19,20 
 
Figure 1.4 Biosynthetic pathways for fatty acid and polyketides. Starter unit and extender 
units are the building blocks. The processing of the elongation intermediates for fatty 
acids, aromatic polyketides, and reduced polyketides differ in the processing of chain 
intermediate.20,2 
The biosynthetic pathway of aromatic polyketides branch from fatty acid 
synthesis in the earlier stages. 16 The chain extension process continues usually 
without reduction for aromatics, generating a highly reactive poly--keto chain. 
The intermediate has to be stabilized during enzyme processing until the entire 
chain assembly is complete. Subsequent cyclization reactions of the chain 
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intermediate result in an aromatic precursor for the biosynthesis of the 
aromatic scaffold.  
Additional degrees of complexity arise from the use of various starter and chain 
elongation units.21 Figure 1.5 exemplifies some of the starter and extender 
building units used in polyketide synthesis by different types of PKS enzyme 
complexes. 
O
SCoA
O
SCoA
O
SCoA
O
SCoA
HO SCoA
OO
HO SCoA
OO
O
SCoA
Acetyl-CoA (10) Propionyl-CoA (11) Butyryl-CoA (13) Isobutyryl-CoA (14)
Malonyl-CoA (15) Methoxymalonyl-CoA (16)
Benzoyl-CoA (12)
 
Figure 1.5 Some starter (upper row) and extender units (lower row) of polyketide 
biosynthesis.21 
Three structurally different main classes of PKSs have been discovered in the 
microbial world until now.  
These classes are: 
 Modular type I PKSs and modular iterative type I in bacteria and fungi 
 Iterative type II PKSs of bacteria 
 Iterative type III PKSs of plants  
Modular type I PKSs consist of multiple active domains organized into modules. 
Component domains of polyketides are acyl-transferases (ATs) to load starter, 
extender and intermediate acyl units; acyl carrier proteins (ACPs) to bind the 
growing chain as a thiol ester; -keto-acyl synthases (KSs) to catalyze chain 
extension; -keto reductases (KRs) to achieve the reduction at a keto to an 
alcohol functionality; dehydratases (DHs) to eliminate water to give an 
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unsaturated thioester; enoyl reductases (ERs) to catalyze the final reduction to 
reach full saturation; and finally a thioesterase (TE) to catalyze macrolide 
release to complete the cyclic structure. 
Each module is responsible for the construction of a carbon-carbon bond, via 
decarboxylative condensation of a ketide extender unit with the growing 
polyketide chain, followed by a programmed reductive cycle. In addition, there 
is a loading module for the starter unit at the front of the first module and TE 
responsible to unload the product at the end of the last module. To process a 
type I polyketide, a functional module is required for each extension step, 
whose domain architecture usually precisely matches the functionality 
introduced into the growing intermediate. Thus, the order of modules is 
generally collinear with the order of functional groups in a polyketide. For this 
assembly line-like process the term colinearity rule has been introduced.22,12,11 
At this point, it is important to discuss the linker regions. It is believed that 
dynamic linkers between modules, domains and the N- and C-terminus of the 
polypeptide chain establish communication by influencing correlated 
movements of various domains.23,24,12  
The modular type I polyketide assembly line is exemplified by the biosynthesis 
of the antibiotic erythromycin (4). Its biosynthesis was mainly investigated in 
the works of Prof. Peter Leadly’s25, Leonard Katz’s and Khoshla’s groups22,26 and 
the schematic of the pathway is shown in the Figure 1.6.22 
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Figure 1.6 Modular polyketide biosynthesis with PKS I type assembly. In this figure 
erythromycin biosynthesis is used to illustrate modular PKS function. 
Type I PKS systems can use modules linearly as described for erythromycin 
biosynthesis in Figure 1.6, or they can use modules iteratively.  Iterative type I 
synthases are typically involved in the biosynthesis of fungal polyketides such 
as the compounds shown in the Figure 1.7, 6-methyl salicylic acid (18) and the 
fungal carcinogenic mykotoxine aflotoxin (19)27,28 The biosynthesis of these 
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fungal aromatic polyketides differ from the biosynthesis of aromatic polyketides 
isolated from bacteria because bacteria use iterative type II PKSs instead.  
 
Figure 1.7. Fungal aromatic polyketides.28 
The biosynthesis by bacterial iterative type II systems is exemplified by the 
actinorhodin PKS from Streptomyces coelicolor. 29,30 In these synthases, active 
sites are contributed by several smaller, usually monofunctional polypeptides. 
Regarding the condensation steps, the PKSs are analogous to bacterial fatty acid 
synthases (FASs) and are responsible for the biosynthesis of bacterial aromatic 
polyketides. Type II synthases catalyze aromatization and cyclization of the 
poly--keto intermediate, but do not perform extensive reduction or 
reduction/dehydration cycles as the modules in type I PKSs do. The detailed 
enzymology of type II PKSs will be further discussed in the next section, since 
they are the main focus of this work. 
Type III polyketide synthases are usually involved in the biosynthesis of 
chalcones and stilbenes in plants and some polyhydroxy phenols in 
bacteria.7,16,31,32 They are comparatively small proteins with single polypeptide 
chains and act in the biosynthesis of flavonoids. Unlike the FASs, type I and type 
II PKSs, these enzymes do not use a phosphopantetheinyl cofactor, and the 
biosynthesis is significantly different than a bacterial type II PKS because of the 
organization of the genes on genome and construction of the biosynthetic 
machinery.27,32 
OHH3C
6-Methylsalicylic acid (18)
O
O
O
OO
O
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O OH
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1.4 Bacterial Aromatic Polyketides 
Bacterial aromatic polyketides, which usually have polycyclic condensed 
aromatic structures, have been mostly encountered in actinomycetes.32 
Actinomycetes belong to Gram-positive bacteria and are a rich source of 
secondary metabolites. These compounds are assumed to be used in self-
defense and bacterial communication.32 The structural diversity, the 
biosynthesis and the organization of the related genes of these natural products 
have been attracting significant interest. Various type II PKS systems are 
encoded in organized gene clusters that contain homologous genes, which help 
identify the gene clusters on the genome of a bacteria. This features is important 
for the discovery and investigation of these systems.33,7,34,35 
Major structural classes of bacterial aromatic polyketides are anthracyclines, 
angucyclines, aureolic acids, tetracyclines, tetracenomycins, pradimicin-type 
polyphenols (29), and benzoisochromanequinones (20).36 Figure 1.8 shows 
actinorhodin (20),29,30,37 tetracyclin (22)38, tetracenomycine (21)39,40 
doxorubicin (24)41,42, landomycin (25) and mitramycin (23) 43,44 as some of the 
genetically best-studied examples of aromatic polyketides.36,12 However, there 
are also several compounds produced by type II PKSs, that have novel scaffolds 
and do not belong to any of these groups, such as enterocin (27),45,46 
resistomycin (28),47,48 fredericamycin A (26),42 and griseorhodin A (5).15 
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Figure 1.8.a Representative structures of aromatic polyketide metabolites falling into 
major structural types. 
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Figure 18.b Representative structures of aromatic polyketide metabolites with divergent 
carbon skeletons. 
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1.5 Enzymology of Bacterial Type II Aromatic Polyketide 
Biosynthesis 
1.5.1 Minimal PKS 
Polyketide synthesis by type II PKSs is a process comprising of several types of 
enzymes with individual activities organized as a multi-enzyme complex. The 
machinery responsible for the assembly of the poly--keto intermediate is the 
so-called minimal PKS, which is made up of a heterodimer ketosynthase unit 
and an ACP. The first ketosynthase unit KSα possesses a cysteine reactive site, 
which plays an essential role in the catalysis of the condensation reactions for 
chain elongation. The second unit KSβ, also called the chain elongation factor 
(CLF), affects the chain length and plays an important role during the selection 
of the starter units.17,29,36 KSα and KSβ units form a cavity, where the growing 
polyketide chain, attached to the ACP, undergoes folding reactions.36,49,50 Figure 
1.9 illustrates a model of this enzyme complex. The size of the cavity limits the 
chain length and determines the folding pattern of the poly--keto chain.36 
 
Figure 1.9 Model for a minimal PKS complex.36 
The acyl carrier protein (ACP) is another key component of the assembly. It has 
a phosphopantetheine arm, to which the poly-β-keto chain is attached during 
synthesis. Studies have shown that, malonyl-CoA: ACP transferase (MAT, MCAT) 
enzymes have an important role at priming and allow the usage of starter units 
other than the commonly used acetyl-CoA. 36 
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Figure 1.10 Stepwise mechanisms for type II PKS catalyzed biosynthesis of aromatic 
polyketides from malonyl CoA.20 
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Figure 1.10 shows the mechanism for the activation of the ACP and priming, 
chain elongation, and termination reactions of the poly--keto chain by the 
minimal PKS enzymes.50,20 
 
Figure 1.11 Mechanism of type II PKS priming. A. Priming involving decarboxylation. B. 
Priming involving a KSIII/ACP module. C. Priming involving direct loading of an  acetyl-
CoA starter.36 
In most cases aromatic polyketide synthases are primed with acetate as in 
actinorhodin (20) and tetracenomycin (21) biosynthesis.37,39 The PKS is primed 
by decarboxylation of a malonyl unit as shown in Figure 1.11A. In addition to 
decarboxylation of malonates, two alternative pathways have been proposed for 
non-acetate PKS primers. The alternative for the biosynthesis and attachment of 
short-chain fatty acids, such as propionate on the benastatins, involves an 
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additional KSIII (and ACP) as shown in Figure 1.11B.51,52 The second alternative 
pathway in Figure 1.11C, which has been proposed for malonamate and 
benzoate starters in tetracycline (22) and enterocin (27) pathways, is the direct 
loading by an acyl-CoA ligase and an acyltransferase (AT).46,21,36 
1.5.2 Accessory Enzymes 
 Accessory enzymes including ketoreductases (KR), cyclases and aromatases are 
crucial for the synthesis of the core aromatic structure because they manage the 
cyclization and folding patterns of the growing chain. The presence of these 
enzymes suppresses the occurrence of spontaneous aldol condensations. The 
so-called cyclases (CYCs), which function in a ‘chaperone-like’ manner, help in 
directing the nascent polyketide intermediates into particular reaction 
channels.36,53 An interesting example of varying folding patterns in the context 
of bacterial accessory enzyme activities are presented in Figure 1.12. The 
folding pattern of the growing decaketide chain produces angular, linear and 
discoid scaffolds as in the case of dehydrorabelomycine (29)54,55 
tetracenomycin F1 (30)39,40 and resistomycin (28).47.36 
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Figure 1.12 U-shape and S-shape folding in angular, linear and discoid polyketide 
pathways.36 
Post-PKS modifications are the next step in the biosynthesis of the aromatic 
polyketides. A wide variety of tailoring enzymes, mainly group transferases 
such as methyl transferases and glycosidases, oxidoreductases and halogenases 
act at the final stages of the biosynthesis and decorate the aromatic core with 
substantial functional groups necessary for the biological activity of the 
compounds. Before proceeding with the details of the post PKS modifications, 
Figure 1.13 depicts an overview of actinorhodin (20) biosynthesis for a better 
understanding of the PKS type II biosynthesis. Note that, the organization of the 
genes encoding PKS type II systems (Figure 1.13) differ vastly from the 
organization of the genes encoding PKS type I systems (Figure 1.6) because they 
do not follow the co-linearity rule.  
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Figure 1.13 A. Actinorhodin minimal PKS gene cluster isolated from S. coelicolor. B. 
Actinorhodin biosynthesis illustrating the aromatic polyketide biosynthesis.11,56 
1.5.3 Tailoring Enzymes 
Tailoring enzymes, also called post-PKS enzymes, provide the aromatic core 
with new functionalities and alter the physical-chemical and stereo-chemical 
properties of the molecule by changing polarity and/or adding new chiral 
centers to it.57 For example, glycosidases change the steric properties and 
solubility of molecules by adding bulky sugar chains. Several oxidases have the 
remarkable ability to reconstruct the whole aromatic core during the post-PKS 
processing via oxidative reactions.36,58 These activities of the post-PKS enzymes 
have also tremendous impact on the binding properties of the polyketide to a 
biological ligand molecule. The possibility to change the binding ability attracts 
research to find new approaches to utilize these enzymes for combinatorial 
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biosynthesis in order to improve the pharmacological profile of certain 
polyketides.59,60 
1.5.3.1 Group Transferases 
The major subgroups of these enzymes are glycosyl transferases, amino 
transferases, alkyl transferases (usually methyl) and acyl transferases. Many 
enzymes are in need of co-factors to activate the donor substrates and transfer 
to new functionalities onto the molecule. For methyl transferases (MTs), use 
usually S-adenosylmethionine (SAM), and most amino transferases use alanine 
or glutamic acid as amino group donors. Glycosyl transferases (GTs) use NDP 
(nucleoside diphosphate) activated sugars as donor substrates. Typical 
nucleosides are TDP (thymine diphosphate), UDP (uracil diphosphate) and GDP 
(guanin diphosphate). TDP is by far the most common in the context of post-PKS 
modifications through glycosyl transferases.58,61 The NDP-activated sugars are 
also called sugar co-substrates. For many of these sugar co-substrates, e.g. the 
NDP-deoxysugars, special biosynthetic pathways exist. The genes encoding 
these special pathways usually cluster with the genes of the metabolites to 
whose biosyntheses the GTs contribute.59 It has been shown that many GTs 
exhibit substrate flexibility either towards their acceptor substrate or their 
sugar donor co-substrates, which makes them even more important for the 
combinatorial biosynthesis of new drug candidate glycosides.61 Possible effects 
of group transfer reactions on the polyketide substrate are shown in the Figure 
1.14.60 
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Figure 1.14 Possible effects of group transferases, such as methyl- and 
glycosyltransferases, MT=methyl transferase, GT=glycosyl transferase.60 
1.5.3.2 Oxidoreductases 
Oxidation reactions are the most frequently occurring post PKS-modifications 
occurring in the aromatic polyketide biosynthesis. Oxygenases, oxidases and 
peroxidases, (keto) reductases and dehydrogenases are the enzymes controlling 
these reactions. Oxygenase actions involve adding and transforming oxygen 
containing functional groups.60,62 These modifications make the molecules more 
polar, change chemical properties, reactivity, and insert new stereo centers as 
illustrated in figure 1.15. Furthermore, oxygenases can catalyze exquisite 
rearrangement reactions, C-C bond cleavages, and complex 
decarboxylations.60,63 On the other hand, reductases generally transform 
aldehydes, ketones, carboxylic acids and alcohols by adding hydrogen atoms. 
60,62,64 
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Figure 1.15 Possible effects of oxidoreductases on the biological activity.60 KR = 
Ketoreductase, OX = oxygenase 
Oxygenases are classified as either monooxygenases or dioxygenases. 
Monooxygenases incorporate an oxygen atom to the product, whereas 
dioxygenases incorporate both atoms of dioxygen into the final product. 
Catechol dioxygenases and the aromatic dihydroxylating dioxygenases are 
interesting examples of dioxygenases.  Mono- and dioxygenases are often 
involved in the bacterial degradation of aromatic compounds in the 
environment.65,66 Commonly occurring reactions of monooxygenases and 
dioxygenases are shown in Figure 1.16. 60 
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Figure1.16 Generation of structural diversity by oxygenases. Examples of products 
observed during mono- and dioxygenases reactions.60 
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These enzymes usually contain a redox-active transition metal or a non-metal 
cofactor. The used cofactor distinguishes between the classes of these 
enzymes.60 The most common classes in aromatic polyketide synthesis are: 
 Cytochrome P-450 monooxygenases (CYP450)  
 Flavin dependent mono- and dioxygenases 
 Anthrone oxygenases 
Cytochrome P-450 monooxygenases (CYP450) are heme-containing enzymes and 
usually require a NADP dependent reductase and a ferrodoxin-like iron sulfur 
protein for the regeneration of the cofactor. These enzymes are involved in 
several essential metabolic pathways, and the genes of the regenerative 
enzymes are not necessarily clustered with the other oxygenase-encoding 
genes.60 The mechanism of hydroxylation by P450 enzymes is shown in Figure 
1.17 and is as follows: The heme cofactor (31) has an iron center resting in the 
enzyme ın the formal oxidation state +3, that is reduced to the +2 oxidation 
state upon substrate binding. This reduction is carried out by a reductase 
subunit of the enzyme. The reduced iron (II) is able to donate a single electron 
to the dioxygen, forming an iron (III) superoxide. Transfer of a second electron 
to the reductases subunit via the iron center generates iron (III) peroxide. 
Cleavage of the dioxygen bond occurs through protonation and results in an 
iron (IV) oxo species, which is believed to exist as an iron (IV) oxo/porphyrin 
radical cation. Oxygen insertion into the substrate can occur over a substrate 
radical or through a concerted mechanism involving oxygen insertion into the 
C-H bond of the substrate.67  
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Figure 1.17 Mechanism for P450-dependent hydroxylation.67 
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Flavin-dependent oxygenases use a flavin cofactor (32) that is in some cases 
covalently bound to the enzyme. Genes encoding flavin-dependent enzymes 
usually have similarities with each other at the binding sites of their cofactors. 
This property enables their identification. Figure 1.18 shows the structures of 
common flavin redox cofactors.67 
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Figure 1.18 Structures of flavin redox cofactors.67 
Flavin cofactors can exist as FAD (34), as reduced FADH2, or as a semiquinone 
radical species as shown in Figure 1.19A. The semiquinone form undergoes a 
single-electron transfer reaction after which the flavin molecule can react with 
molecular oxygen. The cofactor FAD must be regenerated at the end of each 
catalytic cycle by external redox reagents. In vivo, molecular oxygen is used to 
generate FAD from FADH2 as shown in Figure 1.19B. For in vitro studies, usually 
chemical oxidants like benzoquinones are used.67 
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Figure 1.19 A. Redox states of riboflavin. B. Regeneration of oxidized flavin by molecular 
oxygen.67 
Anthrone oxygenases occur very often in aromatic polyketide biosynthesis. Their 
most important property is to carry out oxidation reactions without cofactors. 
They are also called “internal monooxygenases”. They form quinone 
functionalities of the aromatic core by performing an oxidation in which a 
dioxygen molecule is reduced to water.36,60 
Besides the various oxygenases catalyzing hydroxylation, epoxidation and 
anthrone oxidation reactions, there exist unique oxygenases catalyzing 
reactions such as Baeyer-Villiger-68,69 or Favorskii-type46,63 oxidative 
rearrangements. The flavin-dependent enzymes involved in the biosynthesis of 
mithramycin (23) and enterocin (27) are examples of this kind of reactions and 
are shown in Figure 1.20. There are also oxidative reaction cascades observed in 
several biosynthetic pathways.70 Enzymes directing these reactions vary widely 
in their substrate-specificity and requirement of cofactors. 
1 INTRODUCTION 
____________________________________________________________________________________________ 
28 
 
 
O
CH3
OO
OR2
COOH
H
OCH3 OH
OOHOH
H3C
R1O
R1O
H3C
OH OH OOOHOH
H3C
R1O
O
OH
O
CH3
H3CO
H
OR2
OR2
H
OCH3
OH
O
CH3
O
R1= disaccharide,
R2= trisaccharide,
see figure 1.16
Premithramycin (35)
Mithramycin (23)
Active compound
MtmOIV
MtmOIV
[O]
+H2O
SCoA
O
S-EncC
O O O O
O O O
HO
O
O
O
S-EncC
O
O
O
O
OHO
O
O
O
S-EncC
O
O
O
O
HO
OHO
9
H3CO
O
O
O
O
OH
OH
OHO
H
HO
O
O
O
O
OH
OH
OHO
H
HO
Favorskii-type
rearrangment
EncQR
EncM
+
7x Malonyl-CoA
EncABCD
5-Deoxyenterocin (36) Enterocin (27)
11
EncM
B.
A.
Baeyer-Villiger-type
rearrangment
[O]
 
Figure 1.20 Oxidative rearrangements catalyzed by unique enzymes. A. Baeyer-Villiger 
oxygenase MtmOIV acting at the biosynthesis of mitramycin (23).68 B. Enterocin (27) 
biosynthesis in which the gen EncM controls a Favorskii-Typ-rearrangment.46,63 
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1.6 Secondary Metabolite Production and Heterologous 
Expression in Streptomycetes 
Streptomycetes are Gram-positive bacteria that exhibit a complex growth cycle 
consisting of filamentous vegetative growth, the formation of aerial hyphae 
(aerial mycelia) and differentiation of these hyphae into spore chains. An 
important feature of these bacteria is the production of secondary metabolites, 
which is regulated in coordination with morphological differentiation. Among 
these secondary metabolites are several pharmaceutically relevant compounds 
such as streptomycin (from S. griseus), vancomycin (from S. orientalis), 
tetracycline (22) (from S. rimosus), nystatin (from S. noursei), and avermectin 
(from S. avermitilis). In addition, they produce a large number of extracellular 
enzymes that enable them to compete for nutrients in their habitat like many 
other actinomycetes. Streptomycetes have also the ability to sense and respond 
to a variety of environmental physiological signals, making them uniquely 
suitable to a life in a highly competitive soil environment. 71,72 
Figure 1.21 shows an overview of the complex growth cycle of S. coelicolor as an 
example. Under favorable conditions, one or two germ tubes emerge from a 
spore, grow by tip extention and branch formation to give rise to a mycelium. 
After 3-4 days, aerial hyphae, which have apical compartments, grow up, 
forming a spiral syncytium containing many tens of genomes. After aerial 
hyphae growth stops, multiple septa subdivide the apical compartment into 
unigenomic prespore compartments. These compartments change their shapes. 
Wall thickening occurs and grey spore pigments are deposited.72 
 
 
 
 
 
 
1 INTRODUCTION 
____________________________________________________________________________________________ 
30 
 
 
Figure 1.21 Life cycle and natural product production in Streptomycetes. A. The complex 
life cycle of Steptomycetes51. B. & C. Filamentous growth structure of Streptomycetes 
mycelium D. Streptomyces plicatospours spiral syncytium containing various genomes. E. 
Streptomyces coelicolor colonies producing actinorhodin (20). 72,73,74 Pictures from: 
http://microbewiki.kenyon.edu/index.php/Streptomyces 
The genetic and physiological causes for differentiation, antibiotic and enzyme 
production of streptomycetes have been the subjects of research since the 
1950s. Notably, Sir David Hopwood’s research on the Streptomyces coelicolor A3 
strain contributed significantly to the understanding of streptomycetes genetics. 
Streptomycetes posses large (>8 Mb), high-(G+C), linear chromosomes. These 
large linear chromosomes provide twice as much coding capacity than E. coli 
chromosomes and contain more open reading frames (ORFs) than the 
chromosomes of the eukaryote Saccharomyces cerevisiae. Several secondary 
metabolite pathway clusters can be encoded in their genome. The size of the 
clusters in their genome range from 15 kb up to more than 120 kb.75  
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In addition, recent whole genome analysis of several streptomycetes strains 
showed the presence of cryptic or silent secondary metabolite pathway genes 
that either do not provide compounds at detectable levels or are non-functional 
under standard culture conditions. The genome sequence of S. coelicolor 
revealed 18 putative secondary metabolic gene clusters in addition to those 
belonging to the previously known compounds, actinorhodin (ACT) (20), 
undecylprodigiosin (RED), calcium dependent antibiotic (CDA), and the gray 
spore pigment (WhiE). 76 
Genes encoding secondary metabolic pathways in streptomycetes are organized 
in clusters on the chromosome. Regulatory and resistance genes are usually 
found within the gene cluster. Because of gene clustering, once a single gene of 
the pathway is identified, entire pathways can be analyzed by searching the 
adjacent chromosomal region. This feature greatly simplifies the search for 
biosynthetic genes. Up to now, more than 100 secondary metabolite gene 
clusters from streptomycetes have been described.77  
The functionality of the genes in the identified and isolated clusters needs to be 
studied in order to explain the biosynthesis of the metabolites. The wide variety 
of isolated clusters requires a wide variety of gene expression methods. Cloning 
and heterologous expression of gene clusters in genetically improved laboratory 
strains provides a viable solution. The method of heterologous expression is 
based on the idea of introduce the isolated cluster or modified gene cluster of 
the compound into a compatible host, in order to have the host specie express it. 
One option is to integrate the new genes into the genome of the host strain and 
another option is to use an expression vector. An important requirement of 
heterologous expression is that the native strain and the chosen strain for 
expression must have certain genetic compatibilities such as their codon usage. 
77 
Many natural producer Streptomycetes strains cannot be used effectively to 
express a specific gene cluster for research purposes. In addition to the desired 
metabolite, a family of structurally related but unwanted compounds can also 
be produced. As exemplified by S. coelicolor, these bacteria can even produce 
more than one biochemically distinct secondary metabolite.  
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Therefore, a wide range of genetically modified actinomycetes including S. 
coelicolor, S. lividans, S. parvulus, and S. albus were developed as host species for 
the production of polyketides efficiently via heterologous expression.71,78 These 
strains do not contain unknown or unwanted clusters and they can be 
manipulated systematically to increase precursor availability or to eliminate 
compounds that may interfere with downstream processing. This eliminates 
undesirable metabolites from fermentation broths. These strains can also be 
manipulated to increase the yield of the expressed antibiotic or protein. 71,75 
Heterologous expression with these strains increases the ease with which PKSs 
can be genetically engineered for production of new natural products. 
Secondary metabolites whose sources can hardly be cultivated or which are 
produced in unsatisfactory amounts can be obtained by these methods in 
sufficient amounts.  
 
1.7 Recent Advances in Aromatic Polyketide Research 
The first genetic level biosynthesis study of organisms producing aromatic 
polyketides was carried out by Hopwood et al. using the model species S. 
coelicolor in the 1980’s.79,30,37In vivo and in vitro expression studies on the gene 
cluster of the blue pigment actinorhodin (20) produced by S. coelicolor, led to 
the research on organisms making aromatic polyketides with important 
pharmacological activity such as tetracycline (22), doxorubicin (24), 
tetracenomycin (21).33,39,41,80,81 Experience gained on the sequential analysis of 
the genes encoding PKS enzymes enabled the latter rapid developments in the 
isolation and expression of dozens of gene clusters of aromatic polyketides. 
Recently developed molecular biology tools such as recombinant DNA 
modification methods, allowed the in vitro and in vivo investigation of the 
biosyntheses of the metabolites at the genetic level via the expression of PKS 
genes and total biosynthesis clusters in host bacteria.34,79,82 Achievements in 
efficient heterologous expression of polyketide gene clusters in host strains and 
advances in methods to manipulate the gene clusters by adding and deleting 
genes, opened the way for the combinatorial biosynthesis of several unique 
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compounds and compound libraries.12,83 An important example of 
combinatorial biosynthesis is provided by the works of Hopwood and Foss.84,85 
The successful combination of genes from the biosynthesis clusters of 
actinorhodin (20) and medermycin showed that the enzymes of structurally 
and genetically related polyketides could work together to form new 
“unnatural” polyketides.82 These results encouraged research in the field of 
aromatic polyketides because they suggested new ways to obtain 
unprecedented aromatic substances. Today, combinatorial biosynthesis is an 
inseparable part of natural product chemistry.  
In addition to in vivo studies, in vitro reconstruction of aromatic PKSs has 
contributed to the understanding of the detailed mechanics of PKS 
machinery.86,87 In order to engineer targeted aromatic polyketides, efforts have 
been made to unravel the molecular recognition features and structure-function 
relationships of these biosynthetic systems. However, there are still significant 
challenges to overcome to achieve specifically targeted metabolites. The most 
outstanding problems are the substrate specificity and compatibility of 
individual PKS components and their organizational tolerance to each 
other.4,83,84 In order to find compatible components for combinatorial 
biosynthesis, a large PKS gene repertoire encoding diverse polyketide 
structures is necessary. Additional methods to develop these repertoires via 
search for new interesting gene clusters in microbial genomes were reported. 
Among these methods is mining and activat on of cryptic gene clusters. These 
novel approaches look highly promising for the further development of natural 
product libraries.4,88,89 
Using tailoring enzymes to achieve targeted derivatisation of complex molecules 
is a novel idea to obtain diverse compounds whose implementation is currently 
investigated. Heterologous expression of polyketide genes furnishes an 
opportunity to develop new genetic-based strategies to implement this 
idea.56,60,90 Glycosyl transferases that possess substrate flexibility have been 
successfully utilized for the in vivo synthesis of novel glycosylated polycyclic 
aromatic polyketides.89,91-93 Novel oxygenases and methyl transferases are also 
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important tools for the research of new and efficient bio-combinatorial lead 
structure development.94  
On a different front, semisynthetic approaches to improve pharmacological 
activity of heterologously expressed polyketides were investigated e.g. the 
semisynthetic derivatives of fredericamycin (26).95 
1.8 Rubromycins and Griseorhodin A (5) 
Rubromycins are structurally unique among aromatic polyketides. They are 
quinone antibiotics possessing benzotetrahydrofuran and 
benzotetrahydrodipyran rings, linked in a spiroketal moiety wıth non-planar 
molecular architecture. Heliquinomycin (39) and β- and -rubromycin (37) are 
among the most potent known human telomerase inhibitors and they exhibit 
activity against HIV reverse transcriptase according to Goldmann et al. and 
Ueno et al.96,97 Compounds with opened spiroketal functionality, such as α-
rubromycin (40) are found to be inactive in telomerase assays. 97 These 
observations suggest that, pharmacological activity of the rubromycins depends 
strongly on their highly unusual spiroketal moiety. 97In addition, some members 
of the rubromycin family inhibit growth of bacterial strains remarkably.98 Well-
known representatives of the rubromycin family are shown in Figure 1.22. 
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Figure 1.22 Aromatic polyketides representing the rubromycin family.99 
The red pigment -rubromycin (37) was first isolated from cultures of a 
Streptomyces species by H. Brockmann et al. in 1970.100 Subsequently its 
structure was determined using chemical degradation and transformation 
reactions.100-102 Further structural investigations with modern spectroscopic 
methods were performed by C. L. Puder et al. in 2000.98 The absolute 
configurations of -rubromycin (37) and heliquinomycin (39) were determined 
by using quantum chemical CD calculations by G. Bringmann et al. in 2000.103 
Initial insights into the biosynthesis of rubromycins were obtained through 
feeding experiments of Streptomyces sp. A1, a native rubromycin producer, by 
Zeeck et al.98 The molecule was shown to be composed of twelve acetate units 
and a methoxy group that had been derived from L-methionine (42). However, 
the resultant labeling pattern of the molecule could not answer the question 
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whether the molecule was formed from one or two polyketide chains. Figure 
1.23 shows these results of the feeding experiments for rubromycin (37).98 
O O
O
O
O
O
CH3HO
O
OOH
O
CH3
O
CH3
O
OH
H2N
S
CH3
HO OH
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L-[methyl-
13
C] methionine (42) [U-
13
C3] malonic acid (43)
Rubromycin (37)
+
Figure 1.23 Labeling pattern of -rubromycin via feeding experiments with [U-
13C3]malonic acid.98 
The interesting structural and pharmacological features of the rubromycins 
motivated several synthetic approaches for the formation of the aromatic 
spiroketal moiety to be tried out. However the successful total synthesis of -
rubromycin (37) has not yet been achieved. Thus, placing the spiroketal 
function into a highly oxidized aromatic core is still an ongoing synthetic 
chemistry challenge. 104-108  
An important study that provides insights into the biosynthesis of rubromycins 
was performed by Minas, Bailey, and coworkers.109 They isolated a hexacyclic 
tridecaketid called collinone (41), a possible precursor of rubromycins. This 
compound was produced by heterologous expression of randomly chosen 30-50 
kb sized genomic DNA fragments of a putative rubromycin (37) gene cluster 
from the strain S. collinus DSM 2012 using S. coelicolor CH999 as a host. The 
compound collinone (41) has two more carbon atoms than the unmethylated 
core of rubromycins. This structural difference suggests that tailoring enzymes 
remove these carbons from collinone in order to construct the spiroketal moiety 
in the latter stages of biosynthesis. (Figure 1.24) However, their results could 
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not exclude the possibility that the expressed DNA belonged to another pathway 
unrelated to rubromycin (37) biosynthesis. 109 
The structure of collinone (41) with 26 carbon atoms suggests the hypothesis 
that the rubromycins (37) use a highly oxidized pradimicin-type aromatic core 
as a precursor for the construction of the spiroketal moiety. Pradimicin-type 
aromatic compounds have an angular aromatic core comprising of five aromatic 
rings in an arrangement called pentangular formation.110 (Figure 1.24) The 
enzymes and their gene sequences involved in the synthesis of the pentangular 
aromatic core of pradimicin (29) show significant similarities to the enzymes 
and genes involved in the biosynthesis of rubromycin (37) and fredericamycin 
A (26). Rubromycins and fredericamycins are aromatic bacterial polyketides 
with unique spiro centers distorting their aromatic cores. The biosynthetic 
pathways postulated for bacterial aromatic spiro compounds assume the 
presence of a key pentangular aromatic intermediate that acts as a substrate for 
the tailoring enzymes forming the spiro centers by complex oxidative 
modifications.15 Figure 1.24 shows the postulated intermediate and the 
aromatic polyketides exhibiting structural and biosynthetic similarities. 
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Figure 1.24 Postulated biosynthesis of aromatic polyketides involving a pradimicin type 
pentangular intermediate for the construction of aromatic spiro polyketides.15 Figure 
shows members of aromatic spiro compounds such as rubromycins with a spiroketal 
moiety and fredericamycines with a carbaspiro center.  
Griseorhodin A (5) is the most heavily oxidized member of the rubromycin 
family. It has human telomerase inhibition property and antibiotic activity like 
the other rubromycins.97 Its unusually heavily oxidized structure makes the 
biosynthesis even more interesting for research. Griseorhodin A (5) was 
discovered by Treibs et al. in 1961 during his work in the group of K. Eckardt.111 
The compound was isolated from Streptomyces californicus JA2640 and the 
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structure was elucidated in 1978.14,111-113 The griseorhodin A (5) biosynthetic 
gene cluster (Fig. 1.24) was isolated and sequenced by Piel et al.15 The producer 
was the marine bacterium Streptomyces sp. JP95, which was isolated from the 
marine tunicate Aplidium lenticulum in the Great Barrier Reef, Australia. This 
bacterium produces mainly griseorhodin A (5) and a number of other 
rubromycin- type compounds. Knockout studies on the natural producer to 
prove that the isolated genes were involved in griseorhodin A production were 
not successful. The natural producer was not compatible with the methods that 
had to be used. In order to overcome this problem, the isolated cluster was 
transferred into the heterologuous host Streptomyces lividans.15 The gene 
cluster was successfully expressed. This developed expression system proved 
that the isolated cluster contained all the necessary genes for the biosynthesis of 
the compound, opening the way for further gene deletion experiments.15 
 
Figure 1.25. Griseorhodin A gene cluster and the suggested function of the genes assigned 
by the alignment results. 15 The alignment of the genes are shown in Table 1.1. 
The cluster shown in Figure 1.25 has a size of 34.2 kb and contains 33 ORFs. 
According to database homologies, 9 ORFs are core PKS genes, 11 ORFs are 
tailoring genes, 4 ORFs are involved in regulation and resistance, and 9 genes 
have unknown functions.15 Table 1.1 lists the alignment results for the 33 ORFs 
of the cluster and the proposed functions of the encoded proteins. 
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Table 1.1 Deduced functions of the open reading frames (ORF) of the grh 
cluster. 15 
Protein Proposed Function Sequence Similarity 
Similarity 
/Identitiy 
GrhR1 Transcriptonal activator TylS, Streptomyces fradiae114 77%/65% 
GrhR2 Transcriptonal activator SAR,  
Streptomyces ambofaciens114 
85%/74% 
GrhD Thioesterase ORF5, Streptomyces rochei115 68%/58% 
GrhC ACP ORF3, Streptomyces rochei115 63%/52% 
GrhE CYC SimA5, Streptomyces 
antibioticus116 
51%/35% 
GrhF Phosphopantetheinyl 
transferase 
Gra-ORF32, Streptomyces 
violaceoruber117 
48%/39% 
GrhG Acetyl-CoA carboxylase PgaI, S. sp. Pga64 88%/81% 
GrhH Unknown   
GrhI Unknown   
GrhO1 FAD-dependent oxygenase MitR, Streptomyces lavendulae118 57%/44% 
GrhO2 2-oxoacyl-ACP reductase Mtm TII, Streptomyces rimosus68 61%/50% 
GrhO3 Cytochrome P450 PteD, Streptomyces avermitilis 70%/55% 
GrhO4 Ferredoxin PteE, Streptomyces avermitilis 73%/60% 
GrhJ Unknown Dra0019, Deinococcus radiodurans 41%/31% 
GrhO5 FAD-dependent 
monooxygenase 
DntB, Burkholderia sp. RASC119 56%/44% 
GrhR3 MarR family regulatory 
protein 
2SCD64.11, Streptomyces 
coelicolor 
57%/44% 
GrhO6 FAD-dependent 
monooxygenase 
MtmOIV, Streptomyces 
argillaceus120 
56%/45% 
GrhO7 NADPH:quinone 
oxidoreductase 
ActVI ORF2121 59%/43% 
GrhK Efflux protein UrdJ, Streptomyces fradiae122 58%/40% 
GrhL Methyltransferase TcmO, Streptomyces argillaceus123 60%/47% 
GrhO8 FAD-dependent 
monooxygenase 
DntB, Burkholderia sp. RASC119 55%/40% 
GrhO9 FAD-dependent 
monooxygenase 
DntB, Burkholderia sp. RASC119 57%/44% 
GrhM Unknown ORF5, Actinomadura hibisca124 47%/36% 
GrhN Unknown Rv0580c, Mycsobacterium 
tuberculosis 
48%/30% 
GrhP Asparagine synthase TcsG, Streptomyces aureofaciens 58%/46% 
GrhQ CYC RubE, Streptomyces collinus 89%/78% 
GrhS Unknown RubD, Streptomyces collinus 81%/75% 
GrhA KS RubA, Streptomyces collinus 91%/85% 
GrhB KS RubB, Streptomyces collinus 83%/77% 
GrhT Bifunctional CYC-3-oxoacyl-
transferase 
RubF, Streptomyces collinus 77%/69% 
GrhO10 3-oxoacyl-ACP reductase RubG, Streptomyces collinus 87%/79% 
GrhU Unknown RubH, Streptomyces collinus 83%/72% 
GrhV Unknown ORF9, Actinomadura hibisca124 54%/38% 
 
According to alignment results (Table 1.1), genes encoding the minimal PKS of 
the griseorhodin A cluster are grhA, grhB, and grhC, which can be identified by 
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their sequence homology to the other PKS II systems. These genes are 
responsible for the synthesis of the open-chain polyketide precursor. An 
interesting feature of the cluster is that the ACP gene grhC is located 26 kb 
upstream from the two KS/ORFs, representing a rare case of disconnected 
minimal PKS compared to the grouped minimal PKS of rubromycin sequence. 
There are twelve putative redox-tailoring enzymes. grhO1 is a rare 
oxidoreductase gene. The enzyme has a covalently bound flavin-adenine 
dinucleotide (FAD) as a cofactor.15 GrhO3 is a similar to oxygenase of the 
cytochrome P450 family. GrhO4 is very similar to many ferrodoxin proteins and 
it functions as a component of the P450 oxygenase. GrhO3. GrhO5, GrhO6, 
GrhO8, GrhO9 have homologies to FAD-dependent monooxygenases. GrhO6 has 
a very close homology to a rare Baeyer-Villiger-type monooxygenase of the 
mitramycin cluster (MtmOIV) 120. GrhO7 gene aligns well with the genes of the 
enzymes of the NADPH:quinone oxidoreductase/ζ- crystalline (QOR) group 
which catalyze one-electron transfer reactions from quinone to semiquinone 
radicals. GrhO2, GrhO10, and the C-terminal half of GrhT have end to end 
similarities to enzymes of the short chain dehydrogenase/reductase (SDR) 
family. Other proteins structurally related to these redox enzymes are FabG 
enzymes from fatty acid biosynthesis that have 3-oxoacyl-ACP reductase 
function.15 Regulatory genes, grhR1 and grhR2 have functions in the 
transcription control of the metabolites. Their sequences are similar to the 
sequences of the transcriptional activators of the Streptomyces antibiotic 
regulatory protein (SARP) family. GrhR3 has high homology to transcriptional 
repressors of the MarR family.15 The proposed function of this protein is to 
control the transport of the synthesized antibiotic and impart self-resistance to 
the producer. 
There are several genes on the cluster encoding proteins with unknown 
functions. Alignment studies did not provide any clues about the functions of 
the proteins encoded by the genes grhH, grhI, grhJ, grhM, grhN, grhP, grhT, grhU 
and grhV.15 
For the accessory genes, a more recent alignment study was carried out by 
Kathrin Rheinhardt in the Piel group in order to determine sequence 
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similarities to other structurally similar polyketides such as rubromycins (37), 
fredericamycin (26) and pradimicin (29).125 Accessory enzymes are 
responsible for the cyclization of the open chain precursor. The involvement of 
at least two cyclases is expected. In addition, the genes grhS, grhT and grhQ are 
possible candidates to encode the cyclases and aromatases function. Recent 
research on fredericamycin (26) and pradimicin (29) cluster genes suggests 
that the proteins GrhU and GrhV could also be involved in cyclization and 
oxygenation steps for the formation of the pentangular aromatic precursor.15,125  
Another result of this study is that the protein GrhJ has a sequence similar to a 
N-Acetyl-transferase GNAT protein. 125 It is reported that type-I PKSs sometimes 
use GNATs to incorporate acetyl starter-unit into complex polyketides.147 
Based on these homologies, it is hypothesized that griseorhodin A (5) could be 
synthesized by a large number of complex oxidative steps acting on a 
tridecaketide aromatic precursor. The biosynthesis postulated in 2002 is shown 
in the Figure 1.26.15 
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Figure 1.26.Initially postulated biosynthetic pathway leading to the formation of 
griseorhodin A via the hypothetical intermediate didehydrocollinone (45).15 
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2 GOALS OF THE THESIS 
The main objective of this work is the testing of the hypotheses on the 
biosynthesis of the bacterial aromatic polyketide griseorhodin A (5), shown in 
Figure 2.1. Background information about the aromatic polyketide griseorhodin 
A can be found in the introduction. The most important and pertinent 
characteristics of this compound are its highly oxidized nature and its 
pharmacologically important spiroketal moiety. The biosynthesis of this 
polyketide is a current research topic of the research group Piel.  
 
The griseorhodin A gene cluster was isolated and heterologously expressed by 
A. Li. 15In addition, she reported a bioinformatic analysis of the genes on the 
cluster. Assuming the functions of several genes, the biosynthetic pathway 
investigated in this thesis was postulated.15 The postulated biosynthesis 
involves the actions of several tailoring enzymes. 
In order to prove the functions of the genes encoding the tailoring enzymes and 
to investigate the role of the genes with unknown functions, heterologous 
expression systems of individual single gene deletion mutants of the 
griseorhodin A cluster in S. albus host strain had to be obtained and the 
produced metabolites had to be chemically investigated. This chemical 
investigation is summarized in this thesis. For this investigation, 19 single gene 
knockout strains were used, which were successfully produced via λ-red-
mediated gene deletion and the conjugation of these clusters into the expression 
strain Streptomyces albus J1074 in a concomitant work by K. Reinhardt.99,125 In 
O O
O
MeO
O
O
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OH OH O
HO
O
Griseorhodin A (5)
Figure 2.1 The structure of the aromatic polyketide griseorhodin A (5). 
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each mutant strain a different protein involved in the biosynthesis was 
deactivated by deleting the corresponding gene. To obtain insights into the 
biosynthesis of griseorhodin A (5), the metabolites produced by each single 
gene deletion strain had to be investigated to deduce the function of the deleted 
gene and its corresponding protein in the biosynthetic pathway. Figure 2.2 
shows the griseorhodin A gene cluster and the pictures of the 19 one-gene 
knockout strains used for the studies of the pathway.  
 
Figure 2.2 The Griseorhodin A gene cluster and the pictures of the 19 single gene-
knockout strains of the cluster. The cluster contains 33 ORFs. In order to investigate the 
functions of the proteins and the biosynthesis of the compound, 19 single genes of the 
cluster were deactivated by deletion, and the modified clusters were heterologously 
expressed in S. albus host strain. The picture shows the position of each gene on the 
cluster and the heterologous expression strains carrying the deletion of the 
corresponding gene. In the picture of each mutant strain, the deactivated gene is 
indicated. 
In order to achieve the objective of testing the hypothesized pathway, this study 
focuses on the identification of the enzymes involved in the construction of the 
highly unusual spiroketal moiety, the determination of the enzymes essential 
for the epoxidation, the investigation of functions of the genes that were 
formerly reported to have unknown functions and the detailed discussion of the 
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biosynthetic route of griseorhodin A (5) with emphasis on the compounds 
isolated during this study.  
Specifically, the goals of this study were to investigate the metabolites of the 
aforementioned single gene deletion strains, to provide optimized analytical 
methods for screening the extracts using different techniques such as HPLC and 
LC-MS/MS, to develop isolation and purification steps for intermediates and to 
elucidate their structures using HRMS and NMR techniques as well as other 
spectroscopic methods.  
An inseparable part of this project was the examination of better fermentation 
conditions for Streptomyces albus mutants using baffled flasks. The 
fermentations had to be performed in 10-20 L scale in order to obtain 10-20 mg 
of pure compounds for structure elucidation. These amounts were necessary for  
analytical measurements and also for further pharmacological activity assays of 
the compounds, which were partially performed by different collaborators.  
During this work an assay with the overexpressed unusual oxygenase GrhO6 
related to Baeyer-Villigarases also had to be performed to investigate its 
enzymatic activity 
The absolute configurations of griseorhodin A (5) and of some of the other 
novel isolated polyketides had to be determined in collaboration with the group 
of Prof. Dr. G. Bringmann at the University of Würzburg. 
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3 RESULTS AND DISCUSSION 
3.1 Heterologous Expression in the Streptomyces albus Host 
Functional studies of the griseorhodin A (5) gene cluster were performed after 
the entire cluster was heterologously expressed in the host expression strain 
Streptomyces albus J1074.99,125 The use of Streptomyces albus J1074 enables the 
integration of the entire cluster as well as the engineered variants into the host 
strain’s genome red-mediated gene deletion and the conjugation of these 
clusters into the expression strain. This allowes the production of sufficient 
amounts of complex metabolites heterologously not only on agar plates, as is 
the case for other Streptomyces hosts, but also in liquid media. 74 
 This property of the host strain facilitates the production of large amounts of 
metabolites. However, in order to obtain the desired quantities, a few 
challenging issues needed to be resolved. The production efficiency of the S. 
albus mutants varies significantly according to the growth conditions such as 
growth medium, temperature, time and the genes inserted into the genome. 
Moreover, the metabolism of the cultured organism switches at a certain stage 
of the life cycle to sporulation mode inhibiting the production of secondary 
metabolites.74 Finally, the expression of highly oxidized secondary metabolites 
necessitates an adequate oxygen supply from the environment. Therefore, 
either baffled or normal Erlenmeyer flasks containing spiral-steel wires were 
used in order to provide sufficient oxygen to the growth medium during the 
fermentation process in the experiments discussed in this thesis.  
3.1.1 Determination of the Growth- and Production Curve of S. albus 
MP66 
An experiment with the grhO6 gene deletion strain S. albus MP66 was 
conducted to obtain insights into the fermentation process. During the 
experiment, the expression of metabolites and the growth of the bacteria were 
monitored. Since various pigments produced by the strain show strong UV 
absorptions in a broad range, the expression of polyketides related to the 
aromatic quinone compound griseorhodin A (5) were monitored by measuring 
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their absorption at 488 nm. This wavelength is chosen because it is a specific 
absorption maximum of the aromatic quinone function of griseorhodin-type 
compounds. The cell density (OD) of S. albus MP66 was monitored by measuring 
the absorption at the wavelength of 600 nm, which is the wavelength generally 
used to observe bacterial growth. However, the strong absorption of the 
produced pigments and the occurrence of cell clumping during growth 
prevented the accurate determination of bacterial density. Therefore, to 
monitor bacterial growth more accurately, the biomass of the mycelium was 
determined. The bacterium was separated by centrifugation, freeze-dried, and 
weighed so that for each measuring point, the biomass of the bacteria could be 
determined. The details of the experimental procedure are explained in Section 
4.1.5.1. Table 3.1 shows the results of the experiments.  
Table 3.1 Biomass and expression data during the growth of S. albus MP66. 
Measuring point ΔT time [h] OD600 [nm] OD488 [nm] Δ Biomass [mg] 
0 0 0.035 0.05 18 
1 17 0.06 0.11 120 
2 20.5 0.12 0.27 183 
3 40.5 0.88 1.94 327 
4 44.5 1.18 2.99 346 
5 63 1.46 3 342 
6 68.5 1.68 3 362 
7 88.5 1.80 3 389 
8 100 2.55 3 485 
  
Figure 3.1 shows the absorption at 488 nm of the pigments during the 
incubation period. As a result of this experiment, it was concluded that the 
expression reaches a maximum after two days and remains constant up to the 
last measuring point at 88 hours.  
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Figure 3.1 Absorption at 488 nm of the pigments expressed by S. albus MP66 with respect 
to the incubation period . 
The growth curve in Figure 3.1 shows that the strain needs two days to achieve 
maximum production of the metabolites. After four days of incubation, the 
bacteria enter the sporulation phase, during which the secondary metabolite 
production of the strain is suppressed. (Figure 3.2B) The growth curve of the 
cell density values at OD600 shows a steady increase up to the fourth day and a 
rapid increase in growth after that. (Figure 3.2A) The biomass increases rapidly 
in the first two days. The biomass production slows down in the following two 
days. During this period, the absorption measured at 488 nm attains its 
maximum value. This behavior is additional evidence that the strain slows down 
its growth while expression of secondary metabolites occurs. At the last 
measuring point, which shows the amount of bacteria after 100 hours of 
incubation, an increase in the biomass can be observed. At this point, the 
bacterium starts sporulation, suppressing the expression of the secondary 
metabolites. (Figure 3.2B) As a result of these observations, it was concluded 
that four days was a reasonable time period for the incubation of the test strain 
S. albus MP66 in order to obtain the maximum amount of secondary metabolites 
and start the extraction procedure to isolate the compounds in the fermentation 
broth. 
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Figure 3.2 Growth of S. albus MP66. A. Growth of the strain with respect to the incubation 
time measured using absorption at 600 nm. (OD600 values) B. Biomass of the strain with 
respect to incubation time 
3.1.2 Fermentation Media of the Mutant Strains 
The yields of secondary metabolites vary according to growth media. In the 
literature, six different types of media for S. albus can be found. A. Li et al. 15 
reports that LB and TSB growth media are the most efficient media for the 
fermentation of S. albus. On the other hand, for cultivation on plates, 2CM and 
MS agar plates are recommended. To determine the appropriate fermentation 
medium, small-scale fermentations of each strain in LB and TSB were 
performed. The medium providing the best expression was chosen, and the 
yield of the crude extract was determined. Table 3.2 summarizes the results. 
The amounts of crude extract obtained for each mutant strain vary significantly. 
The difference between masses could also be due to the metabolites other than 
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griseorhodin-type metabolites such as lipids. Table 3.2 shows the best growth 
medium for each strain for fermentation. Additionally, yields of the crude 
extracts obtained from small-scale fermentations in 400 mL after extraction 
with ethyl acetate in acidic conditions are listed. The ingredients of various 
growth media are listed in Section 4.1.1. The fermentation procedures are in 
Section 4.1.2.3 and 4.1.2.4. 
Table 3.2 Fermentation conditions and yields of the crude extracts of the 
strains. 
S. albus mutants   Growth medium 
Medium extract 
(mg/400 mL) 
Mycelium extract 
(mg/400 mL) 
S. albus MP31 LB 28 20 
S. albus KR13 LB 50 20 
S. albus KR5 TSB 108 30 
S. albus KR42 LB 83 9 
S. albus KR8 TSB 123 49 
S. albus MP66 LB 83 59 
S. albus KR7 LB 99 56 
S. albus KR40 LB 95 16 
S. albus KR11 TSB 73 50 
S. albus KR53 LB 54 28 
S. albus KR41 LB 99 24 
S. albus KR15 LB 55 42 
S. albus MP63 LB 61 31 
S. albus J1074 TSB 54 21 
S. albus J1074 LB 27 12 
 
The yields obtained from small-scale fermentations are not indicative for large-
scale fermentations. The follow-up large-scale fermentations performed for 
most of the strains exhibited nonuniform production properties and yields. 
Possible reasons for this behavior are the high sensitivity of the host strain to 
small changes in the fermentation environment and the possible phenotype 
differences of the bacteria used for inoculation. 
 In conclusion, it is obvious that the different mutant strains produce very 
different amounts of secondary metabolites and need different fermentation 
conditions for the expression, despite the fact that the host bacteria used for the 
expression are the same. The mutations on the expressed gene cluster and the 
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produced metabolites influence the growth and the expression behavior of the 
host bacteria strongly. 
 
3.1.3 Gene Deletion Strains of the Griseorhodin A Cluster 
In the work of A. Li et al. a strain containing the entire grh cluster, termed S. 
albus MP31, was constructed.15 In addition, four gene deletion strains, S. albus 
MP66, S. albus MP36, S. albus MP70 and S. albus MP63, of the grh cluster were 
prepared by using restriction sides in the gene regions. The genes grhO6, 
grhI+O1, grhR2 and grhO10 were deactivated in that study. These strains were 
used for initial experiments during this PhD thesis. The list of the mutant strains 
prepared by A. Li are in Table 3.3.  
Table 3.3 List of all gene deletion strains prepared by A. Li.  
Number S. albus  mutants  Deleted gene region 
Proposed function of the 
missing protein 
1 S. albus MP31 Entire grh cluster ---- 
2 S. albus MP70 ΔgrhR2 
SARP gene (Regulatory 
protein) 
3 S. albus MP66 Δ grhO6 
FAD-dependent 
monooxygenase  
4 S. albus MP36 ΔgrhI+ΔgrhO1 
GrhI: unknown, GrhO1: 
Covalently bond FAD-
dependent oxygenase 
5 S. albus MP63 Δ grhO10 3-Oxoacyl-ACP reductase 
 
S. albus MP70 is a mutant with a deactivated grhR2 gene region. GrhR2 was 
thought to have a regulatory function. However, deactivation of the gene did not 
affect the production of griseorhodin A (5). Hence it was concluded that grhR2 
was not directly involved in the biosynthesis steps. The putative oxidoreductase 
GrhO10 was supposed to be a tailoring enzyme. Biosynthesis did not occur 
properly and no pigments were produced during the expression of the strain 
with the deactivated grhO10 gene. This is evidence that this gene has a more 
essential role in biosynthesis than a mere tailoring function. The strains S. albus 
MP66 and S. albus MP36 produce colored pigments different from those of S. 
albus MP31, which expresses griseorhodin A (5) as a red colored pigment. The 
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successful expression observed for the mutant strains enabled to apply the 
method of studying the biosynthesis of the compound by deactivating single 
genes of the cluster and expression in a S. albus host strain in order to 
characterize the accumulating intermediates. This enables to assigne the 
functions of many tailoring enzymes on the cluster. 
 In order to realize this goal, K. Reinhardt prepared an additional 17 single gene 
knockout strains by an advanced and more reliable molecular biological method 
using recombination sites to delete a specific gene region precisely. Inactivation 
of the corresponding genes was performed by λ Red-mediated recombination 
on pMP31.125 Primers specific for flanking griseorhodin A gene regions and a 
template plasmid pIJ778, which harbors the spectinomycin resistance gene 
aadA, were used. The prepared recombination cassettes were subsequently 
electroporated into E. coli containing pMP31.99 The resistance gene was 
subsequently removed by selection of spectinomycin-resistant clones carrying 
the aadA gene instead of the target gene and subsequent performens FLP-
mediated excision or SpeI restriction and religation. In this way, deletion of 17 
individual genes from the gene cluster was acomplished. Each gene cluster was 
transferred by conjugation into S. albus, which enables a stable integration into 
the genomic attB site. The host strains were grown and used for heterologous 
polyketide production in the course of the biosynthesis study.99,110 The details 
of the molecular biological methods used can be found in the PhD thesis of K. 
Reinhardt.125 Besides the strain MP66, new strains were created for expression 
and gene function studies. The list of the strains obtained and utilized in this 
PhD thesis is given in Table 3.4. Figure 3.3 displays the clear differences in 
morphological appearances caused by the different coloration of the produced 
metabolites.  
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Table 3.4 List of S. albus MP31 containing the entire griseorhodin A (5) cluster 
and all gene deletion strains used for the biosynthetic study and the assumed 
functions of the deleted genes.  
Number S. albus mutants Deleted gene 
Proposed function of the 
missing protein 
1 S. albus MP31 ---- ---- 
2 S. albus KR13 ΔgrhD Thioesterase 
3 S. albus KR5 ΔgrhO1 FAD-dependent oxygenase 
4 S. albus KR42 ΔgrhJ N-Acetyltransferase (GNAT) 
5 S. albus KR8 ΔgrhO5 
FAD-dependent 
monooxygenase 
6 S. albus MP66 ΔgrhO6 
FAD-dependent 
monooxygenase 
7 S. albus KR7 ΔgrhO7 
NADP:quinone 
oxidoreductase 
8 S. albus KR40 ΔgrhL Methyl transferase 
9 S. albus KR11 ΔgrhO8 
FAD-dependent 
monooxygenase 
10 S. albus KR53 ΔgrhO9 
FAD-dependent 
monooxygenase 
11 S. albus KR41 ΔgrhM Unknown 
12 S. albus KR15 ΔgrhP Asparagine synthetase 
13 S. albus MP63 ΔgrhO10 3-Oxoacyl-ACP reductase 
14 S. albus KR27 ΔgrhH Unknown 
15 S. albus KR4 ΔgrhI Unknown 
16 S. albus KR39 ΔgrhO2 2-Oxoacyl-ACP reductase 
17 S. albus KR43 ΔgrhO3 Cytochrome P450 
18 S. albus KR23 ΔgrhN Unknown 
19 S. albus KR61 ΔgrhU Unknown 
20 S. albus KR58 ΔgrhV Unknown 
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Figure 3.3 Morphological appearances of the mutant strains used for biosynthesis 
pathway investigation. 
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After the fermentation of the various strains in liquid medium, as listed in the 
Table 3.2, the mycelium and the liquid medium were separated by 
centrifugation as described by Eckardt et al. for the isolation of griseorhodin A 
(5).14 A detailed description of the general extraction can be found in Section 
4.1.5.2. Afterwards, these crude extracts were analyzed on HPLC and TLC plates. 
This analysis revealed that several extractable pigments were produced by the 
mutant strains that were not produced by the native host strain. These 
pigments, which might be intermediates of griseorhodin A biosynthesis or a 
shunt products of the pathway, had to be characterized. After comparing of the 
TLC fingerprints of the extracts obtained from the mutant strains to the wild 
type S. albus strain, it was found out that new metabolites were produced in 
addition to the metabolites of the wıld type host strain. This observation 
showed that the host strain produces metabolites unrelated to the griseorhodin 
biosynthesis even though the wild-type host strain supposedly does not contain 
any other polyketide gene clusters. It was observed that these compounds are 
expressed mostly during the fermentation period in liquid medium. The 
experiments revealed that these impurities strongly disturb the HPLC and LCMS 
analysis of the crude extract; furthermore, the impurities prevented the LCMS 
and HPLC analysis from identifing molecular ions of the new metabolites. To 
charecterize the compounds, which could be potential intermediates of 
griseorhodin A biosynthesis, and, which should be isolated from these extracts, 
another set of experiments were conducted.  
It is known that griseorhodin A (5) accumulates on the bacteria during the 
production period. Because of its insolubility in water, similar aromatic 
intermediates were expected to gather on the mycelium as well. It was found 
that less complex extracts of the cells could be obtained, when the strains were 
grown on 2CM and MS agar plates, thus simplifying analysis of the respective 
pathway. The cell extracts obtained from 2CM agar cultures had the least 
impurities. In several cases, the precursor compounds and metabolites were 
observed as single peaks during HPLC analysis, which helped to provide more 
valuable information for the LCMS measurements of the fermentation extracts. 
Nevertheless, the amounts of the compounds obtained from agar plate extracts 
were not sufficient for the isolation of potential intermediates. Therefore, large-
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scale fermentations in LB or TSB medium were used for full structural 
elucidation of the compounds. Figure 3.4 shows the procedure used for the 
investigation of these extracts in a flow chart. 
 
Figure 3.4 The procedure used for the investigation of these extracts in a flow chart. 
.   
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3.2 HPLC and LC-HRMS Analysis of the Strains 
To obtain an overview of the metabolites, strains were grown on 2CM agar 
plates. Details of the cultivation are given in Section 4.1.2.2. The bacteria with 
pigments were scratched off and extracted for HPLC, LC-MS and TLC analysis. 
The procedure for the extraction and the details of the procedures for preparing 
the probes are described in Section 4.1.5.2. The molecular ions of the detected 
metabolites were determined by LC-HRMS. Figure 3.5 shows the HPLC profile of 
the griseorhodin A (5) producing strain MP31, which contains the entire grh 
cluster for the expression. Figure 3.5 also shows the profiles of the mutant 
strains with deactivated grh genes and the predicted molecular formulae of the 
compounds according to the molecular ions characterized using LC-HRMS 
analysis. Table 3.5 shows the predicted molecular formulae according to the 
molecular ions characterized during LC-HRMS analysis of the single gene 
deletion mutants. The putative functions of the deactivated genes are also 
shown in Table 3.5. 
These results show that the mutant S. albus strains KR13, KR27, KR4, KR39, 
KR23 still produce the compound griseorhodin A (5). The genes inactivated 
through deletion from these mutant strains are grhD, grhH, grhI, grhO2 and 
grhN respectively. It seems that proteins expressed by these genes are either 
nonfunctional for the biosynthesis of griseorhodin A (5) or other genes on the 
cluster can take over the functions of the deleted gene so that the biosynthesis 
of the compound is not interrupted. The effect of the genes involved in tailoring 
steps can be observed directly from the oxygen and carbon numbers in 
respective molecular formulae. 
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Figure 3.5 HPLC profile of the extracts and the predicted molecular formulae of the 
compounds according to the molecular ions characterized using LC-HRMS. The first 
extract is obtained from griseorhodin A (5) producing strain S. albus MP31, which 
contains the entire grh cluster for the expression. The HPLC profiles obtained from the 
extracts of the mutant strains with a deactivated grh gene and the predicted molecular 
formulae of the major compounds are also shown. The bacterial extracts were obtained 
by cultivation on 2CM agar plates. 
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Table 3.5 HR-LCMS analysis of the strains. Data are shown for the most 
prominent compounds observed in the bacterial extract obtained by cultivation 
on 2CM agar plates. 
S. albus 
strain 
Deleted 
ORF 
Putative protein function 
Measured 
m/z [M+H]+ 
Predicted 
Molecular 
formula 
JP95a ---- ---- 509.0720 C25H16O12 
MP31b ---- ---- 509.0720 C25H16O12 
KR13 grhD Thioesterase 509.0717 C25H16O12 
KR27 grhH Unknown 509.0720 C25H16O12 
KR4 grhI Unknown 509.0717 C25H16O12 
KR39 grhO2 Ketoreductase 509.0720 C25H16O12 
KR23 grhN Unknown 509.0711 C25H16O12 
KR43 grhO3 Cytochrome P450 495.0922 C25H18O11 
KR7 grhO7 
NADPH: quinone 
oxidoreductase 
495.0922 C25H18O11 
KR42 grhJ 
GCN5-related N-
acetyltransferase family 
493.0769 C25H16O11 
521.0716 C26H16O12 
457.0921 C26H16O8 
MP66 grhO6 FAD-dependent oxygenase 
337.0550 C15H12O9 
521.0720 C26H16O12c 
KR8 grhO5 FAD-dependent oxygenase 535.0877 C27H18O12 
KR53 grhO9 FAD-dependent oxygenase 505.1120 C27H21O10 
KR15 grhP Amido transferase 
491.0975 C26H18O10 
507.0922 C26H18O11 
981.1870 C52H36O20 
KR11 grhO8 FAD-dependent oxygenase 477.1150 C26H20O9 
KR40 grhL Methyl transferase 
489.0785 C26H16O10 
471.0695 C26H14O9 
KR41 grhM Unknown 459.1050 C26H18O8 
KR5 grhO1 
Oxygenase with covalently 
bound FAD 
537.1021c C27H20O12c 
MP63 grhO10 3-Oxoacyl-ACP reductase n.d.d n.d.d 
KR61 grhU Unknown n.d.d n.d.d 
KR58 grhV Unknown n.d.d n.d.d 
 
awild-type griseorhodin producer 
bS.albus carrying the entire grh cluster 
cmodified fermentation and extraction protocol 
dpolyketides bound irreversibly to chromatographic stationary phases or the amount of the 
expressed compounds in the extract were not enough to obtain a molecular ion. 
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Due to the postulated biosynthesis that starts with one initial poly-β-keto chain, 
which is subsequently folded into a pentangular aromatic scaffold and 
methylated, it was expected to obtain intact intermediates with a molecular 
scaffolds having up to 26-27 carbon atoms, depending of O-methylation. 
Molecular ions matching this found could be detrmined in the analysis of the S. 
albus strains KR8, KR53 and KR5, which have the genes for oxygenases grhO5, 
grhO9 and grhO1 deactivated, respectively. These compounds have also the 
highest number of oxygen atoms in their scaffolds. This suggests that these 
deleted oxygenase genes might be involved in oxidation steps resulting in the 
elimination of two carbon atoms of intermediates containing 26 or 27 carbon 
atoms in order to generate the spiroketal compound griseorhodin A (5) with 25 
carbon atoms. Other interesting compounds were observed in the extract of the 
S. albus strain MP66 and KR42, which contain 26 carbon atoms. The evidence 
that the extract of the S. albus strain MP66 and KR42 contain 26 carbon atoms 
shows that the enzyme GrhO6 and the protein GrhJ had a function after a step 
causing the lost of a carbon atom. Extracts of the S. albus strain KR7 and KR43 
contained a highly oxidized intermediate with 25 carbon atoms and 11 oxygen 
atoms. The deactivated proteins probably act during the last steps of the 
biosynthesis. There are compounds in the extracts of the strains KR41 and KR11 
containing 26 carbons but a fewer number of oxygen atoms. This situation may 
indicate an involvement of the deleted proteins in the early oxygenation steps of 
the aromatic polyketide prepared by cyclases and aromatases. The mutant 
strains MP63, KR61 and KR58 showed an observable change in the expression 
on the agar plates in comparison to the wildtype S. albus host. However, there 
were no colorful pigments to observe, and the extracts contained insufficient 
amounts of compounds to determine molecular ions of the metabolites. The 
strain KR15 expressed a few colorless compounds, which diffused into the agar. 
Therefore, the agar was extracted and the molecular ions for the compounds in 
the extract were determined.  
Strains determined by the experiments to produce important metabolites in 
sufficient amounts were used for large scale fermentations from 12 L up to 20 L, 
and the detected components were isolated from the fermentation extracts in 
order to further characterize their structures.  
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3.3  TLC Analysis of the Fermentation Extracts 
In order to compare the components and production of the mutant strains, a 
TLC analysis of the prepared mycelia and medium extracts were performed as 
described in Section 4.1.4.3 in detail. The crude extract was dissolved in the 
mobile phase CHCl3:MeOH (9:1). As a stationary phase, silica plates 
impregnated with 2 M NaH2PO4 or KH2PO4 were used. It was better to use 
impregnated plates, since they simplified the detection of polar compounds. 
Impregnating the silica material before use prevents the polar aromatic 
phenolic compounds and griseorhodin type of compounds from attaching on the 
material. Depending on the pKa value, these compounds become deprotonated, 
and form strong interactions on silica materials. Impregnation of the silica 
plates results in full protonation and decrease of polarity of the analytes, thus 
improving chromatographic behaviour. The same principle also helps during 
flash chromatographic purification of the extracts containing phenolic aromatic 
compounds. The procedures of the impregnation and chromatographic 
applications are elaborated in detail in Section 4.1.4.2 and Section 4.1.4.1. Figure 
3.6A shows the TLC analysis of the medium extracts obtained from the 
fermentation of the strains in the medium mentioned in the Table 3.2. The 
extracts of mycelium can be seen in Figure 3.6B, which shows that the mycelia 
contain more compounds and are less complex than the extracts of the 
fermentation medium shown in Figure 3.6A. The main reason is that the 
compounds were usually insoluble and stuck on the bacterial cell wall during 
fermentation. In many cases for purification, the mycelia extract was used since 
the purification of the compounds from the medium extracts was more time 
consuming and the yield of the compound was insufficient. It was also observed 
that most extracts of the mutant strains, which had an oxygenase deactivated, 
contained red pigments similar to the compound griseorhodin A (5). On the 
other hand, strains such as S. albus KR11, S. albus KR41, S. albus MP63 and S. 
albus KR15 produced rather darker pigments, which were not retained on the 
silica material. S. albus MP63 and S. albus KR15 did not produce a metabolite in 
adequate yields which could be purified further by these chromatographic 
methods.  
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Figure 3.6 TLC analysis of the fermentation extracts. The bacterial extracts were obtained 
using fermentation in liquid medium. As stationary phase, NaH2PO4 impregnated silica 
was used and the mobile phase used was CH3Cl:MeOH (9:1). A. The medium extract of the 
griseorhodin A (5) producing strain S. albus MP31, which uses the entire grh cluster for 
the expression, and the medium extract of the mutant strains with a deactivated grh gene 
were compared. B. The mycelium extract of the griseorhodin A (5) producing strain S. 
albus MP31, which uses the entire grh cluster for the expression, and the mycelia extracts 
of the mutant strains with a deactivated grh gene were compared. The first and second 
spots are the extracts of the host strain S. albus expressed in LB and TSB growth medium.  
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3.4 Isolation and Characterization of Compounds 
The metabolites identified by HRMS as potential intermediate had to be isolated 
in order to elucidate their structure. For measurements and bioactivity assays at 
least 10 mg of compound was necessary. Therefore strains had to be fermented 
in liquid medium. The griseorhodin A (5) producer strain S. albus MP31 and the 
mutant strains S. albus KR7, S. albus KR8, S. albus MP66, S. albus KR5, S. albus 
KR53, S. albus KR41 and S. albus KR11 were fermented in suitable media. The 
general procedure for the isolation a griseorhodin type metabolite is in Section 
4.1.5.4. However, regarding to the properties of the extracts and compounds, 
this procedure was customized according to the properties of the metabolites 
and compounds to be isolated. These customized procedures are described 
further in the Section 4.1.5. 
3.4.1 Isolation and Determination of Absolute Configuration of 
Griseorhodin A (5) 
3.4.1.1 Isolation of Griseorhodin A (5) 
Griseorhodin A (5) was first isolated as a red water insoluble pigment by 
Eckard et al. Tressolt et al. and Zeeck et al. worked on completing the structure 
elucidation.98,112,113 However, its absolute configuration was not determined. 
For the determination of the absolute configuration as well as potential 
biological and pharmacological activities, the compound was isolated from the 
fermentation extracts of the expression strain S. albus MP31, which contained 
the entire griseorhodin A cluster.  
For the identification of the compound, the molecular ion was measured by HR-
ESI-MS analysis with a predicted molecular formula C25H16O12 (509.069 
measured [M+H]+, 509.072 calculated [M+H]+). Figure 3.7 shows the HPLC trace 
of the strain extract from which the compound was isolated, as well as the UV 
absorption spectrum and the total ion current of the peak belonging to 
griseorhodin A (5). 
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Figure 3.7 HPLC trace, UV absorption and the LC-HRMS data of griseorhodin A (5). A. UV 
bsorption of the compound. B. HPLC trace of the mycelia extract obtained from S. albus 
MP31 cultivated on 2CM agar plates. C. The molecular ion [M+H]+ observed at ESI-HRMS. 
The isolation procedure to obtain griseorhodin A (5) is given in Chapter 4.1.5.6. 
The yield of the isolation was 17 mg from 9 L of fermentation. The identity of 
the compound was confirmed by 1H-NMR analysis in DMSO-d6 and HRMS data. 
The spectral data were found to be identical with the published data in the 
literature. Figure 3.9 shows the 1H-NMR spectrum of the isolated compound 
whereas Figure 3.8 provides the published 1H-NMR data by Tresselt et a.113 
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Figure 3.8 Structure and 1H-NMR data provided by Tressolt et al.of griseorhodin A (5). 
 
 
Figure 3.9 1H-NMR spectrum of the isolated griseorhodin A (5). 
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3.4.1.2 Determination of the Absolute Configuration 
In the previous derivatization experiments, Eckardt et al. had established the 
relative configuration.112 In order to obtain the entire stereochemical 
information about the compound, a reliable method was used based on 
comparison of quantum chemical calculation results with measured CD spectra. 
Interestingly, work on the stereochemistry of the griseorhodin A (5) congeners 
heliquinomycin (39) and -rubromycin (37) using quantum chemical CD 
calculation had demonstrated that the spiro centers are configured differently 
in these closely related compounds. In the course of our work, the absolute 
configuration of griseorhodin A (5) was successfully determined in cooperation 
with Prof. Dr. Bringmann and Dr. Torsten Bruhn and published.99 For the 
measurements approximately 4 mg of pure compound was used .The CD 
spectrum was measured and compared to the calculated theoretical CD data, 
which were calculated of the possible stereo-isomers by Dr. Torsten Bruhn. The 
calculated and measured CD spectra and the determined absolute configuration 
of the compound are shown in the Figure 3.10. Comparison of the theoretical 
spectra with the experimental one revealed an excellent agreement with the 
theoretical CD curve of the (2’S,3’S,2S,3S) isomer, while the spectrum calculated 
for the (2’R,3’R,2R,3R) enantiomer showed an inverted curve. The (S)-
configuration of the spiro center in griseorhodin A (5) is therefore identical 
-rubromycin (37) and opposite to that of heliquinomycin (39). 
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Figure 3.10 Calculated and measured CD spectra and the determined absolute 
configuration of griseorhodin A (5). 
3.4.2 Isolation and Identification of Didesoxygriseorhodin C (46) 
This compound was identified as a red pigment in two different oxygenase 
knockout strains S. albus KR7 and S. albus KR43, which seemed to produce the 
same metabolite. S. albus KR7 with a deactivated NADP:quinone oxidoreductase 
GrhO7 and S. albus KR43 with a deactivated cytochrome P450 family oxygenase 
produced a single main metabolite. S. albus KR7 produced the pigment in 
adequate yield, and was therefore chosen for fermentation in order to isolate 
the compound. Figure 3.11 shows the comparison of HPLC traces of the plate-
extracts of S. albus KR7 and S. albus KR43 strains as well as the UV spectrum of 
the compound at RT= 19.5 min. 
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Figure 3.11 HPLC trace, UV absorption of dideoxygriseorhodin C. A. UV absorption of the 
compound. B. HPLC trace of the mycelia extract obtained from S. albus KR7 cultivated on 
2CM agar plates. C. HPLC trace of the mycelia extract obtained from S. albus KR43 
cultivated on 2CM agar plates.  
To verify whether the compounds are indeed identical, an LC-MS/MS 
experiment was performed. The HRMS and the ESI-MS/MS fragmentation of the 
compounds from S. albus KR7 and S. albus KR43 extracts did not differ from 
each other, establishing that the strains produced the same compound. Figure 
3.12A shows the HRMS of the compounds extracted from S. albus KR7, and 
Figure 3.12B shows the HRMS of the compounds extracted from S. albus KR43. 
The Figures 3.12C and 3.12D show the ESI-MS/MS fragmentation of the 
molecular ions. 
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Figure 3.12 HRMS/MS data of the compounds in the extracts of S. albus KR7 and S. albus 
KR43 A. ESI-HRMS data of the compound in the extract of S. albus KR7 B. ESI-HRMS data of 
the compound in the extract of S. albus KR43. C. ESI-HRMS/MS fragmentation of the 
compounds in the extract of the strains. S. albus KR7 D. ESI-HRMS/MS fragmentation of 
the compounds in the extract of S. albus KR43. 
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The molecular formula was deduced by ESI-HRMS analysis as C25H18O11 
(495.089 measured for the molecular ion [M+H]+, 495.085 calculated [M+H]+). 
For the isolation of the compound, S. albus KR7 was fermented. The conditions 
for the fermentation and the details of the isolation are provided in Section 
4.1.5.7. The yield of the isolation was 16 mg from 6 L of fermentation. The 
identity of the compound was confirmed by one- and two-dimensional NMR 
analysis in DMSO-d6 and AN-d3 Measured 1H-, 13C-, HMBC and HMQC NMR 
spectra are provided in Appendix 2, Figure 2.1-2.6. 
The carbon NMR spectra of the compound showed 25 carbon atoms as expected 
from the molecular formula of the compound C25H18O11. The presence of a 
quinone carbonyl group is deduced from the carbon signals at 185.37 ppm and 
179.86 ppm in the 13C-NMR spectrum. Another carbonyl signal was observed at 
165.64 ppm. Three aromatic protons at 6.41 ppm, 6.45 ppm, 6.49 ppm were 
observed in the 1H-NMR spectrum. These hydrogens correlated in the HMQC 
spectra with the carbon atom signals at 110.14, 114.86, and 103.72 ppm, 
respectively. However, no coupling among these protons was observed. A 
methoxy group attached to an aromatic ring with a characteristic signal at 56.97 
ppm was observed in the 13C-NMR spectrum and the three methoxy protons 
showed a singulet signal at 3.92 ppm in the 1H-NMR spectrum. The presence of 
three OH signals at 13.27, 11.84 and 10.78 ppm in the 1H-NMR spectrum 
showed the presence of three kinds of phenolic OH groups forming hydrogen 
bonds. Two carbon atoms at 21.22 and 23.12 ppm showed two methylene 
groups on the 1H-NMR and 13C-NMR-spectra. An additional methyl group at 
18.63 ppm in the 13C-NMR spectrum and at 2.24 ppm in the 1H-spectrum could 
be determined. 
The HMBC correlation of the aromatic proton at 6.41 ppm to the two quinone 
carbonyl groups and the methoxy attached carbon atom at 160.2 ppm and 
additional correlations of the hydroxyl groups forming a hydrogen bond implied 
the partial structure 1a. (Figure 3.13) 
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Figure 3.13 Partial structure 1a of didesoxygriseorhodin C (46). 
The HMBC correlations of the methyl group at 2.24 ppm and methine protons at 
6.49 and 6.85 ppm were observed. However, no couplings among these two 
protons were observed. Additional couplings of the two methylene protons to 
the aromatic proton at 6.85 ppm implied the Western part of the molecule with 
the partial structure 1b. (Figure 3.14) 
Figure 3.14 Partial structure 1b of didesoxygriseorhodin C (46). 
The carbonyl signal at 165.64 ppm can not belong to an ester but an 
unsaturated lactone structure having a hydrogen bond to the hydroxyl group at 
152.14 ppm. The HMBC correlations of the hydroxyl group at 10.78 ppm proved 
the unsaturated lactone structure 1c. Together the partial structures 1b and 1c 
make up the Eastern part of the molecule 1d. (Figure 3.15) 
 
Figure 3.15 Partial structure 1c and 1d of didesoxygriseorhodin C (46). 
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The unassigned partial structures are: one -CH2CH2 unit, one quaternary carbon 
at 114.16 ppm, one CH at 74.06 ppm, one H and three O atoms. The chemical 
shifts of the carbons of the methylene group are 21.22 ppm and 23.12 ppm. One 
has more downfield shift and the protons have a HMBC correlation to the C 
atom at 104.6 ppm. The carbon atom at 74.04 ppm has HMBC correlation to the 
Western part of the molecule and the attached proton correlates with the 
carbon atom at 104.16 ppm. The structure of the molecule was therefore 
predicted as 1e. (Figure 3.16) 
 
Figure 3.16 Partial structure 1e of didesoxygriseorhodin C (46). 
The compound identified as didesoxygriseorhodin C (46). The examination of 
long range 1H-13C correlations and the molecular formula obtained from HRMS 
experiments further established the structure. Figure 3.17 shows the important 
HMBC correlations of the compound.  
 
Figure 3.17 HMBC data of didesoxygriseorhodin C (46). 
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A literature survey showed that didesoxygriseorhodin C (46) was isolated 
before by Suetsuna et al. from Streptomyces sp. 76. All spectral data were 
identical with the published data.126-128 Figure 3.18B shows the published NMR 
data of the compound. Table 3.6 shows the measured 1H-NMR and 13C-NMR 
data obtained in DMSO-d6. 
 
Table 3.6 1H- and 13C-NMR data of didesoxygriseorhodin C (46). 
Didesoxygriseorhodin C (46) (In DMSO-d6, 500 MHz) 
Position 13C-NMR 
[ppm] 
1H-NMR             
[ppm] 
Position 
13C-NMR 
[ppm] 
1H-NMR 
[ppm]  
1 179.86   9a 137.69   
2 160.18   10 103.72 6.49 
3 110.14 6.41(s) 11 113.12   
4 185.37   13 165.64   
4a 106. 35   13a 132.35   
5-OH   13.27(s) 14-OH   10.78 
5 157.14   14 152.14   
5a 130.18   14a 146.79   
6-OH   6.45 (b) 16a 148.58   
6 74.04 5.15(s) 17-OH   11.84 
6a 114.16   17 153.96   
7 21.22 2.20-2.22(m) 17 153.96   
8 23.12 2.50-2.44(m) 17a 114.01   
8a 124.02   18 18.63  2.24 
9 114.86 6.85(s) 2-OCH3 56.97  3.92 
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Figure 3.18 A. Structure of didesoxygriseorhodin C (46). B. Published NMR data of the 
compound by Suetsuna et al. 126-128 
As a result both enzymes GrhO7 and GrhO3 are involved in the formation of the 
epoxied function on the ethylene group at C-7 and C-8. It is a rare case of an 
epoxidation reaction starting on a saturated C-C bond. Figure 3.19 shows the 
proposed involvement of GrhO7 and GrhO3 in griseorhodin A (5) biosynthesis.  
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Figure 3.19 Proposed functions of GrhO7 and GrhO3 in the biosynthesis of griseorhodin A 
(5).  
In order to obtain more information about the suggested function of GrhO3 and 
GrhO7 sequence homologies with other tailoring enzymes were investigated by 
BLAST (Basic Local Alignment Search Tool) analysis by Kathrin Reinhardt. 
Table 3.7 shows the BLAST (Basic Local Alignment Search Tool) results of the 
enzymes.125 
Table 3.7 Homologous proteins to GrhO3 and GrhO7 by the BLAST analysis 
results125 
Protein Amino 
Acids 
Proposed function Sequence Similarity 
(Protein, Origin) 
 
Similarity/ 
Identity [%] 
GrhO3 416 
Cytochrom 
P450 
PteD/ Streptomyces avermitilis 
MA-4680129 
71/55 
I36-105-2/ Streptomyces 
griseolus (Unpublished)125 
70/56 
GrhO7 325 
NADPH:quinone 
oxidoreductase 
Med-Orf9/ Streptomyces sp. AM-
7161130 
61/46 
ActVI Orf2/ Streptomyces 
coelicolor A3(2)131 
59/43 
 
GrhO3 shows sequence homology to the cytochrome P450 family of oxygenases. 
Although cytochromes P450 usually generate epoxides from alkenes,132,133 
examples of the formation of cyclic ethers from saturated precursors have been 
reported, such as the epoxidase OleP from oleandomycin biosynthesis 134 and 
aureothin P450 AurH, which closes a tetrahydrofuran ring by 1,5-
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dehydrogenation of an alcohol precursor.135 GrhO7 shows homology to 
NADPH:quinone oxidoreductases of medium-chain dehydrogenase/reductase 
superfamily (MDR), which take part in electron transfer reactions. An 
involvement at an epoxidation reaction was unexpected. The closest 
homologues of GrhO7 are the enoylreductases Med-Orf9130 and ActVI-Orf2131 in 
the medermycin and actinorhodin biosynthesis, respectively. They are involved 
in stereospecific reduction of the double bond at C14-C15 positions of (S)-DNPA 
(47) (4-dihydro-9-hydroxy-1-methyl-10-oxo-3-H-naptho-[2,3-c]-pyran-3-(S)-
acetic acid) shown in Figure 3.20.  
 
Figure 3.20. The involvement of Med-Orf9 and ActVI-Orf2 in medermycin and 
actinorhodin biosynthesis.130,131 
The formation of identical products in both deletion mutants suggests that 
GrhO7 and GrhO3 jointly participate in epoxide formation. A possible 
explanation might be that the two enzymes are forming a complex to epoxidize 
the olefinic carbon bond. This would suggest that the epoxidation would not 
occur in the absence of either GrhO3 or GrhO7. Another possible explanation is 
that GrhO3 is capable to perform the epoxidation of the olefinic carbon bond 
alone and GrhO7 might be responsible for the reductive recycling of olefinic 
shunt products that arise from an eliminative side reaction. The investigation of 
the monooxygenase gene styAB from Pseudomonas sp. VLB120 showed that the 
rate of epoxidation is depending on the present amount of NADPH.136 This 
would also suggest that GrhO7 belonging to a NADPH:quinone oxidoreductases 
might be involved at the effective regeneration of the coenzyme for the 
oxygenase GrhO3 belonging to cytochrome P450 family. For further 
investigation of the epoxidation on the compound functional enzyme assays 
with GrhO3 and GrhO7 can be suggested.  
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3.4.3 Isolation and Identification of Collinone (41) 
The compound was observed as a pink pigment in the extract of the oxygenase 
knockout strain S. albus KR8. The deleted oxygenase of the cluster GrhO5 is a 
predicted FAD-dependent oxygenase, and the only observed metabolite of the 
strain has a molecular formula C27H18O12. The compound has the largest 
number of carbon and oxygen atoms compared to other stable metabolites. 
Figure 3.21 shows the HPLC trace, the UV spectrum and LC-HRMS data of the 
compound.  
 
Figure 3.21 HPLC trace, UV spectrum and the LC-HRMS data of collinone (41). A. UV 
spectrum of the compound. B. HPLC trace of the mycelia extract obtained from S. albus 
KR8 cultivated on 2CM agar plates. C. The molecular ion [M+H]+ observed at ESI-HRMS. 
For the isolation of collinone (41), S. albus KR8 was fermented in TSB medium, 
and the compound was isolated from the mycelia extract. The conditions for the 
fermentation and the detailed procedure for the isolation are in Section 4.1.5.8. 
The yield of the isolation was 8 mg from 6 L of fermentation. The identity of the 
compound was confirmed by ESI-MS analysis (m/z: 557.067 [M+Na]+) and NMR 
analysis in CDCl3. Measured 1H-, 13C-, HMBC and HMQC NMR spectra of the 
compound are shown in Appendix 2, Figure 2.7-2.11.  
3 RESULTS AND DISCUSSION 
____________________________________________________________________________________________ 
82 
 
The carbon spectra of the compound showed 27 carbon atoms as expected from 
the molecular formula of the compound C27H18O12. The presence of a quinone 
carbonyl group is deduced from the carbon signals at 194.3, 191.01, 188.14 and 
182.65 ppm in the 13C-NMR spectrum. Another carbonyl signal was observed at 
166.51 ppm. Three aromatic protons at 6.54, 6.15 and 6.07 ppm were observed, 
which correlated in the HMQC spectrum with the carbon signals at 115.8, 
110.78 and 104.9 ppm, respectively. However, no couplings among these 
protons were observed. A methoxy group attached to an aromatic ring with a 
characteristic signal at 57.17 ppm was observed in the 13C-NMR spectrum, and 
the three methoxy protons showed a singulet signal at 3.89 ppm in the 1H-NMR 
spectrum. The presence of three OH signals at 13.52, 12.58 and 11.58 ppm in 
the 1H-NMR spectrum showed the presence of three kinds of phenolic OH 
groups forming hydrogen bonds. Two carbon atoms at 26.1 and 27.3 ppm 
showed methylene groups on the DEPT and 13C-NMR spectra. An additional 
methyl group at 2.15 ppm in the 1H-NMR spectrum and at 19.45 ppm in the 13C-
NMR spectrum could be determined. Collinone (41) has an unsaturation index 
of 19, and as the NMR data suggest the presence of 5 carbonyl groups and 8 
carbon-carbon double bounds, the data indicate a hexacyclic structure. 
Structure elucidation was complicated by the presence of no less than 18 non 
protonated carbons, but careful examination of long range 1H-13C correlations 
established the structure. The HMBC correlations of the methoxy group at 3.89 
ppm to the carbon atom at 160.74 ppm and a weak correlation to the adjacent 
carbon atom at 110.78 ppm indicated the presence of methyl enol ether, and 
this is also supported by the chemical shift of the double bound carbons. The 
strong HMBC correlations of the aromatic proton at 6.15 ppm to the carbon 
atoms at 160.74, 182.65, 188.14, 116.7, and 115.9 ppm and the HMBC 
correlations of the hydroxyl protons at 13.48 ppm to the quarternary carbons at 
155.6, 130.9, 128.6, 115.9 and 115.9 ppm supported a dihydroxymethoxy1,4-
napthoquinone structure 2a for the Western part of the molecule. (Figure 3.22) 
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Figure 3.22 Partial structure 2a of the compound collinone (41). 
For the Eastern part of the molecule, a 3-methyl substituted isocoumarin moiety 
2b is indicated by the strong HMBC couplings of the methyl group to the carbon 
atoms 155.12 and 104.09 ppm. Additional couplings of the aromatic proton at 
6.07 ppm to the carbon atoms at 155.12, 103.48 and 159.5 ppm support the 
conclusion as well. The carbonyl signal at 166.51 ppm belongs to the 
unsaturated lactone because of its hydrogen bond to the hydroxyl group at 
11.58 ppm and HMBC couplings with the aromatic hydrogen atom at 6.07 ppm. 
It is an. HMBC correlations of the hydroxyl group at 11.58 ppm and the aromatic 
proton at 6.54 ppm with the aromatic carbon atoms on the isocoumarin moiety 
establishes the substructure 2b. (Figure 3.23) 
 
Figure 3.23 Partial structure 2b of the compound collinone (41). 
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Two methylene units both showed strong correlations to the Eastern part of the 
molecule. The methylene protons at 2.4-2.5 ppm (m) had HMBC correlations to 
the carbonyl group at 191.01 ppm and 194.03 ppm in the Western part of the 
molecule. The quarternary atoms at 80.8 ppm and 78.7 ppm correlated with the 
methylene protons as well. HMBC correlations of the methylene groups enables 
to close the six member ring structure adjacent to the isocoumarin system 2b 
and attaches the Western part to the Eastern part of the molecule, resulting in a 
pentangular moiety. The chemical shift of the two quaternary carbon atoms at 
78.99 and 80.8 ppm can not be an epoxy group, since the chemical shift of the 
carbon atoms of an epoxy group at this position is usually expected at 60-70 
ppm. The molecular formula of the compound and the chemical shift of the 
carbon atoms at C-5 and C-18 supports that two hydroxyl groups are 
substituted at these positions. The identified compound and the correlations 
observed in HMBC experiments are summarized in Figure 3. 24. 
 
Figure 3.19 HMBC data of the compound collinone (41). 
The hydroxyl groups at the positions C5 and C18 could not be observed, because 
CDCl3 was used for the NMR measurements. DMSO-d6, as well as other solvents 
and combinations of solvents, were not suitable for NMR measurements with 
collinone (41), because the 13C-NMR signals for the dihydroxy-methoxy-1,4-
naphthoquinone system could not be observed. This may be caused by a rapid 
interchange between the 1,4-quinone and 1,4-hydroquinone functionalities.137 
The partial structures obtained from the NMR spectra and HRMS data indicate 
the structure of collinone (41).  
 
O 
O O 
O 
O H 
O H 
O 
O 
O H 
O H 
H O O 
H H 
H C H 3 
( 4 1 ) 
                                                                                                  3 RESULTS AND DISCUSSION 
____________________________________________________________________________________________ 
 85 
All spectral data were found to be identical with published data .137 Figure 3.25A 
shows the structure of collinone (41). Figure 3.25B shows the published NMR 
data of collinone (41). Table 3.8 shows the measured 1H-NMR and 13C-NMR 
data. 
 
Figure 3.20A. Structure of collinone (41). 3.25B. The published NMR data of collinone 
(41).137 
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Table 3.8 1H- and 13C- NMR data of collinone (41). 
Collinone(41)(In CDCl3, 300 MHz) 
Position 
13C-NMR 
[ppm] 
1H-NMR 
[ppm]    
Position 
13C-NMR 
[ppm] 
1H-NMR 
[ppm]    
1 166.508   15 155.6  
2 103.481   16 128.6  
3 159.5   17 191   
4 119.54   18 80.8   
5 78.99   19a 26.1 2.4-2.5 (m) 
6 194.3  19b 26.1 2.2-2.3 (m) 
7 130.92   20a,b 27.3 3.1-3.2 (m) 
8 154.65   21 147.9   
9 116.7   22 115.8 6.54 (s) 
10 182.65   23 137.96   
11 160.74   24 104.09 6.07 (s) 
12 110.78  6.15 (s) 25 155.12   
13 188.14   26 19.45 2.15 (s) 
14 115.9   27-OMe 57.17 3.89 
3-OH  11.58 (s) 8-OH  12.58 
    15-OH  13.52 
 
Collinone(41) is a heavily oxidized angular hexacyclic compound containing 
an unusual 1,4,5,8(2H,3H)-anthracenetetrone moiety only reported in the 
glycoside antibiotics SF2446A1, A2, A3, B1, B2 (isolated from Streptomyces sp.), 
SF2446 and the antibiotic tetracyclic quinone glycoside polyketomycin 
(produced by Streptomyces diastatochromogenes Tu6028).137 The absolute 
configuration of collinone (41) was not determined in the previous studies, but 
the relative stereochemistry of C-5/C-18 bridge is suggested to be cis.137 The 
absolute configuration of the compound was determined in cooperation with 
Anu Schaumlöffel in the group of Prof. Dr. Gerhard Bringmann, who compared 
CD spectra from theoretical quantum chemical calculations with the measured 
CD spectrum. For the CD measurements, 2 mg of the compound was provided. 
The experiment showed that the hydroxyl groups are in cis position and the 
determined configuration is (5S,18R). Figure 3.26 shows the results of these 
experiments and the determined absolute configuration of the compound.  
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Figure 3.21 Data of the calculated and measured CD spectra and the determined absolute 
configuration of collinone (41).  
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The group of Minas, Bailey, and coworkers had previously reported the 
compound.137 They produced the compound by heterologous expression using 
randomly chosen 30-50 kb sized genomic DNA fragments of the strain S. collinus 
DSM 2012, which contains a putative rubromycin cluster, using S. coelicolor 
CH999 as a host. However, their results could not exclude the possibility that 
the expressed DNA belonged to another pathway unrelated to rubromycin 
biosynthesis. Their investigations suggested that the rubromycins might have a 
tridecaketide precursor in their biosynthetic pathway. 137 
The characterization of this compound in the extract of the mutant strain S. 
albus KR8 proves the hypothesis that griseorhodin A (5) is built from a single 
polyketide chain and that there exists a pentangular aromatic precursor in the 
biosynthesis of griseorhodin-type aromatic spiroketal polyketides.110 The 
structure shows that at least three carbon-carbon cleaveges are necessary for 
spiroketal formation shown in Figure 3.27. This result clearly suggests that 
GrhO5 initiates the cleavage sequence by using collinone as a substrate. 
Figure 3.27 Predicted cleavages necessary for the formation of griseorhodin A (5) starting with 
the suggested intermediate collinone (41).  
To get more insights in to the possible function of GrhO5, sequence homology of 
GrhO5 was investigated by BLAST (Basic Local Alignment Search Tool) by 
Kathrin Reinhardt. Table 3.9 shows the BLAST results of the protein.125 
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Table 3.9. Homologous proteins to GrhO5 determined by the BLAST analysis.125 
Protein Amino 
Acids 
Proposed function Sequence Similarity 
(Protein, Origin) 
 
Similarity/ 
Identity [%] 
GrhO5 537 
FAD-dependent 
monooxygenase 
RubL/ Streptomyces collinus 
(Unpublished)125 
76/69 
GrhO8/ Streptomyces sp. JP9515 58/45 
GrhO9/ Streptomyces sp. JP9515 58/44 
DntB/ Burkholderia sp. DNT138 57/44 
TcmG/ Streptomyces 
glaucescens139 
56/41 
 
The enzyme GrhO5 shows similarity to FAD-dependent monooxygenases GrhO8 
and GrhO9 of the grh cluster.125 Another enzyme showing sequence homology is 
DntB.138 DntB (4-methyl-5-nitrocatechol (4M5NC (49)) monooxygenase) from 
Burkholderia sp. catalyzes the second step of 2,4-dinitrotoluene degradation by 
converting 4M5NC (49) to 2-hydroxy-5-metylquinone (50) with the 
concominant removal of the nitro group, which is shown in Figure 3.28.138 DntB 
is a flavoprotein that has a very narrow substrate range. 138,140 
 
Figure 3.28 The involvement of DntB in the catalysis of 2,4-dinitrotoluene degradation by 
converting 4M5NC (49) to 2-hydroxy-5-metylquinone (50).140 
The hydroxylase TcmG is an oxygenase in the biosynthesis of the bacterial 
polyketide tetracenomycin C (52). TcmG hydroxylates tetracenomycin A2 (51) 
at positions C-4, C-4A, and C12A to generate tetracenomycin C (52).139 Figure 
3.29 shows the involvement of TcmG in tetracenomycin C biosynthesis, 
catalyzing triple hydroxylation of tetracenomycin A2 (51) to tetracenomycin C 
3 RESULTS AND DISCUSSION 
____________________________________________________________________________________________ 
90 
 
(52). The sequence homology of GrhO5 to TcmG suggests that GrhO5 might be 
involved in a hydroxylation reaction on an aromatic ring or a multiple 
hydroxylation reaction leading to carbon-carbon cleavages. 
 
Figure 3.29 The involvement of TcmG in tetracenomycin biosynthesis catalyzing triple 
hydroxylation of tetracenomycin A2 (51) to tetracenomycin C (52).139 
 
3.4.4 Isolation and Characterization of Lenticulone (53) and ZY1 (54) 
In the extracts of the FAD-dependent oxygenase GrhO6 knockout strain S. albus 
MP66, MP66a was observed as a purple pigment. The gene grhO6 showed 
amino acid sequence similarity to Baeyer-Villiger oxygenase MtmOIV.141 The 
molecular ion detected for this major compound was at m/z: 521.0720 for 
[M+H]+ suggesting a molecular formula C26H16O12 with a calculated exact mass 
521.0716 for [M+H]+ Another strain, S. albus KR42 with a deleted grhJ gene that 
has sequence similarities to GNAT (GCN5-related N-acetyltransferase family) 
genes also produced metabolites suggesting the same molecular formula.125 The 
measured molecular ion for the suggested molecular formula C26H16O12 in the S. 
albus KR42 extract was at m/z: 521.0716 for [M+H]+. In Figure 3.30, a 
comparison of agar plate extracts from S. albus MP66 to S. albus KR42 based on 
their HPLC traces is shown. It was observed that extracts of S. albus KR42 
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belonging to the strain grown on agar produces a major metabolite with a 
suggested molecular formula C25H16O11 with a measured molecular ion at m/z: 
493.0769 for [M+H]+ and calculated exact mass 493.0769 for [M+H]+. 
Additionally, two minor metabolites MP66a and MP66a’ with the same 
molecular formula C26H16O12 were produced. Later investigations of the 
compound MP66a, which was renamed lenticulone (53) after structure 
elucidation, showed that the metabolite MP66a’ occurs also after keeping 
MP66a in solutions over pH 7 as described in Chapter 4.1.6. In order to prove 
that the extracts contain the same compound MP66a, an ESI-HRMS tandem 
MS/MS experiment was carried out. Figure 3.31A and B shows that the ESI-
MSMS measurements of the compound MP66a in the extracts of both strains are 
identical. 
 
 
Figure 3.30 HPLC traces of the strains containing compound MP66a in extracts. A. HPLC 
traces of S. albus MP66. B. HPLC traces of S. albus KR42. 
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Figure 3.31 ESI-MSMS fragmentation comparison of the peak at RT= 19 min of S. albus 
MP66 to S. albus KR42. A ESI-MSMS fragmentation comparison of the compoundat RT= 19 
min of S. albus MP66. B ESI-MSMS fragmentation comparison of the compoundat RT= 19 
min of S. albus KR42. 
Investigation of the metabolites of S. albus MP66, and structure elucidation of 
MP66a was carried out in this work. Further investigation of the metabolites 
from S. albus KR42 was carried out by Kathrin Reinhardt for her PhD. work. 125 
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Figure 3.32 HPLC trace, UV spectrum and the LC-HRMS data of lenticulone (48). A. UV of 
the compound. B. HPLC trace of the mycelia extract obtained from S. albus MP66 
cultivated on 2CM agar plates. C. The molecular ion [M+H]+ observed by ESI-HRMS. 
Figure 3.32 shows the HPLC trace, UV spectrum and LC-HRMS data of MP66a 
produced by S. albus MP66, which was cultivated on 2CM agar plate. For the 
isolation of the metabolites of S. albus MP66a, a similar protocol for the isolation 
of griseorhodin A (5), as described in Chapter 4.1.5.5 was applied. However, 
another compound was observed during the first isolation attempt, which was 
called MP66b. During the isolation steps, it became obvious that MP66a was 
instable even in the presence of small amounts of methanol, especially at acidic 
conditions. During the extraction and also after the chromatographic 
purification with chloroform:methanol (9:1) on impregnated silica plates a 
rapid decomposition was observed. During the first purification attempts the 
compound MP66b, which was named as ZY1 (54), was obtained. The isolation 
procedure of compound ZY1 (54) is described in Chapter 4.1.5.10. The yield of 
the isolation was 6 mg from 12 L of fermentation. The molecular ion was 
determined at ESI-(+)-HRMS as m/z: 337.055 for [M+H]+ suggesting a molecular 
formula C15H12O9 with a calculated exact mass 337.056 for [M+H]+. Figure 3.33 
shows the HPLC trace and UV spectrum of the compound. 
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Figure 3.33 HPLC trace, UV spectrum of ZY1 (54). A. UV of the compound. B. HPLC trace of 
the compound mycelia extract obtained from S. albusMP66 fermentation. 
UV absorption maxima in acetonitrile were observed at 490, 362, 310, and 260 
nm. The NMR measurements for structure elucidation were performed by LC-
NMR in AN-d3 at the University of Greifswald by Dr. Michael Lalk. Measured 1H-, 
13C-, HMBC and HMQC NMR spectra of the compound are shown in Appendix 2, 
Figure 2.12-2.16. 
The NMR spectra of the compound showed an aliphatic impurity. But the 
unrelated peak integrals on the 1H-NMR spectra and HMBC correlations of the 
impurity were distinguishable from the dominating signals of the compound 
ZY1 (54).  
The 13C-NMR showed 14 carbon signals in the lower field of 100 ppm. Two 
signals at 184.35 and 190.13 ppm showed the presence of two quinolic carbonyl 
groups. The signals at 164.82, 164.76 and 162.4 ppm showed the presence of 
carbonyl groups. Two strong methoxy signals at 58.38 and 54.01 ppm showed 
the presence of at least two methoxy groups. In the upper field of the 13C-NMR 
spectra and the HMBC spectra from 10 up to 40 ppm aliphatic carbon atoms 
were observed, which only coupled in the HMBC spectra to the carbon atoms at 
174 and 130.59 ppm in the lower field of the 13C-NMR spectra. These two 
carbon atoms were not correlating with the hydroxy group at 12.86 ppm and 
the proton at 6.34 ppm. The data of the aliphatic carbons showed that a 
commercially prevalent used phthalic acid chain ester derivative was present as 
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inpurity. However, the HMBC and HMQC data were clear enough to allow for an 
evaluation of the structure.  
The presence of two OH signals at 12.87 and 12.16 ppm in the 1H-NMR spectra 
showed the presence of two phenolic OH groups forming hydrogen bonds. One 
methoxy signal at 3.94 ppm and two overlapping methoxy signals at 3.86 ppm 
suggested the presence of three methoxy groups in the compound. Integral of 
the phenolic proton at 6.34 ppm was used as reference for a hydrogen peak.  
The HMQC spectrum showed an aromatic proton attached to a carbon atom at 
111.53 ppm. The methoxy group at 3.94 ppm was attached to a carbon at 58.8 
ppm and the other two methoxy groups were attached at an overlapping carbon 
signal at 53.82 ppm. HMBC correlations of the hydrogens allowed for further 
structure elucidation of the compound.  
The methoxy group at 3.94 ppm had HMBC correlation to the carbon atom at 
162.4, and a week correlation to the adjacent carbon atom at 111.53 ppm 
indicating the presence of a methyl enol ether. This is also supported by the 
chemical shift for the double bond carbons at 162.4 and 111.53 ppm. Strong 
HMBC correlations of the aromatic proton at 6.34 ppm to the carbon atoms at 
162.4, 184.35, 190.13 and 153.12 ppm and couplings to the quaternary carbon 
atoms at 114.52 and 115.10 ppm indicated a naphtoquinone structure. HMBC 
correlations of the hydroxyl proton at 12.87 ppm to the carbon atoms at 153.12, 
130.77, and 114.52 ppm established the dihydroxymethoxy-1,4-naphtoquinone 
structure of the molecule, similar to the Western part of the previously isolated 
molecule collinone (41). The methoxy groups had HMBC couplings with the 
carbon atoms at 164.82 and 162.44 ppm, which indicates the involvement of 
two methyl ester groups to the structure and fulfills the molecular formula 
C15H12O9. The attachment of the two methylester groups on the 
dihydroxymethoxy-1,4-naphtoquinone structure completed the structure of 
ZY1 (54). Figure 3.34 shows the HMBC correlations of the compound. 
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Figure 3.34 HMBC data of ZY1 (54). 
Figure 3.35 shows the structure of ZY1 (54) whereas an overview of the NMR 
data is shown in Figure 3.36. Table 3.10 shows the measured 1H-NMR, 13C-NMR 
and HMBC data obtained. After the structural elucidation was completed the 
literature survey showed that this compound has not been published. 
 
Figure 3.35 Structure of ZY1 (54). 
 
Figure 3.36 1H-NMR and 13C-NMR data of the compound ZY1 (54). 
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Table 3.10 1H- and 13C- NMR Data of ZY1(54). 
ZY1 (54) (in AN-d3), 500MHz, LC-NMR 
Position 13C-NMR[ppm] 1H-NMR [ppm]    HMBC  
1 164.76 -   
1a 132.58 -   
2-OH - 12.16   
2 154.06 -   
2a 115.1 -   
3 184.35 -   
4 162.44 -   
5 111.53 6.34 3; 4; 5; 6; 7 
6 190.13 -   
6a 114.52 -   
7-OH - 12.87 6a; 7; 7a 
7 153.12 -   
7a 130.77 -   
8 164.82 -   
9- OMe 53.82 3.87 7a; 8 
10- OMe 53.82 3.87 1; 1a 
11-OMe 58.18 3.94 3; 4; 5 
 
To enable the isolation and increase the yield of the isolated MP66a, lenticulone 
(53), the work-up procedure was modified. In order to avoid the use of acetic 
acid, TFA was tried. Although TFA had a stronger acidity it was prefered, since 
the boiling point is 78 C. It was easier to remove acid during evaporation of 
ethyl acetate, which has a boiling point of 77 C. Another essential change 
needed was a better mobile phase mixture in order to purify the compound by 
column chromatography with minimum loss. In order to avoid the use of 
methanol a mobile phase of chloroform:ethyl acetate (5:1) on impregnated 
silica was used. For the isolation lenticulone (53), S. albus MP66 was grown in 
LB medium. The yield of the isolation was 20 mg from 12 L of fermentation. The 
description of the isolation procedure is in Section 4.1.5.9. The identity of the 
compound was confirmed by ESI-HRMS analysis for [M+H]+ as C26H16O12: m/z = 
521.0714, calculated [M+H]+ m/z = 521.0720, and NMR analysis in CDCl3. 
Measured 1H-, 13C-, HMBC and HMQC NMR spectra of the compound are shown 
in Appendix 2, Figure 2.17-2.24. 
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The carbon NMR of MP66a showed 26 carbon atoms as expected from the 
molecular formula C26H16O12. DEPT spectra and HMQC spectra showed aromatic 
protons at 110.20, 114.21 and 104.81 ppm connected to the protons at 6.29, 
6.61 and 6.17 ppm, respectively. The signal at 57.33 ppm in the 13C-NMR, and 
DEPT and an aromatic methoxy signal at 4.01ppm in the 1H-NMR showed the 
presence of an aromatic methoxy group on the molecule. The presences of three 
quinone carbonyl groups are indicated by the carbon signals at 188.78, 181.6, 
and 182.81 ppm in the carbon NMR. An additional carbonyl signal was observed 
at 166.6 ppm. Three OH signals at 13.37, 12.74 and 10.98 ppm in the 1H-NMR 
spectrum showed the presence of three phenolic OH groups forming hydrogen 
bonds. Two secondary carbon atoms at 20.59 and 23.96 ppm in the 13C-NMR, 
DEPT and HMQC spectra showed the presence of two CH2 groups. An additional 
methyl group at 19.30 ppm in the 13C-NMR spectrum and at 2.24 ppm in the 1H-
spectrum could be determined. The structure was established by examination of 
long range 1H-13C correlations in the HMBC spectra. The HMBC correlation of 
the aromatic proton at 6.17 ppm with the two quinone carbonyl groups at 
188.78 and 181.67 ppm, and its correlations with the methoxy attached carbon 
atom at 161.15 ppm together with the additional correlations of the hydroxyl 
groups at 13.37 and 12.74 ppm forming a hydrogen bond, showed a 
dihydroxymethoxy-1,4-naphtoquinone structure similar to the compounds 
didesoxygriseorhodin C (46), collinone (41) and ZY1 (54) for the Western part 
of the molecule. Hydroxyl protons at 13.37 and 12.74 ppm showed weak 
couplings to the carbonyl carbon at 182.81 and 158.28 ppm. These HMBC 
correlations implied the partial structure 3a for the Western part the molecule. 
(Figure 3.37)  
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Figure 3.37 Partial structure 3a of lenticulone (48). 
For the Eastern part of the molecule, a 3-methyl substituted isocoumarin 
moiety, similar to the Eastern part of the molecule didesoxygriseorhodin C (46), 
was demonstrated by the strong HMBC correlations of the methyl group with 
the carbon atoms at 152.85, 104.01 and 114 ppm. Additional couplings of the 
aromatic protons at 6.29 and 6.61 ppm with the carbon atoms at 166.66, 
150.15, 105.08, 137.14, 132.09, 152.85 and 19.30 ppm proved the aromatic 
structure. HMBC correlations of the hydroxyl group at 10.98 ppm forming 
hydrogen bond to the quinone carbonyl group oxygen at 166.66 ppm, 
established the unsaturated lactone ring of the methylated isocoumarin moiety 
Figure 3.38 shows the partial structure 3b for the Eastern part of the molecule.  
 
Figure 3.38 Partial structure 3b of lenticulone (53). 
O
OOH
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Ethylene carbon atoms at 20.59 and 23.96 ppm correlated with the aromatic 
protons in the Eastern part of the molecule at 6.61 ppm and with the quinone 
carbonyl group at 182.81 ppm on the Western part of the molecule. Both 
ethylene protons coupled to the carbon atom at 99.08 ppm. The latter shift is 
characteristic for a (hemi)acetal function, suggesting that the compond has a 
spiro system at a position analogous to the spiro center in griseorhodin A (5). 
The presences of a carbonyl signal at 158.28 ppm and an additional carbonyl 
signal occurring with a downfield shift at 182.81 ppm indicated an adjacent keto 
function to the acetal carbon. HMBC couplings of the ethylene group showed 
that the Western part and the Eastern part of the molecule are connected over 
an unusual spiro center as shown in the partial structure 3c. (Figure 3.39). 
Figure 3.39 Partial structure 3c of lenticulone (53). 
The structure of MP66a was estimated and the new compound was renamed 
lenticulone (53). Figure 3.40 shows the important HMBC correlations of the 
compound lenticulone (53). 
 
 
 
 
 
 
 
                                                                                                  3 RESULTS AND DISCUSSION 
____________________________________________________________________________________________ 
 101 
 
Figure 3.40 Important HMBC correlations of lenticulone (53). 
Figure 3.41 shows lenticulone (53). Figure 3.42 shows an overview of the NMR 
data obtained for lenticulone (53). Table 3.11 shows the measured 1H-NMR, 
13C-NMR data and the observed HMBC correlations. 
 
Figure 3.41 Structure of lenticulone (53)  
 
Figure 3.42 1H-NMR and 13C-NMR data of lenticulone (53). 
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Table 3.11 1H- and 13C- NMR Data of lenticulone (53). 
Lenticulone (53) (In CDCl3-d), 500 MHz 
Position 13C-NMR [ppm] 1H-NMR [ppm]    HMBC 
1 181.67 -   
2 161.15 -   
3 110.20 6.29 (s, H) 1; 2; 4; 4a; 5; 18 
4 188.78 -   
4a 117.93 -   
5 153.61 -   
5a 127.7 -   
6 182.81 -   
6a 99.08 -   
7 23.96 2.4-2.5 (m, Ha,b) 6; 6a; 8; 8a; 9; 17 
8 20.59 3.25 (m, Ha); 6a; 7; 8a; 9; 9a; 13a; 14; 14a 
8 20.59 2.85 (ddd, Hb) 6a; 7; 8a; 9a; 14 
8a 132.09 -   
9 114.21 6.61 (s, H) 7;8; 8a; 9; 10; 13; 13a; 14; 14a 
9a 131,387 -   
10 104.01 6.17 (d, H) 8a; 9a; 11; 13a; 14; 19 
11 152.85 -   
13 166.66 -   
13a 105.08 -   
14 150.15 -   
14a 137.14 -   
17 158.28 -   
17a 121.74 -   
18 155.88 -   
18a 118.26 -   
19-Me 19.30 2.24 (d, 3H) 8a; 9; 9a; 10; 11; 13; 14; 14a 
2-Ome 57.33 4.01 (s, 3H) 1; 2; 4 
5-OH - 13.37 (s, H) 4; 4a; 5; 5a; 17; 17a 
14-OH - 10.98 (s, H) 8a; 13; 13a; 14; 14a 
18-OH - 12.74 (s, H) 1; 18 
 
Lenticulone (53), with the HRMS for [M+H]+as C26H16O12 (m/z :521.0714, calcd. 
521.0720) was fragmented to further analyze its constitution by HR-ESI-
MS/MS. The result of the fragmentation is shown in Figure 3.43 and table 3.12 
which was carried out with the help of Dr. Engeser. Collision-induced 
dissociation of the sodium adduct ion [M+Na]+ yielded one major fragment with 
an exact mass difference of Δm = 204.0372. This indicating a loss of C11H8O4. and 
was assigned to a cleavage of ring D (Figure 3.43, fragmentation path A) 
resulting in the formation of the ion [I+Na]+. In addition fragmentation product 
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[II+Na]+ (Δm = 316.0155; loss of C15H8O8). was observed in smaller abundance. 
Two further fragmentation products could be assigned to a cleavage of ring C of 
the compond (Figure 3.43, path B): loss of C13H6O7 (III, Δm = 246.0362) and 
C13H10O5 (IV, Δm = 274.0054). This fragmentation pattern had a diagnostic value 
for the structure of the compound. An MS3 experiment with the main product 
ion [I+Na]+ only showed water expulsion. Therefore, a hypothetical alternative 
formation of [III+Na]+ by subsequent fragmentation of [I+Na]+ could be ruled 
out. Direct fragmentation of lenticulone (53) can lead to [III+Na]+ only if the 
constitution of ring C is the one shown in Figure 3.43, i.e., the carbonyl function 
at C-12 must be connected to ring B. Thus, the MSn data confirmed that 
lenticulone (53) is a novel spiroketal that contains an expanded ring C in 
comparison to griseorhodin A (5). The HR-ESI-MS/MS spectra is shown in 
Appendix 1, Figure 1.3. 
Table 3.12 Fragmentation of lenticulone (53): HR-ESI-MS/MS of [M+Na]+ 
m/z relative intensity Δmexp Δmcalc 
525 M+Na+-H2O 8 18.0098 18.0106 
515 M+Na+-CO 4 27.9935 27.9949 
499 M+Na+-CO2 28 43.9886 43.9898 
481 M+Na+-CO2-H2O 3 61.9952 62.0004 
339 M+Na+-C11H8O4 (D) 100 204.0372 204.0423 
321 M+Na+-C11H8O4-H2O 56 222.0478 222.0528 
311 M+Na+-C12H8O5 3 232.0209 232.0371 
297 M+Na+-C13H10O5 (B) 2 246. 0362 246.0528 
269 M+Na+-C13H6O7 (A) 4 274.0054 274.0114 
227 M+Na+-C15H8O8 (C) 12 316.0155 316.0219 
181 M+Na+- C16H10O10 32 362.0317 362.0274 
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Figure 3.43 ESI-MS/MS fragmentation path of the compound lenticulone (53). 
The characterization of lenticulone (53) in the extract of the mutant strain S. 
albus MP66 and later in S. albus MP42 shows that GrhO6 and GrhJ catalyzea key 
reaction in the biosynthesis of the spiroketal moiety. GrhO6 and GrhJ have the 
function of cleaving the C17-C17a bond to generate the spiroketal moiety as 
shown in Figure 3.44. The presemce of lenticulone (53) and additional 
metabolite with a molecular formula C25H16O11 in the extract of S. albus MP42 
suggested the involvement of GrhJ in this transformation of the compound. The 
investigation of the GrhJ mutant strain by Kathrin Reinhardt resulted with a 
postulated metabolite 7, 8 dideoxy-6-oxygriseorhodin C (55) for the compound 
with a molecular formula C25H16O11.125 This metabolite was not observed in the 
extract of MP66. This compound with one less oxygen atom and one less carbon 
atom suggested that GrhJ together with GrhO6 catalyzes the final steps of 
spiroketal formation. Figure 3.44 shows the postulated involvement of GrhO6 
and GrhJ in the griseorhodin A (5) biosynthesis. 
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Figure 3.44 Proposed functions of GrhO6 and GrhJ in the biosynthesis of griseorhodin A 
(5).  
In order to obtain further information about GrhO6 and GrhJ, sequence 
homology of GrhO6 and GrhJ were investigated by BLAST analysis by Kathrin 
Reinhardt.125. Table 3.13 shows the BLAST analysis results and the enzymes 
showing homologies to GrhO6 and GrhJ.  
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Table 3.13. BLAST analysis results for GrhO6 and GrhJ.125 
Protein Amino 
Acids 
Proposed function Sequence Similarity 
(Protein, Origin) 
 
Similarity/ 
Identity [%] 
GrhO6 520 
FAD-dependent 
monooxygenase, 
Baeyer-Villigerase-
type oxygenase 
RubN/ Streptomyces collinus 
(unpublished)125 
84/76 
PokO4/ Streptomyces 
diastatochromogenes Tü6028142 
59/45 
CmmOI/ Streptomyces griseus143 58/45 
MtmOIV/ Streptomyces 
argillaceu141 
56/45 
GrhJ 295 
N-Acetyl-
transferase (GNAT) 
-/Salinispora arenicola CNS-205 
(unpublished)125 
42/29 
-/ Salinispora tropica CNB-440 
(unpublished)125 
41/29 
Dra0019/ Deinococcus 
radiodurans15 
41/31 
 
Investigations of sequence homologies of GrhO6 showed high protein similarity 
with two Baeyer-Villigerases, CmmOI and MtmOIV in the chromomycin and 
mithramycin biosynthesis, respectively.141,143 However, GrhO6 would be an 
unusual example of a monooxygenase acting on an ester instead of a ketone. 
Flavin-containing Baeyer-Villiger monooxygenases employ NADPH and 
molecular oxygen to catalyze the insertion of an oxygen atom into a carbon-
carbon bond of a carbonylic substrate.144 MtmOIV cleaves a C-C bond, essential 
for the conversion of biologically active inactive precursor, premithramycin B 
(56), into the active drug mithramycin (23). Figure 3.45 shows the involvement 
of MtmOIV in the biosynthetic pathway to mihtramycin (23).69,144 
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Figure 3.45 The involvement of Baeyer-Villiger monooxygenase MtmOIV in the 
biosynthesis of mitramycin (23).69 
Another possibility for the catalytic carbon-carbon cleavage mechanism of 
GrhO6 could be a ring hydroxylation and subsequent fragmentation aided by 
rearomatization. In that case GrhO6 would act as a hydroxylase. For the 
oxygenase OtcC from Streptomyces rimosus in the oxytetracyclin biosynthesis, 
which shows a sequence similarity to GrhO6, a hydroxylation reaction of the 
antracyclin moiety was assigned.145 The position of hydroxylation is shown in 
Figure 3.46. A related mechanism has been proposed for 4-hydroxybenzoate 
hydroxylase of Candida parapsilosis CBS604 on the basis of inhibitor studies and 
molecular orbital considerations. 146 
 
Figure 3.46 The position of hydroxylation of OtcC in the oxytetracyclin biosynthesis.145  
3 RESULTS AND DISCUSSION 
____________________________________________________________________________________________ 
108 
 
These investigations for the function of GrhO6 suggest two alternative routes 
for the reaction mechanism at the generation of the spiroketal moiety that are 
shown in Figure 3.47. (Only the BCD rings are shown). The first possibility is 
that GrhO6 acts as a Baeyer-Villigerase on the ester moiety of lenticulone (53), 
resulting in decarboxylation. The second possibility is that GrhO6 acts as a 
hydroxylase and hydroxylates the ester α-position, and decarboxylation results 
from rearomatization. 
 
Figure 3.47 Two possible pathways for the final carbon-carbon bond cleavage in 
griseorhodin A biosynthesis (only the BCD rings are shown). A: GrhO6 acts as a Baeyer-
Villigerase on the ester moiety, resulting in decarboxylation. B: GrhO6 hydroxylates the 
ester α-position, and decarboxylation results from rearomatization. 
GrhJ shows homology to GCN-5 related N-acetyltransferases (GNATs). It is 
reported that typeI PKSs sometimes use GNATs to incorporate acetyl starter-
unit into complex polyketides.147 Examples of such polyketide clusters are 
known from pederin, onnamide, rhizoxin and myxovirescin biosynthesis.147,148 
Therefore, GrhJ was suspected to play a similar role in griseorhodin A 
biosynthesis initially. However, the examination of the grhJ gene deletion strain 
by Kathrin Reinhard for her PhD work implied the presence of a suggested 
intermediate 7,8-dideoxy-6-oxygriseorhodin C (55) in addition to lenticulone 
(53). Unfortunately, the amounts produced were not enough for a 
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characterization of the metabolite by NMR.125 This compound with one less 
oxygen atom and one less carbon atom suggested that GrhJ together with GrhO6 
catalyzes the final steps of spiroketal formation. 
In order to examine the carbon-carbon cleavage mechanism an in vitro assay 
with the overexpressed GrhO6 was conducted. The experiments could not prove 
an in vitro activity of GrhO6 using lenticulone (53) as a substrate at the assay 
conditions. The results of the in vitro assay with the overexpressed GrhO6 are 
described and discussed further in Section 3.5. 
3.4.5 Isolation and Characterization of Precollinone (58) 
The metabolite precollinone (58) was observed as a yellow compound in the 
extract of the oxygenase knockout strain S. albus KR53. The mutant strain has a 
grhO9 gene deletion on the griseorhodin A cluster. The encoded enzyme at this 
deleted gene is predicted as an FAD-dependent monooxygenase. Figure 3.48 
shows the HPLC trace, UV spectrum and LC-HRMS data of the plate-extracted 
compound produced by S. albus KR53. 
 
Figure 3.48 HPLC trace, UV spectrum and the LC-HRMS data of precollinone (58).A. UV of 
the compound. B. HPLC trace of the mycelia extract obtained from S. albus KR53 
cultivated on 2CM agar plates. C. The molecular ion [M+H]+ observed at ESI-HRMS. 
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For the isolation of the compound S. albus KR53 was fermented in LB medium, 
and the compound was isolated as described in the Section 4.1.5.11. The yield of 
the isolation was 18 mg from 9 L of fermentation. The molecular ion detected 
for this major compound was at m/z: 505.1111 for [M+H]+ suggesting a 
molecular formula C27H20O10 with a calculated exact mass m/z: 505.1135 for 
[M+H]+. The structure of the compound was established by ESI-HRMS data and 
NMR analysis in DMSO-d6. Measured 1H-NMR, 13C-NMR, HMBC and HMQC 
spectra of the compound are shown in Appendix 2, Figure 2.25-2.29. 
The carbon spectra of the compound showed 27 carbon atoms as expected from 
the molecular formula C27H20O10 of the compound. The 1H-NMR and HMQC 
spectra showed the presence of five aromatic protons at 7.75, 7.14, 6.61, 6.57 
and 6.17 ppm attached to the carbon atoms at 118.44, 102.67, 116.10, 103.88 
and 104.06 ppm respetively. A methoxy signal at 3.86 ppm in the 1H-NMR and at 
56.09 ppm in the 13C-NMR spectra was observed. An additional methyl group at 
2.06 ppm in the 1H-NMR and at 19.15 ppm in the 13C-NMR spectra was detected. 
The presence of the quinone carbonyl group is deduced with the carbon signals 
at 198.96 and 197.71 ppm in the 13C-NMR spectrum. The presence of the OH 
signal at 11.36 ppm in the 1H-NMR indicated a phenolic hydroxyl group forming 
a hydrogen bond. Two carbon atoms at 28.05 and 23.76 ppm showed a ethylene 
group in the 13C-NMR spectra. Additional two quaternary carbon atoms at 77.99 
ppm and 80.85 ppm similar to those in collinone (41) were observed.  
For the Western part of the molecule, a 1,8-dihydroxy-3-methoxy naphthalene 
partial structure was indicated. HMBC coupling of the methoxy group with the 
carbon atom at 163.20 ppm was observed. Strong HMBC correlations of the two 
aromatic protons at 7.14 and 7.75 ppm with the carbon atoms at 163.20, 
159.17, 164.40, 140.42, 111.02, 131.45, 106.92 and 103.88 ppm implied a 
naphthalene moiety. The aromatic protons at 7.14 and 7.75 ppm showed a 
typical 3J-coupling of 0.5 Hz for a 1,8- naphtalene substitution. The aromatic 
proton at 6.57 ppm did not show any couplings with the protons at 7.14 and 
7.75 ppm. HMBC correlations of the aromatic proton at 6.57 ppm with the 
carbon atoms at 140.42, 102.67, 164.40 and 106.92 ppm together with the 
corellations of aromatic protons at 7.14 and 7.75 ppm established the structure 
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of the naphthalene moiety. Aromatic protons at 7.75 ppm showed HMBC 
correlations with the two quinolic carbonyl carbons at 197.71 and 198.96 ppm. 
This implied the presence of two quinone carbonyl groups in the Western part 
of the molecule. (Figure 3.49) 
Figure 3.49 Partial structure 4a of precollinone (58). 
NMR data for the Eastern part of the molecule has strong similarities to those of 
collinone (41), which indicates a 3-methyl substituted isocoumarin moiety. 
Strong HMBC couplings of the methyl group with the carbon atoms 155.17 and 
104.06 ppm indicated a methyl substituted aromatic ring. Additional couplings 
of the aromatic proton at 6.17 ppm to the carbon atoms at 155.17, 103.03 and 
159.08 ppm support the conclusion as well. The carbonyl signal at 166.71 ppm 
belongs to an unsaturated lactone forming a hydrogen bond to the hydroxyl 
group at 11.36 ppm, which is attached to the carbon atom at 159.08 ppm. HMBC 
correlations of the hydroxyl proton at 11.36 and the aromatic proton at 6.61 
ppm establish the isocoumarin moiety 4b. (Figure 3.50) 
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 Figure 3.50 Partial structure 4b of precollinone (58). 
Two methylene hydrogens both showed strong correlations with the Eastern 
part of the molecule. The ethylene protons at 2.3-2.5 ppm (m) had HMBC 
correlations with the carbonyl groups at 197.71 and 198.96 ppm and the 
carbonyl group at 194.03 ppm in the Western part of the molecule. Quarternary 
atoms at 80.85 and 77.99 ppm correlated with the ethylene protons as well. The 
HMBC correlations of the metylene groups enables to close the six member ring 
structure adjacent to the isocoumarin system 4b and attaches the Western part 
to the Eastern part of the molecule, resulting in a pentangular moiety. The 
chemical shift of two quaternary carbon atoms at 78.99 and 80.8 ppm can not 
belong to an epoxy group, since the chemical shift of the carbon atoms of an 
epoxy group at this position is usually expected at 60-70 ppm. Additional to 
that, the NMR measurements were carried out in DMSO-d6 and this enabled to 
observe 4 hydroxyl signals in three wide singulets at 14.02, 10.2 and 4.1 ppm. 
The molecular formula of the compound and the chemical shift of carbon atoms 
C-5 and C-18, supported that two hydroxyl groups are substituted at these 
positions of the molecule. The new compound was named precollinone (58). 
The correlations observed in HMBC experiments are summarized in Figure 3.51. 
Figure 3.52 shows the structure of precollinone (58). Figure 3.53 and Table 
3.14 shows the measured 1H-NMR, 13C-NMR and HMBC data. 
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Figure 3.51 HMBC data of precollinone (58). 
 
Figure 3.52 Structure of precollinone (58). 
 
Figure 3.53 1H-NMR and 13C-NMR data of precollinone (58). 
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Table 3.14 1H- and 13C- NMR and HMBC data of precollinone (58). 
Precollinone (58) in DMSO-d6 
Position 13C-NMR [ppm]    1H-NMR [ppm]    HMBC 
1 166.71 - - 
2 103.03 - - 
3 159.08 - - 
4 122.35 - - 
5 77.99 - - 
6 198.96 - - 
7 131.45 - - 
8 118.44 7.75(s,H) 6,7,9,10,11,14,15,16,17 
9 140.42 - - 
10 102.67 7.14(s,H) 8,9,11,12,13,15,16 
11 163.20 - - 
12 103.88 6.57(s,H) 9,10,11,13 
13 164.40 - - 
14 106.92 - - 
15 159.17 - - 
16 111.02 - - 
17 197.71 - - 
18 80.85 - - 
19 23.76 2.46-2.26(m,H) 5,17,18,20,21 
20 28.05 3.12-3.08(m,H) 4,5,18,19,21,22 
21 148.33 - - 
22 116.10 6.61(s,H) 1,2,3,4,20,21,23,24 
23 137.55 - - 
24 104.06 6.17(s,H) 2,23,25,26 
25 155.17 - - 
26 19.15 2.06(s,3H) 2,22,23,24,25 
11-OMe 56.09 3.86(s,3H) 11 
13-OH - 14.17(bs,H) - 
15-OH - 10.09(bs,H) - 
3-OH - 11.36(s,H) - 
 
The relative and absolute configuration of the compound was determined in 
cooperation with Anu Schaumlöffel in the group of Prof. Gerhard Bringmann. As 
for griseorhodin A (5) and collinone (41), the method was to compare the 
calculated CD spectra of all four possible stereo isomers with the measured CD 
spectrum. For the CD measurements 2 mg of the compound was used. Figure 
3.54 shows the results of the method and the determined absolute configuration 
of precollinone (58). The compound was used as an example for a further UV 
calculation experiment, which resulted in a (5S,18R) precollinone (58) 
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configuration as well. The configurations of the stereocenters of precollinone 
(58) are identical with collinone (41).  
Figure 3.54 Data of the calculated and measured CD spectra and the determined absolute 
configuration of precollinone (58). 
The structure of precollinone (58) shows great similarities to collinone (41). 
Two oxidation steps at ring A and ring B are missing. The compound is the 
major metabolite of the mutant strain and occurs as a single peak of the HPLC 
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trace of the plate extract. This shows clearly that GrhO9 acts on the oxidation of 
the first and second ring. These oxidation steps are occurring after methylation 
of the aromatic hydroxyl group at C-11 and lactonization of the ring F. But the 
mechanism of the oxidation, which might start by the hydroxylation of the first 
or second ring and the role of GrhO9 at the formation of the quinolic functions 
on the first ring of collinone (41), needs to be investigated further by functional 
studies. Figure 3.55 shows the suggested oxidation steps catalyzed by GrhO9. 
 
Figure 3.55 Proposed function of GrhO9 in the biosynthesis of griseorhodin A (5).  
To get more insights in to the possible function 0f GrhO9, the sequence 
homology of GrhO9 was investigated by BLAST analysis by Kathrin Reinhardt. 
Table 3.15 shows the BLAST results of the protein.  
Table 3.15. Homologous proteins to GrhO9 determined by the BLAST analysis 
results125. 
Protein Amino 
Acids 
Proposed function Sequence Similarity 
(Protein, Origin) 
 
Similarity/ 
Identity [%] 
GrhO9 529 
FAD-dependent 
monooxygenase 
RubP/ Streptomyces collinus 
(Unpublished)125 
72/78 
GrhO8/ Streptomyces sp. JP9515 63/46 
DntB/ Burkholderia sp. DNT138 58/45 
TcmG/ Streptomyces 
glaucescens139 
55/42 
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The protein sequence shows similarity to the oxygenases GrhO8, TcmG and 
DntB. DntB (4-methyl-5-nitrocatechol (4M5NC (49)) monooxygenase) from 
Burkholderia sp. catalyzes the second step of 2,4-dinitrotoluene degradation by 
converting 4M5NC (49) to 2-hydroxy-5-metylquinone (50) with the 
concominant removal of the nitro group as shown in Section 3.4.3 and Figure 
3.28.138 The hydroxylase TcmG is an oxygenase in the biosynthesis of the 
bacterial polyketide tetracenomycin C (52). TcmG hydroxylates tetracenomycin 
A2 (51) at positions C-4, C-4A, and C12A to give tetracenomycin C (52) as 
shown in Section 3.4.3 and Figure 3.29.139  
3.4.6 Isolation and Characterization of Secocollinone-1 (59) 
The metabolite KR5a was observed as a dark blue pigment on the mycelium of 
S. albus KR5, which changes its color in acidic conditions to pink. The deleted 
gene grhO1 was predicted to be a rare FAD dependet oxygenase carrying their 
cofactor covalently attached to the enzyme. The blue compound was not only 
water insoluble but also insoluble in several common organic solvents such us 
CHCl3, MeOH, acetone or ethyl acetate. After acidifying the bacteria up to pH 3 
by re-suspending in an aqueous solution with TFA, the color turned to pink and 
the compound became soluble in ethyl acetate. Nevertheless, an unusual feature 
of the compound was that it attached strongly to almost every stationary phase 
used for chromatographic purposes, such as silica, impregnated silica, C18 
material and Sephadex LH-20 material, so that it was not possible to further 
purify the extract. It was therefore necessary to derivatize the polar functions 
on the molecule. In order to elucidate the structure of KR5a, through a 
derivatization a reaction was conducted. 
To determine the molecular weight of the native metabolite in the crude extract 
was also difficult, because the metabolites did not appear as defined peaks by 
RP-HPLC and LC-HRMS measurements. As a result, the mass could not be 
obtained using common HPLC solvents. Therefore the extract was dissolved in 
DMSO. This is uncommon for HPLC analysis, since DMSO can also dissolve 
components of the RP-18 HPLC column material. Nevertheless, the extract was 
injected for LC-HRMS analysis and the molecular weight was determined. The 
molecular ion detected for this major compound was at m/z: 537.102 for 
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[M+H]+ suggesting a molecular formula C27H22O12 with a calculated exact mass 
m/z: 537.103 for [M+H]+. Figure 3.56 shows the HPLC trace, the UV spectrum 
and LC-HRMS data of the compound KR5a.  
 
 
Figure 3.56 HPLC trace, UV spectrum and the LC-HRMS data of KR5a produced by S. albus 
KR5. A. UV of the compound. B. HPLC trace of the mycelia extract obtained from S. albus 
KR5 cultivated on 2CM agar plates. C. The molecular ion [M+H]+ observed at ESI-HRMS. 
In order to determine the function of the oxygenase GrhO1, derivatives of the 
metabolite needed to be investigated. Acetylations and methylations are 
common derivatization reactions for aromatic phenolic compounds. Several 
reaction protocols were tested with a commercially available aromatic 
compound, quinalizarin, in order to find an appropriate reaction with a good 
yield. It had to be considered that derivatisation reactions of S. albus crude 
extracts are problematic beacuse the yield of the products are considerably law 
and the result can be a wild mixture of different substances. Test reactions using 
the crude of extract of S. albus KR5 for acetylation and methylation with 
dimethylsilyl diazomethane did not work well. However, the methylation 
reaction with dimethylsulfate (DMS) was promising. The result was a single 
major product, after adapting a reaction from Falc et al.149 Prolongation of the 
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reaction time provided a total methylation and a single product that allowed for 
obtaining the necessary amount of substance for further structur elucidation 
after the purification steps. The reaction procedure for the derivatization is 
described in the Section 4.1.5.13. Figure 3.57 shows the results of the 
derivatisation reaction. The compound was named KR5-a-meth. 
 
Figure 3.57 HPLC trace and UV spectrum and of KR5a-meth. 
For the derivatisation reaction, S. albus KR5 was fermented several times in TSB 
medium. 500 mg brown crude extract was obtained from 12 L of fermentation 
broth. The procedure for the extraction is described in Chapter 4.1.5.12. The 
extract was dried overnight in vacuum and used for the methylation reaction 
with dimethyl sulfate (DMS) as described in 4.1.5.13. The yield of the 
methylated KR5a, which was named KR5a-meth was 13 mg. The molecular ion 
of the compound was identified by ESI-HRMS analysis as m/z: 635.222 [M+H]+, 
and the calculated m/z: 635.2129 for [M+H]+ for the predicted molecular 
formula C34H34O12. The structure elucidation of KR5a-meth was carried out with 
NMR analysis in DMSO-d6 (Figure 3.58). Measured 1H-, 13C-, HMBC and HMQC 
NMR spectra of the compound are given in Appendix 2, Figure 2.30-2.35. 
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Figure 3.58 HPLC trace and LC-HRMS data of KR5a-meth. 
The carbon spectrum of the compound showed 34 carbon atoms as expected 
from the molecular formula C34H34O12. The presence of quinone carbonyl is 
suggested by the carbon signals at 184.01 and 181.12 ppm in the 13C-NMR 
spectrum. Additionally, a carbonyl signal at 158.96 ppm was detected. Evidence 
for 8 methoxy groups was provided by singulet signals at 3.93, 3.90, 3.88, 3.82 
(double), 3.81, and 3.80 ppm in the 1H-spectrum and at 63.51, 62.45, 62, 62.04, 
61.94, 61.87, 57.56 and 57.31 ppm, respectively. Additionally, a methyl group at 
2.18 ppm in the 1H-spectrum and at 19.69 ppm in the 13C spectrum was 
observed. The presence of aromatic protons at 7.08, 7.02 and 6.43 ppm in the 
1H-spectrum was observed. HMBC secondary correlations and DEPT spectra of 
these aromatic protons showed their attachments to the carbon atoms at 
122.26, 103.14 and 103.63 ppm, respectively. Two ethyl carbons had signals at 
31.52 and 26.0 ppm in the 13C-NMR and DEPT spectra.  
The structure of the Eastern part of the molecule was deduced from the HRMS 
correlations of the aromatic protons and the methyl group as a 3-methyl 
substituted isocoumarin moiety, which had similarities of the compounds 
before. The methyl group showed strong correlations with the carbon atoms at 
154.26 and 103.63 ppm and a weak coupling with the quaternary carbon atom 
at 135.79 ppm. Strong HMBC and HMQC correlations of the aromatic protons at 
6.43 and 7.08 ppm allowed establishing the substructure. The attachment of the 
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two methoxy groups at 3.81 and 3.87 ppm to the 3-methyl substituted 
isocoumarin moiety 5a, shown in the Figure 3.51, could be established by the 
HMBC correlations with the carbon atoms at 154.30 and 151.44 ppm. (Figure 
3.59) 
Figure 3.59 Partial structure 5a of KR5a-meth. 
For the elucidation of the Western part of the structure, HMBC correlation of the 
ethylene hydrogen signals at 2.80-2.85 ppm at C-11 and at 2.90-2.95 ppm at C-
12, and the additional aromatic hydrogen at 7.02 ppm aat C-19 were used. The 
hydrogen atom at 7.02 pm showed a HMBC correlation with the quinone 
carbonyl at 181 ppm and strong correlations with the three methoxy 
substituted carbon atoms at 156.76, 158.87 and 140.80 ppm. Additional 
couplings with the two quaternary carbons at 116.03 and 130.79 ppm 
established the substructure 5b. (Figure 3.60) 
Figure 3.60 Partial structure 5b of KR5a-meth 
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 Two ethylene hydrogens at 2.90-2.95 ppm had correlations with three methoxy 
attached carbon atoms at 151.44 (on the Eastern part of the molecule), 154.84, 
156.83 ppm, with a quaternary aromatic proton at 144.81 ppm and with the 
methylene carbon at 31.52 ppm. Two ethylene hydrogens at 2.90-2.95 ppm 
showed HMBC correlations with the carbon atoms in the Eastern part of the 
structure at 122.26, 136.19, 154.30 and 151.44 ppm, with a quaternary 
aromatic proton at 144.81 ppm and with the methylene carbon at 26.02 ppm. 
These correlations showed a connection between the Western part and the 
Eastern part of the molecule via an ethylene Bridge. The substructure 5c was 
obtained. (Figure 3.61) 
 
Figure 3.61 Partial structure 5c of KR5a-meth. 
The unassigned carbon atoms were: a quinone carbonyl at 184.01 ppm, a 
methoxy-substituted aromatic carbon at 147.83 ppm and two quaternary 
aromatic carbons at 129.25 and 125.20 ppm. Important HMBC correlations of 
the compound are shown in Figure 3.62. 
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Figure 3.62 Important HMBC correlations KR5a-meth. 
However, the partial structures obtained, the unassigned carbon atoms in the 
spectral data and the molecular formula C34H34O12 imply two possible 
structures for the compound. The position of the quinolic carbonyl group at C-
23 and the methoxy substitution at position C-25 can not to be proved by the 
obtained HMBC data. Therefore the possibility of structure 59b needed to be 
excluded. Figure 3.63 shows the possible structures 59 and 59b of the 
compound KR5a-meth. 
 
Figure 3.63 Possible structures 59 and 59b of the compound KR5a-meth. 59b is a 
chemically unlikely variant due to the interrupted aromatic system. 
To obtain more information and to distinguish between the large amount of 
methoxy groups and the quarternary carbon atoms, EI- and ESI-MS/MS 
fragmentation experiments were performed, but the fragmentations did not 
provide further information to prove any of the two possible structure. EI-MS 
and ESI-MS/MS spectra of the compound are presented in Appendix 1, Figure 
1.1 and Figure 1.2. An NMR experiment to obtain NOE correlations of the 
methoxy groups was attempted but the amount of the substance needed for this 
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experiment using the infra-structure of the institute could not be obtained. An 
NMR prediction experiment with the NMR program MestreNova was carried 
out. The NMR prediction results supported structure 59, which has at the 
unassigned quinone carbonyl at 184.01 ppm at position C-23 and the methoxy-
substituted aromatic carbon at 147.83 ppm and two quaternary aromatic 
carbons at 129.25 and 125.20 ppm. The obtained NMR predictions for the 
possible structures 59 and 5b are shown in Appendix 2, Figure 2.36-2.39. 
Figure 3.64A shows the elucidated structure of KR5a-meth, which was renamed 
as secocollinone-1 (59) and an overview of the NMR data is shown in Figure 
3.64B. Table 3.16 shows the measured. 1H-NMR, 13C-NMR and HMBC data. 
 
 
Figure 3.64 A Structure of secocollinone-1 (59) .B 1H-NMR and 13C-NMR data of 
secocollinone-1 (59). 
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Table 3.16 1H- and 13C-NMR and HMBC data of secocollinone-1 (59). 
Secocollinone-1 (59) in DMSO-d6 
Position 13C–NMR [ppm] 1H-NMR [ppm] HMBC(Nr. of C) 
C1 158.96   
C2 112.97   
C3 151.44   
C4 154.30   
C5 136.19   
C6 122.26 7.08 (s) 2,3,4,5,7,8,11,12 
C7 135.79   
C8 103.63 6.43 (s) 2,6,7,9,10 
C9 154.26   
C10 19.69 2.18 1,2,6,7,8,9 
C11 31.52 2.80-2.85 (m) 3,5,6,12,19 
C12 26.02 2.90-2.95 (m) 4,5,6,11,13,14,26 
C13 144.81   
C14 154.84   
C15 125.20   
C16 181.12   
C17 116.03   
C18 156.76   
C19 103.14 7.02 (s) 16,17,18,20,21,22,23 
C20 158.87   
C21 140.80   
C22 130.79   
C23 184.01   
C24 129.25   
C25 147.83   
C26 156.63   
C3-OMe 57.31 3.87 (s) 3 
C4-OMe 62.04 3.81 (s) 4 
C14-OMe 62.45 3.80 (s) 14 
C18-OMe 61.87 3.88 (s) 18 
C20-OMe 57.31 3.97 (s) 20 
C21-OMe 63.51 3.79 (s) 21 
C25-OMe 62.41 3.81 (s)  25 
C26-OMe 57.56 3.91 (s) 26 
 
The characterized structure of methylated KR5a, secocollinone-1 (59), indicates 
for the structure of KR5a, a related structure to the highly oxidized metabolite 
collinone (41). The metabolite KR5a was renamed as secocollinone-2 (60) and 
the structure is shown in Figure 3.65. 
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Figure 3.65 Structure of secocollinone-1 (59) and secocollinone-2 (60). 
The structure of secocollinone-2 (60) suggests that GrhO1 acts after another 
oxidation reaction, which opens ring D of collinone (41). GrhO5 was suggested 
to initiate reactions leading to three C-C bond cleavages. In that case GrhO1 
should act after GrhO5 during the biosynthesis. In this case, the metabolite 
secocollinone-2 (60) is very unlikely a substrate of GrhO1 because the substrate 
of the enzyme GrhO1 should be in a higher oxidation state than collinone (41) 
after the first bond cleavage reaction of collinone (41). But the ring C of 
collinone (41) is reduced and aromatization of the ring C is observed, which is 
much unexpected. Therefore the structure of secocollinone-2 (60) suggests that 
this metabolite is a reduced derivative of an intermediate in the pathway for the 
generation of the spiroketal function of griseorhodin A (5). A possible 
explanation for the reduction might be that the native intermediate is reduced 
with the involvement of another enzyme of the host bacterium S. albus. Another 
possibility is that the native metabolite reacts further immediately after 
expression by the mutant strain, which makes difficult a detection of the native 
metabolite in a higher oxidation state than collinone (41). A reduction reaction 
as a side reaction during the methylation procedure is rather unexpected. In 
order to obtain an explanation if and how the enzyme might involve in the 
spiroketal formation, an oxidized derivative of secocollinone-2 (60), 
secocollinone-3 (61) is suggested as a possible intermediate as shown in Figure 
3.66.  
                                                                                                  3 RESULTS AND DISCUSSION 
____________________________________________________________________________________________ 
 127 
 
Figure 3.66 Postulted biosynthesis step of GrhO1 and GrhO5 leading to the generation of 
lenticulone (53) using the suggested intermediate secocollinone-3 (61). Postulated 
structure secocollinone-3 (61) is shown in paranthesis. 
The plate extract of S. albus KR5 was reinvestigated and a metabolite with a 
molecular ion at m/z: 551.O79 for [M+H]+ suggesting a molecular formula 
C27H18O13 with a calculated exact mass m/z: 551.082 for [M+H]+ was detected in 
small amounts. This metabolite has the same molecular formula with the 
postulated intermediate secocollinone-3 (61) and supports the possibility of a 
higher oxidized metabolite as a native intermediate for GrhO1.  
These investigations for the function of GrhO1 and the postulated intermediate 
secocollinone-3 suggested a mechanism for the first C-C bond cleavage 
performed by GrhO5, shown in Figure 3.67 (Only the CDE rings are shown). The 
function of GrhO1 might be the subsequent biosynthetic decarboxylation 
reaction of the postulated intermediate (61), leading to the generation of 
lenticulone (53) as shown above in Figure 3.66.  
3 RESULTS AND DISCUSSION 
____________________________________________________________________________________________ 
128 
 
 
Figure 3.67 Suggested mechanisms for the first C-C bond cleavage generating the 
postulated intermediate secocollinone-3 (61).  
The literature survey showed the presence of an intermediate that is similar but 
not identical to the suggested intermediate secocollinone-3 (61 in the 
fredericamycin A (26) carbaspirocyle formation.150 Deletion of the oxygenase 
FdmE resulted in a spiro[4.5]decane scaffold characterized by a cyclohexa-1,2,4-
triketone moiety (63), serving as a missing link between FDM B (62), and FDM 
A (26).150 The isolation of relatively unstable metabolite FDM E (63), supports a 
biosynthetic benzilic acid-like rearrengment leading to a decarboxylation for 
fredericamycin A (26) biosynthesis. Figure 3.68 shows the postulated 
involvement of the enzyme Fdm E in the fredericamycin A (26) biosynthesis.150 
 
Figure 3.68 Postulated involvement of FdmE in fredericamycin biosynthesis. 150 
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In order to obtain more information about the suggested function of GrhO1, 
sequence homology to other tailoring enzymes were investigated by BLAST 
analysis by Kathrin Reinhardt. (Table 3.17).125 
Table 3.17. BLAST analysis results for GrhO1.125 
Protein Amino 
Acids 
Proposed function Sequence Similarity 
(Protein, Origin) 
 
Similarity/ 
Identity [%] 
GrhO1 475 
FAD-dependent 
oxygenase 
RubI/ Streptomyces collinus 
(Unpublished)125 
72/68 
MitR/ Streptomyces 
lavendulae118 
57/44 
SACE_4040/ Saccharopolyspora 
erythrae NRRL 2338151 
55/44 
 
The deleted gene grhO1 was predicted to encode a rare FAD-dependent 
oxygenase carrying their cofactor covalently attached to the enzyme. These 
types of oxygenases are involved in unusual oxidative C-C bond cleavages, such 
as EncM in the enterocin biosynthesis shown in Figure 1.20 in Section 1.5.3.63 
GrhO1 showed homologies to the proteins MitR and SACE_4040, but the 
functions of the proteins are unknown yet.118,151  
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3.4.7 Isolation of Compounds Produced by S. albus KR41 and Structure 
Elucidation of the Compound KS-619-1 (64). 
The metabolites of the knockout strain S. albus KR41, which has the gene grhM 
deleted, were observed as an orange pigment on the mycelium on 2CM agar 
plate growing cultures. In the beginning of the research, the function of the gene 
grhM could not be predicted as an oxygenase because it sequence does not 
show any similarities to any other oxygenase with an identified function. Later 
publications, such as the investigation of the oxygenases FdmM and FdmM1 in 
the fredericamycine A (26) biosynthesis showed that the protein might have a 
function as an oxygenase.152 The HPLC traces and the UV spectra of the 
metabolites in the plate extract of S. albus KR41 are shown in the Figure 3.69. 
Two major components are observed and named as KR41c and KR41c’. Both 
compounds had the same UV spectra, the same ESI-HRMS molecular ion m/z: 
459.1050 [M+H]+ and m/z: 459.1069 [M+H]+ and the same deduced molecular 
formula C26H19O8 (calculated [M+H]+=459.1074 for [C26H19O8]+), which implies 
that the two compounds peaks are isomers of each other. Figure 3.69 shows the 
HPLC trace of the extract and UV spectra of the metabolites KR41c and KR41c’. 
Figure 3.70 shows the HRMS data of both metabolites. 
 
 
Figure 3.69 HPLC trace of the plate extract from S. albus KR41 with UV spectra and LC-
HRMS data of the two major compounds KR41c and KR41c’.  
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Figure 3.70 ESI-HRMS molecular ions observed for the peaks KR41c and KR41c’.  
For the isolation of KR41c and KR41c’, S. albus KR41 was fermented in TSB 
medium. The bacterial mycelium and the growth medium were extracted 
separetly. The detailed procedure for the fermentation and extraction are 
presented in Section 4.1.4.14 and 4.1.4.16. HPLC traces and molecular ions 
detected by ESI-HRMS at m/z: 459.104 for [M+H]+ and at m/z: 459.107 for 
[M+H]+ supporting a molecular formula for both compounds C26H18O8 
(calculated [M+H]+=459.1074 for [C26H19O8]+) shows that KR41c and KR41c’ are 
produced in the liquid culture as well. Extracts of the liquid culture contained 
additional compounds. Figure 3.71 shows the HPLC traces of the fermentation 
extracts obtained from the mycelium (Figure 3.71A) and medium (Figure 
3.71B.). An interesting new component was KR41a, which also occurred in the 
fermentation extract of the GrhO8 oxygenase knockout S. albus KR11. GrhO8 
enzyme predicted to be a FAD-dependent monooxygenase. Detailed 
investigation of S. albus KR11 and the characterization of their metabolites are 
explained further in Section 3.4.8.  
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Figure 3.71. HPLC trace of the fermentation extract of S. albus KR41. A. HPLC trace of the 
mycelium extract. B. HPLC trace of the medium extract. C. UV spectra of the observed 
metabolites KR41a, KR41c, KR41c’, KR41a’. 
KR41a was analyzed by ESI-HRMS. The molecular ion for KR41a was measured 
as m/z: 475.100 [M+H]+. This suggests C26H18O9 as the molecular formula for 
KR41a with a calculated [M+H]+=475.1024 for [C26H19O9]+. Another compound 
KR41a’ has the same suggested molecular formula as KR41a, thus being an 
isomer of KR41a. A red pigment, observed in small amounts, was named KR41b. 
The molecular formula of KR41b was suggested as C26H18O10 with a measured 
m/z: 491.099 for [M+H]+ by ESI-HRMS analysis, and a calculated m/z: 491.097 
for [M+H]+. Figure 3.72 shows the ESI-LC-HRMS data of KR41a, KR41c, KR41b, 
KR41c’, and KR41a’ obtained from the fermentation extract. 
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Figure 3.72 HRMS data of the compounds of the fermentation extract from S. albus 
KR41A. A. LC trace of the metabolites in the extract. B. LC-ESI-HRMS data of the observed 
molecular ions for the detected metabolites. 
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For the isolation of the compounds, S. albus KR41 was grown in 19 L TSB 
medium which was distributed to 1 L baffled flasks, so that each flask contained 
400 mL fermentation culture. After incubation at 220 rpm for 4 days at 30 °C 
the bacteria were harvested by centrifugation and suspended in 50 mL H2O and 
subsequently freeze-dried. The mycellia extract contains the yellow compounds 
KR41c and KR41c’ as major components that have a characteristic UV 
absorption at 360 nm. The extract was used for the isolation of KR41c as 
described in the section 4.1.4.16. The yield of the isolation was 12 mg from 19 L 
of fermentation. During the purification steps it was observed that the two 
compounds were always occurring together even after several separation steps. 
The fraction of KR41c and KR41c’ were rather in an equilibrium state instead of 
occurring as a single peak. KR41c was purified by HPLC several times and was 
used for the NMR measurements. The first attempt to measure NMR spectra in 
DMSO-d6 failed because of decomposition to a green unidentified mixture. The 
color of the compound changed during measurement to green, suggesting 
degradation. The isolation procedure was repeated, and the obtained 10 mg of 
the compound were dissolved in AN-d3. The obtained 1H-NMR, 13C-NMR, HMBC 
and HMQC spectra of the compound are shown in Appendix 2, Figures 2.40-
2.43) 
The carbon spectra showed 22 carbon atoms. The 1H-NMR and HMQC spectra 
showed the presence of two aromatic protons at 6.19 and 6.75 ppm attached to 
the carbon atoms at 107.11 and 123.63 ppm, respectively. Signals in the 1H-
NMR at 11.93 and 11.85 ppm showed the presence of two aromatic hydroxyl 
groups forming hydrogen bonds. Four wide singulets observed at 12.3, 7.4, 5.9 
and 3.3 ppm might belong to additional hydroxyl groups on the compound. One 
methyl group at 1.77 ppm, one ethylene group as a multiplet in the region 2.5 to 
3 ppm and one hydrogen proton at 4.35 ppm were detected in 1H-NMR. The 
carbon atoms observed in 13C-NMR spectra were one quinone carbonyl at 
189.99 ppm, one ester carbonyl at 170.08 ppm, 16 carbon atoms in the aromatic 
reagion from 100 up to 168 ppm, one CH at 54.33 ppm attached to the hydrogen 
atom at 4.35 ppm, one methylene group at 29.27 ppm, and a methyl carbon at 
19.02 ppm. However, the correlations in the HMBC spectra did not allow 
establishing any partial structure of the compound. Low solubility of the 
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compound in the NMR solvents and insability might be a reason for the missing 
spectral data necessary for a further investigation. 
Attempts to derivatize KR41c and KR41c’ with DMS or by acetylation, in order 
to produce a more stable and better soluble derivative, resulted in brown 
colored compound mixtures without any specific product in sufficient amounts, 
which would help for further structure elucidation. The procedure of the 
methylation attempt is described in the Section 4.1.5.17. 
Other metabolites in the S. albus KR41 extract were further investigated. KR41a 
and KR41b with the suggested molecular formulae C26H18O9 and C27H22O12 were 
isolated. Both compounds have a characteristic UV absorption maximum at 470 
nm indicating to a quinolic aromatic structure. The compounds were isolated as 
described in Section 4.1.5.14. The medium extract contained KR41a, KR41b, 
KR41b’ and KR41c. The yellow compounds KR41c and KR41c’ with UV 
absorption maximum at 360 nm were separated from KR41a and KR41b by 
subjecting the extract to Sephadex LH20 column chromatography using 
methanol as mobile phase. Further purification of the compounds KR41a and 
KR41b was carried out by preparative HPLC. The yield of the isolation for 
KR41a was 17 mg and for KR41b 4 mg from 19 L of fermentation. 1H-NMR of 
KR41b showed that the amount and the purity of the compound was not 
sufficent to use for further NMR experiments. For KR41a, 1H-NMR, 13C-NMR, 
HMBC and HMQC spectrum were completely measured. However, it was 
unusual to see that a set of peaks was doubled. The data allow for establishing 
the Western part of the molecule but HMBC correlations of the Eastern part did 
not show correlations for a full structure elucidation. The NMR spectra of KR41a 
is shown in Appendix 2, Figure 2.44-2.48. 
The 1H-NMR spectra showed the presence of four aromatic protons at 8.52, 
6.76, 7.05 and 6.45 ppm. The aromatic hydrogens at 8.52 and 6.45 ppm 
occurred as dublets. The hydrogens at 7.05 and 6.45 ppm gave split signals with 
a coupling constant 2.2 Hz. The HMQC spectra revealed the connection of the 
hydrogens at 7.05 and 6.45 ppm to the carbon atoms at 108.99 and 107.66 ppm, 
respectively. Two hydroxyl groups at 12.40 and 11.98 ppm in the 1H-NMR 
showed the presence of two aromatic hydroxyl groups forming hydrogen bonds. 
An additional aromatic hydroxyl group forming a hydrogen bond at 12.24 ppm 
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was detected. However the integral of the peak was 1/3 of an assigned hydroxyl 
group. Two wide singulets on 11.42 and 3.61 ppm showed the presence of 
additional hydroxyl groups on the compound. One CH3 group at 2.4 ppm, two 
CH2 groups as a multiplet between 2.72 to 2.75 ppm, and, one CH group at 3.3 
ppm were detected in the 1H-NMR spectrum. A methylene group was observed 
at 49.07 ppm in the DEPT, HMBC and HMQC spectra. 13C-NMR spectrum showed 
26 carbon atoms as expected for the predicted molecular formula C26H18O9. 13C-
NMR and DEPT spectra showed the presence of two quinone carbonyls at 
189.38 and 180.92 ppm, one ester carbonyl at 169.11 ppm, 18 carbon atoms in 
the aromatic region from 106 up to 165 ppm, one CH group at 49.07 ppm, two 
CH2 groups at 19.52 and 28.27 ppm and a methyl group at 2.4 ppm. The 
measured 1H-NMR, 13C-NMR, HMQC, DEPT and HMBC spectra are shown in 
Appendix 2, Figures. 2.44-2.48. 
The correlations in the HMBC spectra allowed establishing the partial structure 
KR41a-partial (6c) for the Western part of the compound, which is shown in 
Figure 3.73.  
 
Figure 3.73 The substructure KR41a-partial (6c). (Dashed lines of ring E assigns bonds 
with missing HMBC corelations of the missing substituents causing uncertainity in 
characterizing of the configuration.) 
The aromatic protons at 6.45 and 7.05 ppm showed a meta coupling. The HMBC 
correlations of these protons and the correlations of the hydrogen-bonded 
hydroxyl group at 11.98 ppm did allow establishing the structures of the ring 
system AB fully and the positions of the quinone carbonyl groups. HMBC 
correlations of the aromatic proton at 8.52 ppm and the hydrogen-bonded 
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hydroxyl group at 12.40 ppm were used to confirm the antrachinone structure 
of the ring ABC. Hydrogens of two CH2 groups occurring at 2.72-2.75 ppm 
coupled with the carbon atoms of ring C. Additionally, the ethylene carbon 
atoms coupled with the hydrogen-bonded hydroxyl group at 12.40 ppm and 
aromatic protons at 6.76 ppm connected to ring E. These HMBC correlations 
allowed establishing ring D. However, the suggested hydrogen-bonded hydroxyl 
group at 12.40 ppm showed an uncomplete peak integral of 1/3 of an assigned 
hydrogen atom. HMBC correlations of this hydroxyl proton with the carbon 
atoms at 106.32, 118.45, 138.68 and 159.40 ppm in ring E, with a carbonyl 
carbon at 169.11 ppm and an unassigned carbon atom at 148.15. .The aromatic 
proton at 6.76 ppm occured as a splitted one in the 1H-NMR spectrum. This 
proton is not coupling with any other aromatic proton on the antraquinone part 
of the molecule. It showed HMBC correlations with the ethylene carbon atoms 
and the aromatic carbon atoms at 106.32, 138.68, 139.96 and 159.40 ppm in 
ring E, with a carbonyl carbon at 169.11 ppm and an unassigned carbon atom at 
148.15. It can be expected to have a hydrogen bond causing substitution on the 
ring E, which would lead to the occurring of the hydrogen bonded hydroxyl 
group at 12.24 ppm. The carbon signal at 169.11 ppm suggets that a lactone ring 
might be attached to ring E, but the HMBC correlations of the unassigned 
carbons at 148.15, 49.07, 37.47 and 22.18 ppm did not provide the data to 
prove the structure of ring E further. DEPT spectra showed a CH2 group at 37.47 
ppm. The HMQC spectra showed the connection of this carbon atom to a proton 
at the region 3.2-3.1 ppm but the peak integral in the 1H NMR spectrum was ½ 
of an assigned CH2 signal. Although, the CH2 group at 37.47 ppm showed HMBC 
coupling with the aromatic hydrogen at 6.76 ppm in the ring E. But the spectral 
data did not provide the certain positions of these carbon atoms. The 
substructure for the Eastern part of the molecule could not be established with 
the NMR data obtained.  
The problems occurring with the integrals and the split signals of the peaks on 
ring E might have been evidence, that the molecule was not stable but in an 
equilibrium state causing double peaks and umcomplete peak integrals in the 
1H-NMR spectral data. Therefore a temperture experiment was conducted. The 
1H-NMR spectrum of the compound was measured from 20 °C up to 60 °C in 
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order to observe spectrals, which can prove a temperature depended 
equilibrium. The 1H-NMR measurements were repeated with continuous 
scanning under stepwise increase in temperature up to 60 C, but any changes 
on the could not be observed. The NMR of the temperature experiments are 
shown in Appendix 2, Figure 2.49. 1H-NMR and 13C-NMR data of KR41a-partial 
(6c) for the compound KR41a is shown on Figure 3.74. HMBC correlations of 
the substructure are shown in the Figure 3.75. Table 3.18 shows the NMR data 
obtained for KR41a.   
 
Figure 3.74 The 1H-NMR and13C-NMR data of the partial structure for the compound 
KR41a-partial (6c). (Dashed lines of ring E assigns bonds with missing HMBC corelations 
of the missing substituents causing uncertainity in characterizing of the configuration)  
 
Figure 3.75 The HMBC data of the partial structure for the compound KR41a-partial (6c). 
Table 3.18. Overview of the NMR data obtained for the compound KR41a.  
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1H-NMR peaks are occurring as dublets.  
1H-NMR peaks have incomplete integrals but HMBC couplings with the substructure KR41a-
partial (6c). 
A literature survey showed that the obtained spectral data and the physical 
properties of the compound showed high similarities to a polyketide already 
reported in the literature as KS-619-1 (64), a phosphodiesterase inhibitor with 
the same molecular formula as C26H18O9.153 Figure 3.76 shows the reported 
structure and the NMR data of KS-619-1 (64) reported by Sano et al. 153 
KR41a ( In DMSO-d6) 
Nr. 13C-NMR [ppm] 1H-NMR 
[ppm] 
Nr. 13C-NMR [ppm] 1H-NMR [ppm] 
1 189.38  17 113.26  
2 180.92  18 108.99 7.05 (d,H,CH, J3=2.2 Hz) 
3 169.11  19 107.66 6.45 (d,H,CH, J3=2.2 Hz) 
4 164.42  20 106.51  
5 163.78  21 106.32  
6 159.40  22 49.07 3.3 (H) 
7 157.72  23 37.47 3.2-3.1 ((1/2)CH2) 
8 148.45   24 28.27 2.72-2.75(m,2H,CH2) 
9 139.96   25 22.18 2.4 (3H,CH3) 
10 138.69   26 19.52 2.72-2.75(m,2H,CH2) 
11 138.68      
12 135.16     12.40 (OH) 
13 132.26     12.24 (1/3 OH) 
14 130.09    11.98 (OH) 
15 119.05  8.52(H,CH)   11.42 (bs, OH) 
16 118.45 6.76(H,CH)    3.61 (bs, 2OH) 
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Figure 3.76 A.The structure of the polyketide KS-619-1 (64). B. 1H and 13C NMR data of KS-
619-1 by Sano et al .153 
The NMR data and the antraquinone part of the molecule KS-619-1 (64) 
showed high similarities to KR41a-partial 6c. However, the carbon signals of an 
aldehyde carbonyl and the carbon signals for the methyl group of KS-619-1 (64) 
were not observed in the NMR data of KR41a-partial 6c. It was suggested that 
the structure of the Eastern part of KR41a-partial 6c may be a lactone or 
another ring structure. It was expected to have a hydrogen bond causing 
substitution on the ring E, which would lead to the occurring of the hydrogen 
bonded hydroxyl group at 12.24 ppm. The carbon signal at 169.11 ppm suggest 
that a lactone ring might be attached to ring E, as well. Although with the 
possibility to have the molecular formula C26H19O8 and a pentangular structure, 
as it can be seen by the structure of KR41a-partial 6c, it is very unusual to have 
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problems to see the substituents on ring E. A suggested reason might be that the 
suggested Eastern Part of the molecule is influenced by a intramolecular 
equilibrium. A suggestion for such equilibrium is shown in Figure 3.77. 
 
Figure 3.77 A suggested intramolecular equilibrium as the disturbance of the NMR 
measurements of KR41a. 
It was reported that applying a methylation reaction with diazomethane 
enabled the structural elucidation of the compound KS-619-1 (64). The product 
of the derivatisation reaction KS-619-2 was used for the further structural 
elucidation.153 The compound KS-619-2 was a methylated derivative with four 
methoxy groups and a free hydroxyl group at position 9. According to this 
evidence, a methylation reaction of the compound KR41a it was suggested that 
this could help to obtain more information about the structure of the metabolite 
KR41a and enable elucidating the structure of KR41a. 
KR41a was methylated with dimethyl sulfate (DMS). The procedure for the 
experiment is described in Section 4.1.5.15. The molecular ions detected for the 
resulting compounds by ESI-HRMS analysis were at m/z: 545.1869 [M+H]+, 
543.1677 [M+H]+, 531.1699 [M+H]+ .The suggested molecular formulae for the 
derivatives are  C31H29O9 , C31H26O9 , and C30H26O9 with a calculated molecular 
ion for m/z: 545.1806, m/z: 543.1649, and m/z: 531.1649 for [M+H]+, 
respectively. Figure 3.78 shows the HPLC trace of the products after 
methylation and the detected ESI-HRMS molecular ion of the compounds.  
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Figure 3.78 HPLC trace of the methylation reaction of the compound KR41a and the ESI-
HRMS molecular ion of the major derivatives.  
 
The reported methylated derivative of KS-619-1, KS-619-2, with a molecular 
formula C30H26O9 was suggested to be among the derivatisation products of 
KR41a. However the amount of the compound was not sufficant for further 
NMR experiments. The yield of another major derivative with a molecular 
formula C31H28O9 was 6 mg. The molecular ion detected for this compound was 
at m/z: 545.187 for [M+H]+ The major product of the derivatisation reaction 
was characterezied by 1H-NMR, 13C-NMR and DEPT NMR analysis in CDCl3. KS-
619-2 has four methyl groups and the compound with the suggested molecular 
formula C31H29O9 has five methyl groups, which implies an additional 
methylation of the compound KS-619-1. The compound was named KS-619-3 
(65).The spectral data found to be almost identical to the published data of the 
literature KS-619-2. However, there was a difference regarding a methoxy 
group at C-9 instead of the hydroxyl group at the compound KS-619-2. This was 
evident from extra methoxy group signals in the NMR, as well as from chemical 
shifts of the carbon atoms in the ring C, which were slightly different due to the 
less polar methoxy substituent. The structure of KS-619-3 (65) is shown on 
Figure 3.79. The measured 1H-NMR and 13C-NMR spectra and DEPT data are 
shown in Appendix 2, Figures 2.50-2.54. Table 3.19 shows the obtained 1H-NMR 
and 13C-NMR data for KS-619-3 (65). 
 
530dw Yunt KR41-meth-4_11_01_5587.d: UV Chromatogram, 254 nm 
0 
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Figure 3.79 .Structure of KS-619-3 (65).  
Table 3.19 1H-NMR and 13C-NMR data for KS-619-3 (65). 
KS-619-3 (65). (In CDCl3) 
Position 13C-NMR[ppm] 1H-NMR [ppm]    Position 13C-NMR 
[ppm] 
1H-NMR 
[ppm]  
1 156.61  17 137.06  
2 128.62  18 183.73  
3 132.99  19 125.65  
4 126.16 6.97(s,H) 20 122.46 9.01(s,H) 
5 143.04  21 140.38  
6 29.09 3-3.5(m,2H) 
(8M(m,2H) 
22 126.29  
7 21.70 2.8-2.6(m,2H) 
(m,2H) 
23 168.33  
8 134.18   24 48.52 3.77 (s,2H) 
9 157.01   25 205.26  
10 118.81   26 29.88 
,\ 
 
2.24 (s,3H) 
11 181.94   1-OMe 62.02 3.69 (s,3H) 
12 118.57   15-OMe 56.66 4.00 (s,3H) 
13 162.01   13-OMe 56.03 4.01 (s,3H) 
14 105.29  6.82(s,H) 9-OMe 62.11 4.03 (s,3H) 
15 164.49   23-COOMe 52.53 3.98 (s,3H) 
16 102.42 7.41(s,H)    
 
As a result, the structure of the metabolite KR41a with the molecular formula 
C26H18O9 from grhM deleted strain S. albus KR41 was identified as KS-619-1 
(64). The metabolites KR41c and KR41c’ showed no quinone absorbence at UV 
spectra in the quinolic region 470 nm to 490 nm. The metabolites KS-619-1 
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(64) and KR41b showed UV absorption maxima at 475 nm, which indicates 
aromatic quinone absorption of an antraquinone-type substructure. The 
structure of the quinolic metabolite KR41a, which was identified as KS-619-1 
(64) suggests that the structures of the other quinolic metabolite in the liquid 
culture, KR41b, with a molecular formula C26H18O10 might be a structurally 
related pentangular polyketide. 
However, the structures of both KR41c and KR41c’, which are suspected to be 
tautomers or configuration isomers with a molecular formula C26H18O9, could 
not be obtained. The structure of the quinolic metabolite KR41a with an 
additional oxygen atom, identified as KS-619-1 (64) might suggest that the 
structure of the intermediates KR41c and KR41c’ are structurally related 
pentangular polyhydroxyl aromatic polyketides. It is possible that the 
metabolite KR41c and KR41c’ converted to oxidized species KR41a and KR41b 
during fermentation. However, it can not be excluded that the polyketide 
metabolites produced by S. albus KR41 in liquid medium and on agar plates are 
structurally unrelated, since the metabolite KS-619-1 (64) and KR41b were 
only observed in liquid cultures.  
The identification of the metabolite KS-619-1 (64) provides clear evidence that 
the protein GrhM functions in an early oxidation reaction of pentangular 
biosynthesis intermediates. 
In order to obtain more information about the suggested function of GrhM 
sequence homologies with other tailoring enzymes were investigated by BLAST 
analysis and the results were provided by Kathrin Reinhardt. Table 3.20 shows 
the BLAST results of the enzymes.125 
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Table 3.20 Homologous proteins to GrhM by the BLAST analysis results125 
Protein Amino 
Acids 
Proposed function Sequence Similarity 
(Protein, Origin) 
 
Similarity/ 
Identity [%] 
GrhM 150 Oxygenase 
RubQ/ Streptomyces collinus 
(Unpublished)125 
85/77 
LlpQ/ Streptomyces tendae 
(Unpublished)125 
60/50 
FdmM/ Streptomyces griseus152 54/46 
LlpB/ Streptomyces tendae 
(Unpublished)125 
48/37 
BenG/ Streptomyces sp. 
A299120052 
50/32 
 
Homologs of GrhM can be found in biosynthetic gene clusters of many other 
aromatic polyketides ranging from dodecaketides to pentadecaketides. These 
includes RubQ in γ-rubromycin (37), LlpQ and LlpB in lysolipin X, 125 FdmM in 
fredericamycin A (26),152 and BenG in the benastatin A biosynthetic pathways.52 
Investigation of FdmM and FdmM1 mutant strains showed that the enzymes 
perform early hydroxylations on C-6 and C-8 in the fredericamycin biosynthesis, 
as shown in Figure 3.80.152 The ΔfdmM mutant strain accumulated three 
compounds FDM M-1 (66), FDM M-2 (67) and FDM M-3 (68) whereas FDM M-2 
(67) and FDM M-3 (68) were reported as shunt products of the rapidly 
oxidizing FDM M-1 (66). The ΔfdmM1 mutant strain produced FDM1-1 (66) 
which reacts further to FDM C (70). Figure .3.80 shows the postulated 
involvement of the monooxygenases FdmM and FdmM1 in the fredericamycin 
biosynthesis.  
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Figure 3.80 The postulated involvement of the monooxygenases FdmM and FdmM1 in the 
fredericamycin biosynthesis.152 
The homology of GrhM to FdmM suggests a function for GrhM in the 
hydroxylation of ring C of an aromatic pentangular intermediate. Additionally, 
the presence of the metabolite KS-619-1 (64) in the extract of another mutant 
strain that has the grhO8 gene deleted allows suggesting that the two 
oxygenases work simultaneously or in series which is discussed further in 
Section 3.4.8 and Section 3.7. Figure 3.81 shows the suggested reactions for 
GrhM. The enzyme GrhM is suggested to be responsible for the hydroxylation of 
ring C of the compound KS-619-1 (64) or a previously suggested intermediate 
(71). 
                                                                                                  3 RESULTS AND DISCUSSION 
____________________________________________________________________________________________ 
 147 
 
 
Figure 3.81 The postulated involvement of the oxygenase GrhM in the griseorhodin A 
biosynthesis. 
 
3.4.8 Compounds Produced by S. albus KR11 
The knockout strain S. albus KR11 has the gene grhO8 deleted. This gene is 
supposed to be a FAD-dependent monoxygenase. The metabolites of the 
knockout strain S. albus KR11 were observed after 2 days cultivation on agar 
plates as a yellow pigment, which changed the color to dark brown on the third 
day. The initial compounds observed after 2 days cultivation were extracted 
from the agar plates by using acidic ethyl acetate and measured immediately by 
HPLC and LC-HRMS in order to obtain molecular ions. During extraction, a fast 
colour change in 15 to 20 minutes of the extract to brown was observed, which 
showed that the compounds were highly unstable. It was not possible to 
prevent its degradation either after extraction or during growth in the 
incubator. Figure 3.82A shows the UV spectra, Figure 3.82B the HPLC trace of 
the fresh extract measured, from a plate incubated for 2 days. The measured 
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molecular ion for the initially observed yellow major compound KR11x before 
degradation is shown in Figure 3.82C. 
 
Figure 3.82 UV spectra, HPLC and ESI-HRMS of KR11x of S. albus KR11. 
 
The molecular ion for the metabolite KR11x was measured as m/z: 477.1175 
[M+H]+ and the suggested molecular formula C26H20O9 with the calculated m/z: 
477.1180 for [M+H]+ was obtained. Figure 3.83 compares HPLC traces of the 
fresh extract (A), the same extract after 40 minutes (B), and the extract from a 
plate culture incubated a day longer (C). The Figure 3.83 shows that the 
compound is unstable after extraction and even during incubation in the dark. 
This means the metabolite KR11x is very sensitive to the oxygen in the air. 
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Figure 3.83 A. HPLC trace of the initial metabolites in the plate extract of S. albus KR11 
after 2 days of incubation B. HPLC trace of the plate extract of S. albus KR11 after 40 min. 
C. HPLC trace of the metabolites in the plate extract of S. albus KR11 after 3 days of 
incubation. 
Liquid cultivation of the mutant strain in TSB medium provided another set of 
metabolites with predominating green polymeric pigments on the mycelium 
and brown compounds in the medium. During fermentation, the lipophilic 
absorption material amberlite XAD7 (Sigma-Aldrich, Seelze ) was used to test 
whether the instable compounds would be extracted more efficiently but none 
significant improvement was observed. In order to prevent the degradation of 
the produced metabolites, the incubator was covered up to minimize light 
exposure during fermentation but any change in the fermentation broth was not 
obtained. This showed that the isolation of the initially produced substance 
KR11x from the liquid fermentation procedure was inefficient. However, further 
investigation of the extract was performed, with the hope to isolate a 
structurally related degradation product of the compound, in order to obtain 
insights, about the structure of the initial metabolites. Therefore, the 
fermentation medium was acidified to pH 3 and extracted with ethyl acetate. 
The compound KR11a was isolated by the procedure described in Section 
4.1.5.18. Figure 3.84B shows the HPLC trace of isolated yellow compound 
KR11a with a molecular ion in the MS analysis at m/z: 475.1077 [M+H]+ 
matching a calculated molecular formula C26H18O9 with the calculated [M+H]+ 
m/z: 475.1024 for [M+H]+. The UV spectrum, HPLC retention time and the 
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molecular formula of the compound were identical with the identified as KS-
619-1 (64) in the grhM mutant strain S. albus KR41, which was described in 
Section 4.2.7 in detail. Figure 3.84A shows the HPLC trace of the fermentation 
extract of S. albus KR41 showing KR41a, which was identified as KS-619-1 (64), 
in order to compare the trace of the isolated compound KR11a from grhO8 
mutant strain S.albus KR11. Figure 3.84B shows the HPLC trace of the 
metabolite KR11a. UV spectra of the metabolites KR41a and KR11a are shown 
in Figure 3.84C and 3.84D. 
 
Figure 3.84 A. HPLC trace of the extract from S. albus KR41 B. HPLC trace of KR11a 
isolated from S. albus KR41 C. UV spectra of KR41a identified as KS-619-1 (64) and 
KR11a. D. UV spectra of KR11a identified as KS-619-1 (64) and KR41a 
 
For the isolation of KR11a, S. albus KR11 was grown in 18 L TSB medium. The 
yield of the isolation was 12 mg from 18 L of fermentation. The NMR data of the 
compound were acquired in DMSO-d6. The NMR spectra had great similarity 
with the NMR spectra of KS-619-1 (64). The problem for structural 
characterization was the same with the previous structure elucidation attempts, 
that the NMR correlations of the Western part of the molecule could be 
KR41a KR11a 
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observed but not the NMR correlations of the Eastern part. Based on the 
available data, KR11a suggested being identical to KS-619-1 (64). To verify 
these assumptions, LC-MS/MS data of the compounds were compared. Figure 
3.85 shows the HPLC and ESI-HRMS data KS-619-1 (64) and KR11a. The ESI-
MS/MS fragmentations were identical.medium and mycelium contained 
insoluble green pigments. The medium was extracted and the compound KR11a 
was isolated with the procedure as described in Section 4.1.5.18.  
 
 
 
Figure 3.85 The HPLC and ESI-HRMS data of KS-619-1 (64) that was identified in the 
mutant strain S. albus KR41 and KR11a from the mutant strain S. albus KR11. 
 
For a further prove, KR11a was derivatized with DMS as previously described 
for KS-619-1 (64). The procedure of the methylation is described in detail at 
Section 4.1.4.19. For the reaction 12 mg of KR11a was used. The yield of the 
isolated methylated compound was 3 mg. The identity of the compound was 
determined by comparing the ESI-MS/MS fragmentation pattern KS-619-1 (64) 
to that of KR11a. The HPLC traces of the methylation reaction of KS-619-1 (64) 
and KR11a are shown in Figure 3.85. The ESI-MS/MS fragmentation pattern of 
the two compounds KS-619-1 (64) and KR11a are shown in Figure 3.85. The 
differences at the retention times of the compounds are because of the changing 
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pressure conditions on the HPLC used for the LCMS mashine, which caused a 
deletion in the retention times due to this defect. However, the high resolution 
molecular ions of the derivatisation products and the MS/MS fragmentations of 
the obtained molecular ions proved that the methylated compound KR11a and 
KR41a showed identical methylated derivatives, such as KS-619-3 (65). Figure 
3.86 shows the products of the methylation reactions of KR41a and KR11a. 
Figure 3.87 shows the identical MS/MS fragmentation proving the presence of 
the same compound KS-619-3 (65) as a product of the methylation reactions of 
the metabolites KR41a and KR11a. The identity and structure of KS-619-3 (65) 
is described in detail in Section 3.4.7.  
 
 
Figure 3.86  HPLC traces of the products obtained from the methylation reactions of 
KR41a and KR11a. The compound with an asterix is identified as KS-619-3 (65). 
 
 
Figure 3.87 ESI-MS/MS fragmentation showing the presense of KS-619-3 (65) in both 
products obtained from the methylation reactions of KR41a and KR11a.  
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The fermentation broth of S. albus KR11 also contained a characteristic green 
pigment KR11b, which was also observed in the fermentation broths of the 
grhP and grhL mutant strains. The gene grhP has sequence similarities to 
asparagine synthetases, and the gene grhL suggested being a methyl 
transferase. The green pigment was insoluble in all tested polar and unpolar 
organic solvents. All attempts to isolate this compound were unsuccessful and 
the structure of this green pigment could not be identified.  
In order to obtain KR11b, the bacteria were freeze-dried and stored under 
argon. The only successful method to remove this green pigment from the 
bacterial mycelium was using a mixture of 90% acetone and 10% saturated 
NaHCO3 solution. After filtration of the mycelium and removal of the solvent 
with a rotary evaporator, the crude extract obtained was eluted over silica with 
methanol. However, the compounds bound irreversibly on silica, impregnated 
silica, Sephadex LH-20 material and also reverse phase (C18) silica. With the 
crude extract, a methylation reaction with DMS was also carried out. The 
protocol of the methylation reaction is described in Section 4.1.4.20. The 
product had several green components, but none of the green pigments were 
retained on C18 silica as a definite peak. After purification attempts with 
Sephadex LH-20 using methanol as a mobile phase and subsequent purification 
on silica column chromatography with a mobile phase methanol:ethyl acetate 
(5:1) a green fraction was collected, but the 1H-NMR of the compound showed 
rather a mixture of compounds, which could not be used for further structure 
elucidation experiments. HRMS and EI measurement of the fraction did not 
provide a molecular ion peak. These investigations suggested that the green 
fraction was a mixture of components. It might be also a product of a 
polymerization reaction of an unstable phenolic aromatic intermediate, reacting 
during the fermentation process. 
As a result, the investigation of the extracts from the strain S. albus KR11 proved 
that KR11a from S.albus KR11 is identical to KR41a from S.albus KR41 and both 
metabolites are identified as KS-619-1 (64). The presence of identical 
metabolites in both extracts implies that the substrates of GrhM and the 
oxygenase GrhO8 might be related. However, their function is not identical. The 
unstable metabolite with a molecular formula C26H20O9 that was observed in the 
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extract of the grhO8 mutant strain was not in the extract of the grhM mutant 
strain. Additionally, the intermediates with the molecular formula C26H18O8 that 
are observed in the extract of the grhM mutant strain were not in the extract of 
the grhO8 mutant strain. However, the GrhO8 and GrhM gene deletion strains 
both have the aromatic pentangular compound KS-619-1 (64) with a molecular 
formula C26H18O9 in their extract. The molecular formula of the metabolites with 
an additional oxygen atom KR11x and KS-619-1 (64) suggests that GrhO8 
functions after the oxygenase GrhM and before GrhO9. It can also be suggested 
that the methylation and lactonization reactions are occurring in a later stage of 
the biosynthesis.  
In order to investigate the possible function of GrhO8, sequence homologies of 
GrhO8 were investigated. The results of the BLAST are provided by Kathrin 
Reinhardt. Table 3.21 shows the BLAST results of the protein.125 
Table 3.21. Homologous proteins of GrhO8 determined by the BLAST analysis 
results125. 
Protein Amino 
Acids 
Proposed function Sequence Similarity 
(Protein, Origin) 
 
Similarity/ 
Identity [%] 
GrhO8 534 
FAD-dependent 
monooxygenase 
GrhO9/ Streptomyces sp. JP9515 63/46 
RubL/ Streptomyces collinus 
(Unpublished)125 
60/46 
RubP/ Streptomyces collinus 
(Unpublished)125 
59/46 
GrhO5/ Streptomyces sp. JP9515 57/45 
DntB/ Burkolderia sp. DNT138 56/40 
TcmG/ Streptomyces 
glaucescens139 
57/38 
 
The protein sequence of GrhO8 shows similarities to the oxygenases GrhO9 and 
GrhO5 in griseorhodin A biosynthesis125, RubL and RubP in γ-rubromycin 
biosynthesis,125 TcmG in tetracenomycin biosynthesis,139 and DntB.138 DntB (4-
methyl-5-nitrocatechol (4M5NC (49)) monooxygenase) from Burkholderia sp. 
catalyzes the second step of 2,4-dinitrotoluene degradation by converting 
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4M5NC (49) to 2-hydroxy-5-metylquinone (50) with the concominant removal 
of the nitro group ) as shown in Section 3.4.3 and Figure 3.28.138 The 
hydroxylase TcmG is an oxygenase in the biosynthesis of tetracenomycin C (52). 
TcmG hydroxylates tetracenomycin A2 (51) at positions C-4, C-4A, and C12A to 
give tetracenomycin C (52) as shown in Section 3.4.3 and Figure 3.29 .139 
The isolated pentagular metabolite shows that the initial substrate of GrhO8 is 
an intermediate of the early tailoring steps. This suggests that GrhO8 is a 
hydroxylase. Since the function of the other monooxygenases GrhO9 and GrhO5 
could be predicted by the isolated metabolites collinone (41) and precollinone 
(58) GrhO8 is the last possible candidate among the griseorhodin A cluster 
tailoring enzyms in respect to the sequence homology analysis, which could 
perform the hydroxylation reactions at the carbon atoms at C-6 and C-17 of the 
compounds collinone (41) and precollinone (58). Figure 3.88 shows the 
suggested reactions for the enzymes GrhO8 and GrhM. 
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Figure 3.88 The postulated reactions of GrhM and GrhO8 in the griseorhodin A 
biosynthesis. 
A literature survey revealed a similar dihydroxylation reaction that was 
published by Daum et al. for the monooxygenase PokO2 in the polyketomycin 
(76) biosynthesis.142 Figure 3.89 shows the involvement of the oxygenases 
PokO1 and PokO2 in the polyketomycin biosynthesis. In this case, PokO1 
hydroxylates the position C-4. Subsequently, PokO2 performs a dihydroxylation 
at C-4a and C-12a as shown in Figure3.89. The dihydroxylation reaction will be 
initiated by a proposed epoxidation reaction with a subsequent ring opening 
with addition of a water molecule those results in cis configuration of the 
hydroxyl groups at C-4a and C-12a.142 Further experiments sing gene deletion 
mutants of ΔpokO1, ΔpokO2 and ΔpokO1/ ΔpokO2 showed that the enzyme 
PokO1 can take over the function of PokO2.142 
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Figure 3.89 Proposed involvement of the oxygenases PokO1 and PokO2 in the 
biosynthesis of polyketomycin (76).142 
3.4.9 Compounds Produced by Other Mutant Strains  
After incubation of the grhP and grhL mutant strains on MS agar plates and 
subsequent HRLC-MS analysis, new metabolites were determined. Figure 3.90 
shows the HPLC traces of the ΔgrhL, ΔgrhP and ΔgrhV mutant strains and the 
predicted molecular formulae for the observed metabolites.  
 
Figure 3.90 A. HPLC trace of the extract from grhL mutant S. albus KR4O B. HPLC trace of 
the extract from grhP mutant S. albus KR15 C. HPLC trace of the extract from grhV 
mutant S. albus KR58.( The molecular formulae of the metabolites could not be 
determined by HR-LCMS.) 
 
The mutant strain grhP with a deleted amidotransferase gene produced major 
metabolites with the predicted molecular formulae C26H18O10 (for [M+H]+ 
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measured m/z: 491.0975, calculated m/z: 491.0973), C26H18O11 (for [M+H]+ 
measured m/z: 507.0922, calculated m/z: 507.0922 ) and C52H36O20 (for [M+H]+ 
measured m/z: 981.1870, calculated m/z: 981.1873). The mutant strain grhL 
with a deleted methyl transferase gene produced major metabolites with 
predicted molecular formulae C26H14O9 (for [M+H]+ measured m/z: 471.0695, 
calculated m/z:471.0711), and C26H16O10 (for [M+H]+ measured m/z: 489.0785, 
calculated m/z: 489.0816). In both strain extracts, several additional 
metabolites with 26 carbon atoms were observed. However, the fermentation 
broth of these strains contained also rather green and black unidentified 
pigments, which did not allow isolation of a metabolite in proper amounts for 
further structure elucidation. The observed metabolites indicate intermediates 
with 26 carbon atoms as the detected metabolites in the mutant strain grhM 
and mutant strain grhO8. All intermediates observed indicate an involvement 
of GrhP and GrhL in early tailoring steps. The investigation of the extracts from 
these strains suggested that these compounds might be polyketides with an 
unmethylated pentangular aromatic moiety, but these unmethylated 
metabolites are not stable enough to permit isolation for structure elucidation. 
The lack of the enzymatic methylation on ring A and the lactonization of the ring 
F might be a reason for the observation of instable metabolites and the 
dominantly produced green and black pigments, which might be polymerization 
products initiated by radicalic reactions or oxidations during fermentation.  
The mutant strains S. albus KR61 and S. albus KR58 with a single gene deletion 
of grhU and grhV, respectively, had extremely low production of metabolites. 
Further investigations for a better production of GrhU and GrhV gene deletion 
strains and the produced metabolites of GrhU and GrhV gene deletion strains 
were performed by Kathrin Rheinhardt and Minna Eklund in the group of Prof. 
Piel.  
In order to assign possible functions of the enzymes for which structures could 
be obtained, sequence homology to other tailoring enzymes were investigated. 
The BLAST results for the sequence homology of GrhL, GrhP, GrhU and GrhV 
were carried out by Kathrin Reinhardt. Table 3.22 shows the homology to the 
enzymes to other polyketide tailoring enzymes.125  
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Table 3.22. Homologous proteins to GrhL, GrhP, GrhU and GrhV determined by 
the BLAST analysis results125. 
Protein Amino 
Acids 
Proposed 
function 
Sequence Similarity 
(Protein, Origin) 
 
Similarity/ 
Identity [%] 
GrhL 343 
Methyl 
transferase 
TcmO/ Streptomyces glaucescens123 60/47 
LlpMII/ Streptomyces tendae 
(Unpublished)125 
60/46 
PdmT/ Streptomyces griseus154 54/46 
CmmMI/ Streptomyces griseus143  58/46 
GrhP 625 
Asparagin- 
synthetase 
RubR/ Streptomyces collinus 
(Unpublished)125 
84/76 
Orf1/ Streptomyces refuienes 
subsp. thermotolerans156 
62/48 
LlpA/ Steptomyces tendae 
(Unpublished)125 
62/49 
GrhU 107 Unknown 
RubH/ Streptomyces collinus 
(Unpublished)125 
83/72 
LlpOIII/ Steptomyces tendae 
(Unpublished)125 
80/60 
PdmH/ Actinomadura hibisca154 73/63 
GrhV 102 Unknown 
RubT/ Streptomyces collinus 
(Unpublished)125  
78/70 
FdmQ/ Streptomyces griseus42 66/45 
LlpOII/ Steptomyces tendae 
(Unpublished)125 
66/47 
BenJ/ Streptomyces sp. 
A299120052 
65/47 
 
The protein sequence of GrhL shows homology to O-methyl transferases. 
Homologs of GrhL can be found in biosynthetic gene clusters of other aromatic 
polyketides TcmO in tetracenomycin123, LlpMII and LlpMI in lysolipin X125, PdmT 
in pradimicin154, and CmmMI in chromomycin143 biosynthetic pathways. 
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Griseorhodin A (5) has one methoxy group at ring A, which suggests the 
function of the only metyltransferase homolog GrhL. The importance of the 
investigation of the enzyme was to determine at which stage the methylation 
occurs. The molecular formula C26H16O10 of the major metabolite suggests that 
the methylation occurs to the unmethylated backbone of the compound 
precollinone (58) with a molecular formula C27H20O10. The major metabolites of 
the ΔgrhO8 and ΔgrhM gene deletion strains provided metabolites with less 
than ten oxygen atoms and 26 carbon atoms. The major metabolites of the 
ΔgrhP gene deletion mutant strain that might be involved at the generation of 
lactone function of ring F provided metabolites with 26 carbon atoms and 10 to 
11 oxygens. This suggests that the lactonization occurs before methylation with 
a loss of water and the following methylation leads to formation of the 
metabolites with 27 carbon atoms, such as collinone (41) and precollinone 
(58). 
The protein sequence of GrhP shows homology to asparagine synthetases B. 
These enzymes are glutamine-amido transferases and catalyze an ATP-
dependent transformation of asparaginic acid to asparagin with the usage of 
glutamine as a nitrogen source. This kind of enzymes can also be found in 
biosynthetic gene clusters of other aromatic polyketides such as RubR in the γ-
rubromycin,125 LlpA in the lysolipin X,125 PdmD in the pradimicin,154 and FdmV in 
the fredericamycin A42 biosynthetic pathways. Fredericamycin A (26) and 
pradimicin (29) have lactam rings in their scaffold. However, rubromycins and 
griseorhodin A (5) have lactone rings. Recent work of Chen et al. proved the 
function of FdmV as a tailoring enzyme that is responsible for the generation of 
the amide bond formation for the lactam ring.155 FdmV converts FDM M-3 (66) 
to the corresponding amide FDM M-6 and FDM C (70) to the corresponding 
amide FDM B by utilizing L-Asn, L-Gln, or free amine, as a nitrogen source for 
the lactamization generating the last ring.155 The sequence homology of GrhP to 
FdmV suggests an involvement of GrhP in the lactonization of ring F in the 
griseorhodin A biosynthesis. The metabolite KS-619-1 (51) in the extracts of 
ΔgrhM and ΔgrhO8 mutant strains indicates that the lactone formation of ring F 
occurs after the oxidation steps of GrhM and GrhO8, as a tailoring step. This 
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assumption needs to be proven by further investigation of the enzyme or the 
metabolites. 
Homologs of GrhV can be found in biosynthetic gene clusters of other aromatic 
polyketides. RubT in the γ-rubromycin,125 FdmQ in the fredericamycin A,42 
LlpOII in the lysolipin X,125 and BenJ in the benastatin A52 biosynthetic pathways 
are homologous proteins. Up to now, the functions of these homologous 
enzymes are not clear. to GrhV. The investigation of the mutant strain grhV by 
Kathrin Reinhardt provided metabolites with predicted molecular formulae 
C23H22O10 (for [M+H]+ measured m/z: 459.1319, calculated m/z: 459.1286), and 
C25H18O7 (for [M+H]+ measured m/z: 431.1108, calculated m/z: 431.1125). The 
amount of carbon atoms less than 26 and large amount of hydrogens in the 
predicted molecular formulae indicates that the enzyme might act in the early 
biosynthesis as an early oxygenase or cylase.  
Another enzyme with an unassigned function is GrhU. The mutant strain 
produces extremely small amounts of metabolites. This enzyme shows 
homology to RubH in the γ-rubromycin,125 FdmQ in the fredericamycin A,42 
LlpOIII in the lysolipin X,125 and PdmH in the pradimicin154 biosynthetic 
pathways. The investigations for the function of monooxygenase PdmH in 
pradimicin biosynthesis showed that the enzymes PdmH, and the two cyclases 
PdmK and PdmL are working in synergistic actions to generate the ring C and D 
of the molecule.157 In the absence of one of these enzymes random cyclication 
products are observed. The reason for this is suggested that sequential binding 
and tailoring of long poly-β-ketone by individual enzymes may not be fast 
enough to prevent spontaneous cyclization of the reactive backbone. While an 
individual tailoring enzyme can only bind a portion of the extended polyketide 
chain, a multienzyme complex can effectively span the entire length of the 
uncyclized polyketide to lock the backbone in place and to suppress aberrant 
cyclizations.157 Figure 3.91 shows the postulated early steps of pradimicin A 
biosynthesis.  
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Figure 3.91. Postulated early steps of pradimicin A biosynthesis. 157 
Further functional investigation of the enzymes GrhU and GrhV are necessary to 
assign the oxidation step of these enzymes. At this point it would be necessary 
to remind a successful attempt of Kathrin Reinhardt to obtain a hybrid product, 
benarhodin A (78), of the polyketides griseorhodin A (5) and benastatin A 
(77).125 For this combinatorial approach the minimal PKS of the grh cluster was 
replaced by the minimal PKS of benastatin A cluster. This experiment showed 
that the early oxygenases of grh cluster are able to perform tailoring reactions 
on the polyketide backbone produced by benastatin A minimal PKS. Figure 3.92 
shows the structures of griseorhodin A (5), benastatin A (77) and the 
combinatorial product benarhodin A (78).125 
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Figure 3.92. Griseorhodin A (5), benastatin A (77) and the combinatorial product 
benarhodin A (78) of the griseorhodin A tailoring enzymes and benastatin A minimal PKS 
.125 
This result suggests that the early tailoring enzymes of the grh cluster are able 
to use wide range of substrates for their tailoring reactions. These features of 
the early tailoring enzymes might also be in usage at the griseorhodin A 
biosynthesis and usage of alternative substrates during the early biosynthesis 
could be an option for the early biosynthetic pathway.  
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3.5 In Vitro Enzyme Assay for the Overexpressed Oxygenase 
GrhO6 
To obtain more information about GrhO6 an in vitro activity assay was 
conducted with the isolated compound lenticulone (53). Lenticulone (53) was 
isolated from the extracts of the grhO6 deletion mutant S. albus MP66 as 
described in Section 4.1.5.9. The compound was a good candidate to be an 
important biosynthesis intermediate and a substrate of GrhO6. Investigations of 
sequence homology of the FAD-dependent monooxygenase GrhO6 showed high 
protein similarity with two Baeyer-Villigerases, CmmOI and MtmOIV in the 
chromomycin and mithramycin biosynthesis, respectively.141,143 MtmOIV is a 
Baeyer-Villiger oxygenase in the biosynthesis of the aromatic polyketide 
mithramycin (23), as shown in Figure 3.45, Section 3.4.4. The crystal structure 
of MtmOIV and the kinetic characterization of the enzyme were achieved 
successfully by the group of Prof. Jürgen Rohr.69,144,158 For the kinetic 
characterization of MtmOIV an in vitro assay was performed by using an 
isolated mithramycin precursor, premithramycin (56) (Figure 3.45), on an 
optimal pH of 8.25.69 The procedure for the in vitro activity assay reported by 
Rohr and coworkers Gibson et. al was applied for the compound lenticulone 
(53) and GrhO6, in order to find out whether the enzyme accepts this 
compound as a substrate and if the enzyme acts in a similar way as MtmOIV.69 
Additionally, the experiment was an option to obtain possible products of the 
oxygenation reaction of GrhO6. 
A first important aspect for the assay was to find suitable conditions for the 
optimal activity of GrhO6 in vitro. Second, the stability of the compound was 
investigated because some of the griseorhodin biosynthesis intermediates and 
metabolites detected are not stable at basic conditions, especially lenticulone 
(53). It was an additional challange that in comparison to lenticulone (53) in 
comparison to premithramycin (56), the former precursor used in the in vitro 
assay studies for MtmOIV, is a less stable compound.69 Therefore, optimal pH 
conditions for the assay were to be determined through examining the stability 
of the compound over a range from pH 6 up to pH 8.5. Meanwhile the 
expression, kinetics and the stability of Grh06 were investigated as a part of the 
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PhD work of K. Rheinhardt and H. Niederkrüger, and is described in details in 
their PhD thesis.125 Determination of an optimal pH, monitoring the assay and 
chemical investigation of the resulting products, which was the analytical part 
of the assay, were done in the context of this work.  
3.5.1 Optimal pH Determination  
The test substance lenticulone (53) was dissolved in Tris buffer at pHs 6; 6.5; 7; 
8.25; 8.5 and 9 to test the stability of the compound. This was monitored by 
HPLC. MtmOIV is functioning in slightly basic solution at pH 8.25 but the test 
substance GrhO6 is instable at pH 7 and higher. Figure 3.93A shows the HPLC 
trace of lenticulone (53) dissolved in acetonitrile after isolation procedure 
described in Section 4.1.5.9. The occurrence of lenticulone (53) peak is marked 
with an asterix. Figure 3.93B shows the compound redissolved in Tris buffer at 
pH 6.5 and Figure 3.93C shows the compound redissolved in Tris buffer at pH 
8.25. The compound is unsatbleand at pH values higher than 7 leading to the 
occurrence of a second substance with the same molecular weight. Therefore, 
an assay condition between at pH 6 and pH 7 was preferred.  
Figure 3.93A. HPLC trace of lenticulone (53) dissolved in acetonitrile. B. HPLC trace of 
lenticulone (53) redissolved in Tris buffer at pH 6. C. HPLC trace of lenticulone (53) 
redissolved in Tris buffer at pH 8.25. The occurrence of lenticulone (53) peak is marked 
with an asterix. 
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3.5.2 Assay 1: 
For the first assay the reaction was performed in an open 50 ml Falcon tube at 
30 C at 250 rpm with a total volume of 2 ml. The assay was carried out in 1 M 
Tris buffer at pH 6 with 1 mM NADPH and 10 M FAD as co-factor for a total of 
4 hours reaction time as described in Section 4.1.6.1. 150 L of 1 mM enzyme 
was added to the prepared mixture and every 30 min 400 L of the solution was 
removed and extracted with 250 l ethyl acetate. Subsequently, the organic 
phase was evaporated on a speed evaporator. The extract was dissolved in 50 
L acetonitrile and subjected to RP-HPLC with a mobile phase of 
acetonitrile/water (40:60 to 100:0). In parallel to this reaction a positive 
control reaction without enzyme and a negative control reaction without 
substance were also performed. During the reaction a light precipitation was 
observed. The detailed procedure of the reaction is described in Section 4.1.6.1. 
Figure 3.94 shows the monitored results of assay 1 and the control reaction 
monitored for assay 1. The control reaction did not contain the enzyme but all 
other components of the assay mixture. 
As a result, the first assay at pH 6 and at 30 C did not show any differences 
between the test reaction and the control reactions. The additional compound at 
the retention time of 11 min, which was mentioned in the degradation of the 
compound in the pH determination, was observed again. This assay leads to the 
assumption that the change in composition was due to the natural degradation 
but not the activity of the enzyme. 
In order to observe more metabolites the assay was performed at larger scale 
and the reaction conditions were slightly changed. of the extraction For 
monitoring the composition of the assay better, the extraction procedure was 
additionally improved.  
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Figure 3.94 HPLC traces of assay 1 at pH 6 and the control reaction. The assay on the top 
was performed for a period of 4 hours and the composition was monitored by taking 
samples every hour. Meanwhile a control assay without enzyme was monitored, which is 
shown at the bottom. 
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3.5.3  Assay 2: 
The reaction was performed in an open 50 ml Falcon tube at 30 C at 225 rpm. 
The total volume of the reaction was 5 ml. The assay was performed in 1 M Tris 
buffer at pH 6 and 7 as assay 2a and 2b, respectively. It was performed with 1 
mM NADPH and 10 M FAD as co-factor for a total of 4 hours reaction time. The 
detailed procedures for the assays 2a at pH 6 and 2b at pH 7 are in Section 
4.1.6.2. For the assay, freshly purified GrhO6 was used. A light precipitation 
during the assay and strong precipitation during the extraction procedure was 
observed. Figure 3.95 shows the results of assay 2a at pH 6 and the results of 
the control reaction for the assay 2a. Figure 3.96 shows the results of the assay 
2b at pH 7 and the results of the control reaction for the assay 2b. 
As a result, in the second assay at pH 6 at 30 C, the assay mixture contained the 
same compounds as the compounds in the control reaction. The presence of 
enzyme did not result in a formation of a new product. However, the 
concentrations of the compounds in the first assay differed from the 
concentrations observed in the control assay. The likely main cause for this 
observation might be the protein precipitation in the reaction mixture effecting 
the extraction of the components and the yield of the compounds changes due 
to the extraction method used. Analysis of 2a at pH 6 showed that the change of 
the substrate due to the natural degradation of the compound but not the 
activity of the enzyme. Analysis of 2b at pH 7 at 30 C showed the same results 
as 2a. The presence of enzyme did not cause formation of a new product at the 
chosen pH conditions.  
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Figure 3.95 HPLC traces of assay 2a at pH 6 and the control reaction. The assay on the top 
was performed for a period of 4 hours and the composition was monitored by taking 
samples every hour. Meanwhile a control assay without enzyme was monitored, which is 
shown at the bottom. 
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Figure 3.96 HPLC traces of assay 2b at pH 6 and the control reaction. The assay on the top 
was performed for a period of 4 hours and the composition was monitored by taking 
samples every hour. Meanwhile a control assay without enzyme was monitored, which is 
shown at the bottom. 
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3.5.4  Assay 3: 
In order to obtain better conditions for the enzyme activity and stability, in 
another assay at the temperature was lowered to 27 C and the pH 8.25 was 
tested, although the risk of substance degradation of lenticulone (53) was 
higher. The rationale was here that the enzyme might function better at this 
basic pH.  
The reaction was performed in 1 M Tris buffer at pH 7 and 8.25 with 1 mM 
NADPH and 10 M FAD as co-factor in a total of 4 hours reaction time. The 
detailed procedure is as described in the Section 4.1.6.3. The extraction 
procedure for the metabolites was slightly changed. The changes applied were 
that the solution taken out every hour was acidified before proceeding with the 
extraction with ethyl acetate. The compound was not soluble in organic solvents 
without being protonated; therefore samples of the assays at pH 7 were diluted 
with an equal amount of 0.025 % TFA solution and then extracted. The samples 
of the assays at pH 8.5 were diluted with 2 ml of the 0.025 % TFA solution. 
Figure 3.97 and 3.98 shows the observed metabolites during the assay at pH 7 
and 8.25. Figure 3.97 shows the monitored composition of the assay 3a at pH 7 
and the control solution without enzyme. Figure 3.98 shows the monitored 
composition of the assay 3b at pH 8.25 and the control solution without enzyme. 
As before, assays at both pH values did not yield any compounds different from 
the ones observed in the control assays without enzyme. Thus it was concluded 
that the products of the assays were again a result of a spontaneous degradation 
of the initial substrate lenticulone (53). 
In summary, in vitro enzyme assays for the overexpressed GrhO6 oxygenase 
were investigated for the acidic pH 6, for pH 7, and for the basic pH 8.25 and 
compared to the control assay without enzyme. There was no difference 
observed to the natural degradation of the compound. The reason for these 
results might be that the substrate lenticulone (53) is not the natural substrate 
of the enzyme or the assay conditions found in the literature is not applicable 
for this substrate. The substrate lenticulone (53) is less stable than the 
substrates used in other assays, such as premithramycin (56). Additionally, 
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lenticulone (53) has low solubility in aqueous solutions; therefore small 
amount of DMSO was added to increase the solubility of the compound and to 
avoid a precipitation of the compound, which might have a negative effect on 
the enzyme function. Another possibility is that the overexpressed GrhO6 
enzyme was not active at the chosen in vitro assay conditions. At that point it is 
important to recall, that the metabolic analysis of the mutant strains suggested 
an involvement of the protein GrhJ at the processing of the candidate substrate 
lenticulone (53). GrhO6 and GrhJ might therefore form a complex and 
lenticulone (53) might not be oxygenated in the absence of GrhJ.  
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Figure 3.97 HPLC traces of assay 3a at pH 6 and the control reaction. The assay on the top 
was performed for a period of 4 hours and the composition was monitored by taking 
samples every hour. Meanwhile a control assay without enzyme was monitored, which is 
shown at the bottom. 
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Figure 3.98 HPLC traces of assay 3b at pH 6 and the control reaction. The assay on the top 
was performed for a period of 4 hours and the composition was monitored by taking 
samples every hour. Meanwhile a control assay without enzyme was monitored, which is 
shown at the bottom. 
Assay 3b: pH 8,25 / 27° C
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3.6 Assays For Determining The Bioactivity of Isolated 
Compounds 
To determine the bioactivity of the isolated compounds, the antibacterial 
activity of pure polyketides and some of the crude extracts were tested. In order 
to determine the impact of the oxidative modifications occuring during 
griseorhodin A (5) biosynthesis on the bioactivity of the metabolites, 
antiproliferative and cytotoxic properties of the compounds were tested in 
cooperation with the group of Hans Martin Dahse in HKI, Jena.  
It was reported that some oxaheterocylic natural products are known to inhibit 
serine proteases. Examples are the inhibition of trypsin by flavonids and of 
thrombin by triterpene lactones from Lantana camara. 159 The substances of the 
griseorhodin family, which carries a lactone ring attached to the aromatic spiro 
moiety, were never tested for such an activity. Therefore, serine protease 
inhibiting activity of the isolated compounds and some extracts were tested in 
the group of Michael Gütschow. 
3.6.1 Assays for Determining Antibacterial Activity 
To determine the antibacterial activity of the compounds and metabolites in the 
extracts, two assays were performed. For the compound collinone (41), an 
antibacterial activity for Gram-positive and Gram-negative bacteria has been 
reported in the former studies.82 The first assay was an agar diffusion assay, 
which was performed on agar plates. For compounds showing an activity, a 
second assay was performed to determine the minimal inhibition concentration 
(MIC). This assay is for determination of the concentration range of growth 
inhibition on the test bacteria. 
3.6.1.1 Agar Diffusion Assay 
 Water-soluble molecules can diffuse through the agar. The compound can be 
applied to a well that is cut into the agar. Alternatively, a cellulose disk with the 
compound applied on it can be used to place the substance on the agar. The 
compound will tend into the agar depending on its solubility. Before placing the 
substance on the agar plate, a bacterial test strain without antibiotic resistance 
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has to be spread on the plate, so that the growth inhibition of the strain can be 
observed after an overnight incubation. The principle is that the antibiotic will 
diffuse out of the disk into the agar and in the surrounding area of active 
compounds, generating a zone without bacterial growth. The radius of the area 
can then be measured, providing the inhibition zone of the compound for the 
chosen strain. This version of agar diffusion assay is known as the Kirby-Bauer 
disk diffusion assay.160,161 Isolated substances and some of the crude extracts 
were used for this assay to observe the ones with an inhibition activity and to 
proceed further with a MIC assay. The compounds and some of the crude 
extracts obtained from the mutant strain were tested against the test bacterial 
strains below, which were available in our labarotories. 
 Escherichia coli DH5α (Gram-) 
 Staphylococcus carnosus DSH 20501 (Gram+) 
 Bacillus amyloliquefaciens (Gram+) 
 Pseudomonas fluorescens DSH 50090T (Gram-). 
 
The aromatic polyketides used for the assay had very low water solubility. In 
order to achieve a better solubility, a little amount of DMSO was used to 
increase diffusion properties. The diffusion was few and unsymmetrical. 
Therefore the inhibition zone could not be determined as a value, but the 
growth inhibition on the disc surface and borders was an evidence for an 
antibacterial activity. A detailed procedure of the assay carried on is given in 
Section 4.1.7.1.  
For the assay, the compounds griseorhodin A (5), dideoxygriseorhodin C (46), 
lenticulone (53)were used, which have differently configured spiro centers. 
Additionally, the compounds collinone (41) and precollinone (58) with a 
pentangular aromatic moiety were tested. For all compounds the procedure for 
isolation are given in Chapter 3.4. The crude extract of the mycelium obtained 
from the strains S. albus KR5 and S. albus KR11 and the extract of the medium 
from the fermentation of S. albus KR11 were also used for this assay. The 
extracts of these strains contained compounds that could not be characterized 
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without derivatisation reactions. In order to see if the original metabolite 
mixture contains active compounds, the test with these crude extracts was 
performed. The procedures of the extraction are provided in Chapter 3.4, as 
well. The substances with an assumed activity against test bacteria were 
assayed further to determine the MIC values as described in Section 3.6.2 in 
detail. Results of the agar diffusion assay are listed in Table 3.23. Figure 3.99 
shows pictures of the assay plates. 
Table 3.23 Results for agar diffusion assay. Presence of an inhibition zone is 
remarked as (+) and upsence of an inhibition zone is remarked as (-). 
Bacterial strains Tested compounds on agar diffusion assay 
 Lenticulone 
(53) 
Collinone 
(41) 
Griseorhodin A 
(5) 
Dideoxygriseorhodin 
C (46) 
Escherichia coli 
DH5α 
- + - - 
Staphylococcus 
carnosus DSH 
20501 
+ + + + 
Bacillus 
amyloliquefaciens  + + + + 
 
Bacterial strains Tested compounds and extracts on agar diffusion assay 
 S. albus 
KR11 
Medium- 
Crude 
extract 
S. albus 
KR11 
Mycellium-
Crude 
extract 
S. albus 
KR5 
Mycellium 
Crude extract 
Precollinone 
(58) 
Escherichia coli DH5α  - - - - 
Staphylococcus carnosus DSH 
20501 
+ - - + 
Bacillus amyloliquefaciens  + - - + 
Pseudomona fluorescens 
DSH 50090T  - - - - 
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Figure 3.99 Results for agar diffusion assay. Pictures A, B, C, D show the agar diffusion 
assays of griseorhodin A (5), didesoxygriseorhodin C (46), lenticulone (53), and collinone 
(41) to the strains Staphylococcus carnosus DSH 20501, Bacillus amyloliquefaciens DSH 
50090T and Escherichia coli DH5α shown as a, b and c, respectively. Pictures E and F show 
the agar diffusion assays of precollinone (58) and the extract of the medium from the 
fermentation of S. albus KR11 to the strains Staphylococcus carnosus DSH 20501, Bacillus 
amyloliquefaciens DSH 50090T, Escherichia coli DH5α and Pseudomonas fluorescens DSH 
50090T shown as a, b, c and d, respectively. (K= Control disk without compound, 1, 2 and 
3 = disks with 20, 10 and 5 µg test substance, respectively. For the assay F, 1, 2 and 3 = 
Disks with 40, 20 and 10 µg test extract, respectively.) 
As a result of the agar diffusion assays for the antibacterial activity, it is 
concluded that lenticulone (53), griseorhodin A (5), didesoxygriseorhodin C 
(46), precollinone (58) and collinone (41) inhibit the growth of the two Gram+ 
strains, Staphylococcus carnosus DSH 20501 and Bacillus amyloliquefaciens DSH 
50090T. It was also observed that collinone (41) inhibits also the growth of the 
Gram- strain Escherichia coli DH5α. The crude extract of the mycelium obtained 
from S. albus KR5 and S. albus KR11 showed no activity. The extract of the 
medium from the fermentation of S. albus KR11 tested showed low inhibition of 
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the two Gram+ strains, Staphylococcus carnosus DSH 20501 and Bacillus 
amyloliquefaciens DSH 50090T. 
 
3.6.1.2 Minimum Inhibitory Concentration (MIC) Assay 
This method is used to determine the minimum concentration of a potential 
antibiotic compound at which the growth of a selected test organism is 
inhibited. A set of tubes with decreasing amount of the test compound is 
prepared in a growth medium and is inoculated with the test organism. For an 
active compound, growth diminishes as the concentration of antibiotic 
increases and a minimal concentration can be observed at which growth does 
not occur. This concentration is the MIC value. A detailed procedure of the assay 
carried on is is in Section 4.1.7.2. For all the used compounds the procedure for 
isolation are given in Chapter 4.1.4. The compounds obtained from the mutant 
strain were tested against the bacterial strains below.  
 Staphylococcus carnosus DSH 20501 (Gram+) 
 Bacillus subtilis (Gram+) 
 
The list of the determined MIC values for the test compounds griseorhodin A 
(5), didesoxygriseorhodin C (46), lenticulone (53), precollinone (58) and 
collinone (41) are listed in Table 3.24. 
Table 3.24 Results for MIC assays. 
Tested Substances 
MIC value for 
Staphylococcus carnosus 
[µg/ml] 
MIC value for 
Bacillus subtilis 
[µg/ml] 
Griseorhodin A (5) 1.44 0.013 
Lenticulone (53) 22.25 5.56 
Collinone (41) 5.38 2.69 
Didesoxygriseorhodin C (46) 0.23 0.004 
Precollinone (58) 3.92 3.92 
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As a result of the MIC assays, it is concluded that the spiroketal compounds 
griseorhodin A (5), didesoxygriseorhodin C (46) and the spiro compound 
lenticulone (53) have higher antibiotic activity against both Gram-positive 
strains in comparison to the pentangular aromatic polyketides precollinone 
(58) and collinone (41). The exact mechanism of the inhibition is not known 
but the spiro structures might play an important role at the antibacterial 
activity of these aromatic compounds. On the other hand, the lower solubility of 
these aromatic spiro compounds in water is a disadvantage for the use of their 
high activity as an antibiotic. 
3.6.2 Antiproliferative Activity and Cytotoxicity 
Organisms are utilizing against oxidative damage polyphenolic compounds, 
such as quercetin and myricetin and it is suggested that they may have the same 
role in humans.162,163 Their features include antitumoral, antiviral, antibacterial, 
cardioprotective and anti mutagenic activities. They may play a role at different 
stages of malignant tumors by protecting DNA from oxidative damage.164,165 
Inactivation of carcinogens by inhibiting the expression of mutogenic genes; 
inactivation of the enzymes activating procarcinogenes and activation of the 
systems responsible for the detoxification of xenobiotics are some properties 
observed among these compounds which makes them an important tool for the 
life prolongation of organisms. 166,167 
For some polyphenolic compounds, such as flavanones, it is known that the 
antiproliferative activity and the cytotoxicity can be strongly influenced by the 
oxidation degree of the compounds.166 Cytotoxicity compounds are toxic to cells 
and antiproliferative compounds are toxic to certain tumoral cells. It is 
important for a potential drug candidate compound to obtain low cytotoxicity, 
whilst also conserving the neccesary pharmacological activity in order to 
achieve an in vivo application as a drug. 
 To determine how the degree of oxidative modification during griseorhodin 
biosynthesis affects bioactivity, collinone (41), griseorhodin A (5), lenticulone 
(53), and didesoxygriseorhodin C (46) were tested in antiproliferative and 
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cytotoxicity assays in the facilities of the HKI, Jena, by Hans Martin Dahse. Table 
3.25 shows the determined activity of the compounds. 
As a result, in general, the activity of all those compounds were in the same 
range, with didesoxygriseorhodin C (46), being slightly less active in all assays 
and lenticulone (53) showing decreased activity only in the Huvec assay. 
 
Table 3.25 Antiproliferative activity and cytotoxicity of the compounds 
obtained from the mutant strains.  
 Antiproliferative activity Cytotoxicity 
Compound Huvec 
 GI50   
µg/mL 
K-562  
GI50  
 µg/mL 
HeLa  
CC50  µg/mL  
(CC10  µg/mL) 
Collinone (41) 22.6 19.4 30.7 (8.6) 
Griseorhodin (5) 42.8 36.5 38.5 (14.2) 
Lenticulone (53) 34.2 19.8 33.8 (12.4) 
Didesoxygriseorhodin C (46) >50 18.4 47.0 (21.8) 
 
3.6.3  Protease Inhibiting Activity 
A protease is an enzyme that breaks down proteins and initiates the protein 
catabolism by hydrolysis of the peptide bonds. Proteases can either break 
specific peptide bonds or break down a complete peptide to amino acid 
monomers depending on the sequence of a protein. Proteases can be classified 
regarding to the amino acids at the peptide bond they break as serine, 
threonine, cysteine, asparagine and glutamic acid proteases.168 Alternatively, 
proteases may be classified by the optimal pH in which they function optimal 
such as acid, neutral or basic proteases or the structural features can also be 
used for classification such as metalloproteases.168 
Proteases naturally occur in all organisms. They are involved in many 
physiological reactions. These reactions can be found in digestion or highly 
regulated cascades such as blood cloting, apoptosis, and the complement 
system.168 They determine the lifetime of other proteins playing important 
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physiological roles like hormones, antibodies or other enzymes. In organizms 
these enzymes are used as one of the fastest switching tool for the regulatory 
mechanism.168,169 
Bacteria also secrete proteases to digest proteins.168 They can utilize these 
enzymes as exotoxins to destroy extracellular structures or as virulence factors 
in bacterial pathogenesis. Some viruses, such as HIV, are dependable on the 
activity of specific proteases in their reproductive cycle. They are Protease 
inhibitors investigated and developed for antiviral activity. One example of 
protease inhibition is the serpin superfamily.168-170  
3.6.3.1 Serine-Protease Inhibiting Activity 
To determine whether the metabolites of mutant S. albus strains show any 
activity against serine proteases, an enzyme inhibition assay for the serine 
proteases trypsin, chemotrypsin and human leukocyte elastase (HLE) were 
performed in the group of Prof. Michael Gütschow by Stephanie Hautmann 
using the crude extracts. The assays were carried out in vitro. The assays for 
chymotrypsin and trypsin inhibiting activity were performed with 25 ng/mL 
enzyme and 50 μg/mL test extract. Changes in the relative enzyme activity were 
monitored with a UV spectrometer. For the assay with human leukocyte 
elastase (HLE), 20 μg/mL of each extract was used and the activity of the 
enzyme was monitored by the concentration changes of the substrate para-
nitroaniline (pNA) at 405 nm. The crude extracts do not show trypsin and 
chymotrypsin inhibitin activity. Inhibition of the enzyme human leukocyte 
elastase (HLE) was observed and was investigated further.  
3.6.3.2 Elastase-Inhibiting Activity: 
Elastase is an enzyme from the class of proteases. Human elastase breaks down 
elastin. Elastin fibers and collagen determine the mechanical properties of 
connective tissue. It cleaves the peptide bonds on the carboxy side amino acids 
such as glycine, alanine, and valine. Other features of these enzymes are to 
break down the outer membrane protein of Gram-negative bacteria, and also to 
break down Shigella virulence factors. 171-173 
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Organisms such as P. aeruginosa also produce specific elastases, that are 
considered as virulence factors.174 Some bacterial elastase has been shown to 
damage tissue, break down cytokines and alpha proteinase inhibitors, 
disturbing the complement system and decrease the ability of neutriphiles to 
kill bacteria by phagocytosis and contribute to human pathology. 171 
In order to determine extracts containing potential HLE inhibitors, a preassay 
was carried out by the group of Prof. Gütschow at the Pharmaceutical Institute 
in the University of Bonn. Table 3.26 shows the provided extracts for the assay 
and the effects of the extracts on the relative enzyme activity. The crude extracts 
of the strains S. albus KR4, S. albus KR5, S. albus KR7 S. albus KR8, S. albus KR13 
and S. albus MP70 showed activity in the HLE screening.  
Table 3.26 Effects of the compounds in the crude extracts of the mutant S. albus 
strains on the activity of human leukocyte elatase (HLE) screening. Active 
extracts are marked with an asterisk. 
Crude extract of the strain Concentration used 
[μg/mL] 
Relative activity of the 
enzyme (HLE) in % 
S. albus KR4 20 18 
S. albus KR5 100 16 
S. albus KR7 20 17 
S. albus KR8 20 20 
S. albus KR13 20 46 
S. albus MP31 20 40 
S. albus MP36 20 64 
S. albus MP63 20 71 
S. albus MP66 20 31 
S. albus MP70 20 26 
 
The crude extracts of the strains S. albus KR4, S. albus KR5, S. albus KR7, S. albus 
KR8, S. albus KR13 and S. albus MP70 were further used to determine the IC50 
values for the concentration of HLE inhibition. The obtained values for the crude 
extracts are listed in the Table 3.27. 
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Table 3.27 IC50 values of the crude extracts for the inhibition of the HLE 
enzyme. 
Crude extract of the strain Consentration range tested IC50 [μg/mL] 
S. albus KR4 6.67-26.67 μg/mL 6.63± 0.63 μg/mL 
S. albus KR5 25-100 μg/mL 9.21±2.05 μg/mL 
S. albus KR7 6.67-26.67 μg/mL 3.10±0.83 μg/mL 
S. albus KR8 6.67-26.67 μg/mL 7.41±1.48 μg/mL 
S. albus KR13 10-40 μg/mL 16.3±0.5 μg/mL 
S. albus MP70 6.67-26.67 μg/mL 14.4±2.7 μg/mL 
 
The extracts were further investigated and the major compounds in the extracts 
were determined and isolated. Griseorhodin A (5) is the major component of 
the extracts from S. albus KR4, S. albus KR13, and S. albus MP70. 
Didesoxygriserhodin C (46) is the major component of the extract from S. albus 
KR7. The strain S. albus KR8 produces the compound collinone (41) as a major 
metabolite. The major metabolite of S. albus KR5 could not be obtained without 
derivatisation reactions and was not used for further experiments. Lenticulone 
(53) was isolated from S. albus MP66 and was also provided for further 
investigation of the active compounds. The IC50 values for the compounds were 
determined in the group of Prof. Gütschow. The details of the test methods were 
used are published. 13 Table 3.28 shows the obtained IC50 values for the 
compounds.  
 
Table 3.28 The obtained IC50 values for the active compounds. 
Compound IC50 [μg/mL] 
Collinone (41) 4.763±1.040 
Griseorhodin (5) 0.957±0.086 
Lenticulone (53) 1.396±0.308 
Didesoxygriseorhodin C (46) 0.690±0.160 
 
 As a result of these assays, the spiro structure of the compounds directly 
influences the inhibiting activity for the HLE enzyme. Didesoxygriseorhodin C 
(46) showed a considerable activity, and it became the first reported aromatic 
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polyketide inhibiting the HLE enzyme strongly.99 Additionally, the spiro 
compounds griseorhodin A (5) and lenticulone (53) exhibited stronger 
inhibitors than the pentangular aromatic compound collinone (41). These 
compounds are the first reported aromatic polyketides with high HLE inhibitory 
activity. An important achievement of this investigation is that it opens the way 
for a new class of HLE-inhibiting substances containing aromatic spiro moietys. 
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3.7 Summary and Discussion of Griseorhodin A Biosynthesis 
 
Griseorhodin A (5) is the most heavily oxygenated member of the rubromycin 
family of aromatic polyketides with a unique epoxyspiroketal moiety. Many 
rubromycins, such as γ-rubromycin (37), purpuromycin (38), and griseorhodin 
A (5) are inhibitors of human telomerase and β-rubromycin shows inhibiting 
activity of retroviral reverse transcriptases, such as HIV.97 They possess a non-
planar structure due to the presence of this spiroketal moiety. Telomerase 
inhibition depends on the presence of the spiroketal moiety.97 Therefore, the 
study of the biosynthesis of the spiroketal moiety is important for the 
development of more potent and selective inhibitors. 
The compound is synthesized by a type II PKS. The initial steps of the 
biosynthesis are the synthesis of a poly-β-keto chain by the minimal PKS 
GrhABC initiated with an acyl-CoA starter and the iterative condensation of 12 
malonyl-CoA extender units for the chain elongation of the chain. Reduction of 
the poly-β-keto chain intermediate at C-19 by a ketoreductase and catalytic 
cyclization reactions directed by the cyclases generate a pradimicin-type 
pentangular aromatic core that is further converted by the tailoring enzymes 
into griseorhodin A (5).15 The biosynthetic steps in the generation of the 
aromatic core were not investigated during the course of this work. However, 
sequence homology of GrhU, GrhQ and GrhS to the cyclases PdmHKL in the 
pradimicin biosynthesis suggest that GrhU, GrhQ and GrhS act early in the 
biosynthesis of the pradimicin-type aromatic core.154,157 The focus of this work 
is the tailoring steps that generate the spiroketal pharmacophore in the 
biosynthesis of griseorhodin A (5). This section provides an overview of the 
studies performed to gain deeper insights into the complex biosynthesis of the 
compound, and discusses the postulated biosynthesis pathway suggested by the 
results obtained from the investigations of the griseorhodin A cluster. 
In general, a heterologous expression system has to be created in order to 
simplify studies on the biosynthesis of griseorhodin A (5) and rubromycin-type 
spiroketal compounds. Such an expression system was created by Aiying Li.15 
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The expression strain S. albus MP31, which carried the entire griseorhodin A 
gene cluster integrated into its genome, was constructed by using the host 
strain S. albus J1074. For further functional investigation of the genes and the 
biosynthetic pathway, 20 genes of the cluster were individually deleted by 
Kathrin Rheinhardt via -red-mediated recombination on the plasmid pMP31 
containing the entire griseorhodin A cluster. Subsequently, the resultant mutant 
clusters were heterologously expressed after conjugation into the S. albus J1074 
host strain.99,125  
 To achieve the major objective of this thesis, the chemical investigation of these 
mutant strains was performed and the determination of the functions of the 
encoded enzymes of the deleted genes was attempted. To characterize the 
metabolites resulting from the single gene knockout experiments, the mutant 
strains were grown on 2CM agar plates; metabolites were extracted and were 
analyzed by TLC, HPLC and HRLC-MS. The isolation of sufficient amounts of 
metabolites for structure elucidation required time-consuming large-scale 
fermentations of the knockout strains. During this thesis work, isolation and 
characterization of the produced metabolites, performance improvements in 
strain fermentations, and development of isolation methods for potential 
intermediates were accomplished. In addition, derivatization procedures were 
developed for the unstable metabolites. Isolation and characterization of the 
derivatization products provided further information for the possible 
biosynthesis intermediates. 
Initially, chemical investigations focused on the 10 oxygenases and a methyl 
transferase, suspected to be involved in the tailoring steps. However, the HRMS 
analysis of the provided 20 gene deletion mutants showed that additional genes 
with unknown functions were involved in the tailoring steps of griseorhodin A 
(5). During the course of this work, besides the compound griseorhodin A (5), 
seven metabolites, which were present in the extracts of fourteen mutant 
strains, were identified. Three mutant strains did not produce detectable 
amount of metabolites, and two strains did not produce sufficient amounts for 
structure elucidation of the detected metabolites at the tested fermentation 
conditions. Table 3.29 summarizes the most important data obtained and used 
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to propose a biosynthesis pathway. Table 3.29 includes the names of the mutant 
strains; the putative function of the deleted genes, the HRMS analysis results, 
the suggested molecular formulae of the observed metabolites, and in the last 
column contains the numbers corresponding to the structures in Figure 3.100. 
Figure 3.100 shows the structures obtained from the chemical investigation of 
the mutant strains. The structure of KS-619-1 (64) is shown in parenthesis, 
because the structure was identified indirectly using the structure elucidation of 
a fully methylated derivative KS-619-3 (65) as described in Section 3.4.7. The 
compound secocollinone-2 (60) could be identified in the extract of S. albus 
KR5. Similarly, the identification of the metabolite was performed indirectly via 
structure elucidation of a fully methylated derivative, secocollinone-1 (59) as 
described in Section 3.4.6. Therefore, its structure is shown in parenthesis, too. 
Investigation of the gene deletion strains in Table 3.29 by HRMS provided 
further information about the functions of the genes in the biosynthesis. The 
mutant S. albus KR39 with a deleted GrhO2 oxygenase gene still produces 
griseorhodin A (5). The unaffected biosynthesis of the compound in the absence 
of GrhO2 suggests that GrhO2 has no function or the function of GrhO2 can be 
performed by another enzyme. Similarly, the deletions of the genes grhD, grhH, 
grhI, and grhN with unknown functions did not affect the production of 
griseorhodin A (5) by the mutants S. albus KR13, S. albus KR27, S. albus KR4, S. 
albus KR23, respectively. Additionally, in the absence of grhJ, grhP, grhM, grhU, 
and grhV genes with an unassigned function, the single gene deletion mutants 
could not produce griseorhodin A (5) but small amont of several other 
metabolites which are used for further investigation of the biosynthesis. The 
analysis of the metabolites produced by the mutants proves the necessity of 
these genes for the generation of griseorhodin A (5).  
The mutants with grhO10, grhV, and grhU gene deletions produced extremely 
small amounts of various unidentified metabolites even though the growth 
conditions were altered to increase the yields. The presence of griseorhodin A 
(5) in the extracts was not confirmed for these cases. The absence of the 
compound shows that these genes are crucial for the biosynthesis, but it is 
difficult to propose functions for these genes without analyzing any metabolites. 
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It is thought that these genes affect the early steps of the biosynthesis 
generating pradimicin-type metabolites as oxidoreductases or cyclases because 
aromatic polyketide metabolites are produced in extremely low quantities in 
the absence of these genes. These genes are further investigated by Minna 
Eklund in the group of Piel.  
The function of grhJ in the construction of the spiro moiety is identified using 
the metabolites lenticulone (53) and didesoxygriseorhodin C (54) detected in 
the extracts of the mutant strain as described in Section 3.4.4. The function of 
GrhJ is suggested as a oxygenase and the function is described further at the 
discussion of the generation of the spiroketal moiety in this section.  
In the extract of the grhP gene deletion mutant, major metabolites with 26 
carbon atoms were detected, which suggested the involvement of the protein in 
the tailoring steps of the pradimicin-type core. The gene grhP has homology to 
an enzyme from oxytetracycline biosynthesis (OxyD)38 that is responsible for 
the synthesis of the malonamate starter unit. Additionally, grhP has homology 
to amidotransferase genes, which are responsible for the transfer of an amide 
function to the polyketide core of the compounds such as fredericamycin 
(FdmV)42 and lysolipin (LlpA).175 The function of FdmV as a tailoring enzyme at 
the generation of the lactam ring F in the biosynthesis of fredericamycin A (26) 
is proven.155 Since the compound griseorhodin A (5) does not have any amide or 
lactam group, the involvement of the protein GrhP in the biosynthesis needs to 
be proven. Unfortunately, the isolation and structure elucidation of the 
metabolites produced by the mutant strain could not be achieved due to the 
mutant strain producing insufficient amounts. However, the metabolite KS-619-
1 (51) in the extracts of ΔgrhM and ΔgrhO8 mutant strains indicates that the 
lactone formation of ring F occurs after the oxidation steps of GrhM and GrhO8, 
as a tailoring step. 
In the extract of the mutant formed after grhM gene deletion, two major 
metabolites with an identical suggested molecular formula C26H18O8  were 
detected. Additionally the metabolite KS-619-1 (64) was identified as described 
in Section 3.4.7. This shows the involvement of this gene in the early tailoring 
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steps as an oxygenase as described further at the discussion of the postulated 
early tailoring steps in this section. 
An insightful finding of the HRMS analysis was that some metabolites carry 27 
carbon atoms. Note that griseorhodin A (5) has only 25 carbon atoms. The 
additional carbon atoms support the hypothesis that the biosynthesis of 
griseorhodin A (5) is completed after the loss of two carbon atoms from a highly 
oxidized polycylic core. The compound collinone (41) that was discovered by 
Minas et al. as described in Section 3.4.3, was also detected in the extracts of the 
mutant strain S. collinus DSM 2012, which contains a putative rubromycin 
cluster, using S. coelicolor CH999 as a host.137 Previously the compound was 
suggested as a possible intermediate of the rubromycins. 
In this work, this hypothesized intermediate collinone (41), which is a pink-
colored stable solid with the molecular formula C27H18O12, was identified and 
isolated in the extract of S. albus KR8, a mutant that lacked the FAD-dependent 
oxygenase GrhO5. The isolation and identification of this compound from S. 
albus KR8 proved the hypothesis that griseorhodin A (5) is built from a single 
tridecaketide chain and that a pentangular aromatic precursor exists in the 
biosynthesis of rubromycin-type aromatic spiroketal polyketides.110  
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Table 3.29 Metabolites observed in HRMS analysis of the mutant strains 
created in order to study the functions of tailoring enzymes via single gene 
deletions. (n.d: The strain did not produce secondary metabolites in sufficient 
amounts.)  
Strain ORF 
Putative protein 
Function 
Measured 
m/z [M+H]+ 
Predicted 
Molecular 
Formula 
Structure 
Nr. 
 
MP31 ---- ---- 509.0720 C25H16O12 5 
KR5 grhO1 
Oxygenase with 
covalently bound FAD 
537.1021 C27H20O12 60 
KR39 grhO2 Ketoreductase 509.0720 C25H16O12 5 
KR43 grhO3 Cytochrome P450 495.0922 C25H18O11 46 
KR8 grhO5 
FAD-dependent 
oxygenase 
535.0877 C27H18O12 41 
MP66 grhO6 
FAD-dependent 
oxygenase 
337.0550 C15H12O9 54 
521.0720 C26H16O12c 53 
KR7 grhO7 
NADPH: quinone 
oxidoreductase 
495.0922 C25H18O11 46 
KR41 grhM Unknown oxygenase 
459.1050 C26H18O8 n.d 
459.1069 C26H18O8 n.d 
475.1114 C26H18O9 64 
KR11 grhO8 
FAD-dependent 
oxygenase 
477.1150 C26H20O9 n.d 
475.1077 C26H18O9 64 
KR53 grhO9 
FAD-dependent 
oxygenase 
505.1120 C27H20O10 58 
MP63 grhO10 
3-Oxo-acyl-ACP 
reductase 
n.d. n.d. n.d. 
KR15 grhP Amidotransferase 
491.0975 C26H18O10 n.d 
507.0922 C26H18O11 n.d 
981.1870 C52H36O20 n.d 
KR40 grhL Methyl transferase 
489.0785 C26H16O10 n.d. 
471.0695 C26H14O9 n.d. 
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Figure 3.100 Structures of possible intermediates and metabolites isolated during the 
chemical investigation of the 20 gene deletion strains. Structures shown in parenthesis 
are possible intermediates suggested by the isolated methylated derivative of the native 
metabolites.  
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The biosynthesis of griseorhodin A (5) can be analyzed in two parts. The first 
part is the oxidation of an initial intact pradimicin-type intermediate to the 
highly oxidized collinone (41) (Collinone (41) has the largest number of carbon 
and oxygen atoms compared to the other metabolites.) and the second part is 
the construction of the spiro system of griseorhodin A (5). The tailoring 
enzymes involved in this biosynthesis are therefore separated into two groups 
based on their relationships to this intermediate collinone (41). The enzymes, 
which are involved in the early biosynthetic steps leading to collinone (41), 
constitute the first group and enzymes responsible for the construction of the 
complex epoxy spiroketal structure constitute the second group. 
In this section, first the functions of the enzymes in the second group are 
discussed because of their unique role in the construction of the 
pharmacologically significant epoxyspiroketal group. Then, the functions of the 
enzymes in the first group are discussed. 
Figure 3.101 shows the enzymes involved in the biosynthesis starting with the 
compound collinone (41) and ending with griseorhodin A (5). GrhO5 is a FAD-
dependent monooxygenase. S. albus KR8, a mutant with a grhO5 gene deletion, 
produces the compound collinone (41) as a single metabolite. This clearly 
suggests that GrhO5 initiates the cleavage sequence steps by using collinone 
(41) as a substrate. S. albus KR5 which lacks the covalently bound FAD-
dependent oxygenase GrhO1 produces metabolites with 27 carbon atoms as 
well but it does not produce collinone (41). Further investigation of metabolites 
of S. albus KR5 provided secocollinone-2 (60). This compound indicates that the 
substrate of GrhO1 had already a bond cleaved at the ring D. This suggests that 
GrhO5 together with GrhO1 act in the cleavage of three carbon bonds. Ring D of 
the collinone (41) would lose a carbon atom, which leads to the generation of 
the suggested intermediate lenticulone (53). The absence of collinone (41) in 
the extracts of the grhO1 gene knockout strain suggests that the two enzymes 
are not acting simultaneously, but in series to form lenticulone (53).  
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Figure 3.101 Enzymes involved in the tailoring steps after the formation of collinone (41). 
Structures in parenthesis are proposed intermediates implied by the compounds 
obtained via derivatization reactions.  
Secocollinone-2 (60) was detected in the crude extract of S. albus KR5 but to 
elucidate the structure, the crude extract was methylated as described in 
Chapter 3.4.6 and the fully methylated derivative secocollinone-1 (59) was used 
for structure elucidation. The structure of the methylated derivative shows 
clearly that the native intermediate produced by the strain is an open ring form 
of collinone (41). This suggest that the enzyme GrhO1 acts after a bond cleavage 
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reaction catalyzed by GrhO5, which should open ring D. (Figure 3.76A). 
However, the structure of the possible metabolite obtained based on the 
isolated derivative is in a reduced state compared to the postulated biosynthesis 
intermediate. This is rather unlikely for a reaction catalyzed by an oxygenase. A 
possible explanation for the aromatization on ring C is that secocollinone-2 (60) 
is a reduced derivative of an unstable intermediate. In this case an enzymatic or 
spontaneous reduction of the native intermediate during the fermentation, 
isolation or derivatization reactions could cause the generation of the 
compound secocollinone-2 (60). For the biosynthetic pathway, a predicted 
intermediate secocollinone-3 (61) is suggested as a substrate for the enzyme 
GrhO1 based on the obtained metabolite secocolline-2 (59). An intermediate 
related to the structure (61) would also explain the generation of the isolated 
metabolite lenticulone (53) as described in Section 3.4.6. 
Lenticulone (53) was isolated from the extracts of S. albus MP66, a mutant with 
a grhO6 gene deletion. In basic solutions the compound is not stable, and in the 
presence of acids and methanol the compound decomposes to ZY1 (54). 
Lenticulone (53) and ZY1 (54) were isolated and characterized during this 
study as new compounds from the stain S. albus MP66.99 
A surprising result related to S. albus KR42 is that GrhJ, which has a homology to 
a GCN5-related N-acetyltransferase (GNAT) family enzyme, acts like a tailoring 
enzyme. Lenticulone (53) was also observed as a minor component in extracts 
of this strain S. albus KR42, a mutant with a grhJ gene deletion. The main 
compound produced by S. albus KR42 plate extracts had been previously 
suggested in the work of K. Rheinhardt as 7,8-didesoxy-6-oxo-griseorhodin C 
(55) with a molecular formula C25H16O11.125,176 The presence of the same 
metabolite in both extracts suggests that the oxygenases GrhO6 and GrhJ are 
responsible for the formation of the suggested metabolite 7,8-didesoxy-6-oxo-
griseorhodin C (55) that has one carbon atom less than lenticulone (53). 
However, the extracts of the GrhO6 deletion mutant did not contain 7,8-
didesoxy-6-oxo-griseorhodin C (55). This suggests that the enzymes GrhO6 and 
GrhJ act together in the oxidation reactions in which a fourth bond cleavage and 
loss of another C atom occurs. In addition, GrhJ might be involved in the 
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downstream reactions converting 7,8-didesoxy-6-oxo-griseorhodin C (55) to 
the next isolated intermediate didesoxygriseorhodin C (46).  
The enzyme sequence of GrhO6 shows sequence homology to the Baeyer-
Villigerase-type oxygenases, such as MtmOIV in mithramycin (23) 
biosynthesis.141 This homology and the structure of the potential substrate 
lenticulone (53) suggest that GrhO6 might act as a Baeyer-Villigerase on the 
ester moiety of the compound resulting in decarboxylation. However, an 
alternative mechanism could not be excluded, in which GrhO6 hydroxylates the 
ester α-position, and the subsequent decarboxylation results from 
rearomatization as discussed in Section 3.4.4. 
In order to obtain more insight into the enzyme function and to test whether 
GrhO6 directs the second oxidative decarboxylation by itself, an in vitro enzyme 
assay with the over-expressed enzyme GrhO6 and the compound lenticulone 
(53) as a substrate was performed. GrhO6 did not function as expected at the 
chosen conditions of the in vitro assay. A possible reason might be that the 
substrate is unstable in the basic conditions over pH 7. The poor water 
solubility of lenticulone (53) and the enzyme at the assay conditions might also 
be a reason that the assay did not provided further results about the reaction of 
GrhO6. Another reason might be that the enzyme does not function properly in 
the absence of the protein GrhJ as suggested before. The details of the assays are 
described in Section 4.1.6 and discussed in Chapter 3.5. 
S. albus KR7 with a deactivated NADPH:quinone oxidoreductase enzyme GrhO7 
and S. albus KR3 with a deactivated cytochrome P450 family oxygenase GrhO3 
both produced a single main metabolite characterized as didesoxygriseorhodin 
C (46) with a molecular formula C25H18O11. This result implies an unusual 
involvement of these oxygenases in the epoxidation of didesoxygriseorhodin C 
(46). Although cytochrome P450 enzymes usually use alkenes to generate 
epoxides, they are few examples of the formation of cyclic ethers from saturated 
precursors have been reported. The epoxidase OleP from oleandomycin 
biosynthesis134 and the aureothin P450 AurH that closes a tetrahydrofuran ring 
by 1,5-dehydrogenation of an alcohol precursor can be found as an example.135 
To our knowledge, this is the first case reported that a NADPH:quinone 
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oxidoreductase participates in the epoxidation reaction of a polyketide. The 
production of the same substance by the two mutant strains, GrhO3 and GrhO7 
was unexpected. In the case that the compound didesoxygriseorhodin C (46) is 
the true substrate of GrhO3 and GrhO7, a possible explanation would be that the 
two enzymes form a complex, which is inactive if one component is absent. This 
suggests that GrhO7 and GrhO3 jointly participate in epoxide formation. 
Another possible explanation is that GrhO3 is capable of the epoxidation of the 
olefinic carbon bond alone and GrhO7 might be responsible for the reductive 
recycling of olefinic shunt products that arise from an eliminative side reaction. 
The investigation of the monooxygenase gene styAB from Pseudomonas sp. 
VLB120 showed that the rate of epoxidation depends on the amount of NADPH 
present.136 This would also suggest that GrhO7, a member of the 
NADPH:quinone oxidoreductases, might be involved in the effective 
regenerating of the coenzyme for the oxygenase GrhO3, a member of the 
cytochrome P450 family. For further investigation of the epoxidation on 
didesoxygriseorhodin C (46), functional enzyme assays with GrhO3 and GrhO7 
can be performed.  
In summary, the isolated and characterized compounds, collinone (41), 
secocollinone-2 (60), lenticulone (53), didesoxygriseorhodin C (46) and the 
suggested metabolite 7,8-didesoxy-6-oxo-griseorhodin C (55) provide deeper 
insights to the functions of the oxygenases GrhO1, GrhO3, GrhO5, GrhO6, GrhO7 
and the protein GrhJ in the construction of the epoxyspiroketal moiety of 
griseorhodin A (5) via four complex bond cleavages and the loss of two carbon 
units.  
The investigation of the metabolites for the first part of the biosynthesis showed 
that the early intermediates are very unstable. Metabolites in the plate extracts 
of the knockout strains of suggested early oxygenases were different from the 
metabolites obtained from their fermentation extracts. Large amounts of green 
and black unidentified pigments in the fermentation extracts of the strains S. 
albus KR11, S. albus KR40 and S. albus KR15 prevented the isolation of the 
metabolites detected by HRMS analysis. Therefore the functions of grhO8, grhL, 
and grhP could not be determined exactly. However, structures of two isolated 
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metabolites from the extracts of grhM, grhO8 and grhO9 gene deletion strains, 
the amounts and the molecular formulae of the metabolites detected by HRMS 
analysis and sequence homology results provided additional information that 
enabled the suggestion of a preferred biosynthetic pathway for the early 
tailoring steps of griseorhodin A (5). Figure 3.102 shows the proposed early 
tailoring steps and the participation of enzymes in the early oxygenation 
reactions. 
The presence of the metabolite KS-619-1 (64) in the fermentation extracts of 
grhM and grhO8 mutants could be proven as described in Section 3.4.7 and 
3.4.8. The structure of KS-619-1 (64) implies that the two oxygenases GrhM and 
GrhO8 act prior to the lactonization and methylation reactions. The metabolite 
has an antraquinone Western part due to an oxidation at ring B, which might be 
a result of a spontaneous oxidation of an unstable pradimicin type intermediate. 
Analysis of the structure of KS-619-1 (64) suggests structure (71) as an earlier 
intermediate. However, the possibility of an enzymatic oxidation cannot be 
excluded. In that case, KS-619-1 (64) would be an early intermediate of an 
alternative oxidation cascade. The other two metabolites predominantly 
produced by the grhM mutant strain with a molecular formula C26H18O8 and 
fewer oxygen atoms than the metabolites produced by the grhO8 mutant strain 
indicate that the two oxygenases act rather in series than simultaneously. 
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 Figure 3.102 A. Proposed early oxidation steps leading to the formation of collinone (41) 
starting with the pradimicin-type intermediates. The structures in the parentheses are 
suggested intermediates. 
The investigation of the early tailoring steps of the aromatic polyketide 
fredericamycin A (26) showed that two aromatic hydroxylases, FdmM and 
FdmM1, which have high sequence similarities to the oxygenases GrhM and 
GrhO8, are acting in series and add three hydroxyl groups to the aromatic 
pentangular core. FdmM is an aromatic hydroxylase and stabilizes the 
substrates of the oxygenase FdmM1 during the early biosynthesis steps of 
fredericamycin A (26) as described in Section 3.4.7 (Figure 3.80).152 The 
structure of the isolated intermediate KS-619-1 (64) and the sequence 
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homology of GrhM and GrhO8 allow suggesting that the two oxygenases act as 
hydroxylases like FdmM and FdmM1 at the rings C and D. In that case, GrhM 
would first hydroxylate ring C and GrhO8 would perform the oxidation 
reactions on ring D. A similar dihydroxylation reaction was published by Daum 
et al. for the monooxygenase PokO2 in polyketomycin (76) biosynthesis.142 In 
that case PokO1 hydroxylates ring C. Subsequently, PokO2 performs a 
dihydroxylation at ring D. The dihydroxylation reaction is initiated by a 
proposed epoxidation reaction with a subsequent ring opening with addition of 
a water molecule that results in a cis configuration of the hydroxyl groups at 
ring D as described in Section 3.4.8 (Figure 3.89).142 Further experiments with 
thegene deletion mutants of ΔpokO1, ΔpokO2 and ΔpokO1/ ΔpokO2 showed that 
the enzyme PokO1 can take over the functıon of PokO2.142 
The predominant metabolites produced by the grhP and grhL mutant strains 
with the suggested molecular formulae C26H18O11 and C26H16O10, respectively, 
imply that the lactonization of ring F takes places before the methylation 
reaction at ring A. Both strains produced large amounts of unidentified green 
and brown pigments during fermentation. These pigments prevented the 
isolation of any metabolites from the fermentation extracts as described in 
Section 3.4.9. Investigations of the extracts point to the presence of random 
polymerization products of easily oxidized metabolites. GrhL is the only methyl 
transferase gene found in the cluster. Therefore it is very likely that GrhL is 
responsible for the methylation at ring A. GrhP does not show homology to 
oxygenases. However, its sequence has sequence homology to several putative 
and proven asparagine synthetases, such as RubR in γ-rubromycin, LlpA in 
lysolipin X, OxyD in oxytetracyclin, PdmD in pradimicin, and FdmV in 
fredericamycin A biosynthetic pathways. Proposed function of PdmD and FdmV 
is transfer of an amine function of an amino acid to the polyketide scaffolds of 
pradimicin. The function of FdmV as a tailoring enzyme at the generation of the 
lactam ring F in the biosynthesis of fredericamycin A (26) has been 
demonstrated.155 Both polyketides have a lactam ring in their scaffolds. 
However, rubromycins and griseorhodin A (5) have lactone rings. The sequence 
homology to the lactam generating PdmD and FdmV suggests a function of GrhP 
in the lactonization of ring This assumption needs to be proven by further 
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investigation of the enzyme GrhP and/or the metabolites that were produced in 
miniscul amounts.  
Precollinone (58) was produced by the grhO9 mutant strain as a major 
metabolite during the early tailoring steps. The compound was produced both 
in plate and fermentation extracts as a stable metabolite. This indicates that the 
methylation of ring A and the lactonization of ring F, which stabilizes the 
intermediates of early tailoring enzymes, are key reactions for the stability of 
the aromatic pentangular metabolites. Precollinone (58) is hydroxylated at 
rings C and D, but not at rings A or B. This shows that GrhO9 participates in the 
oxidation of rings A and/or B on route to collinone (41). The structures of 
precollinone (58) and KS-619-1 (64) raise questions about the oxidation 
sequence at rings A, B, C. 
One possible explanation is that GrhO9 and several other tailoring enzymes can 
utilize alternative metabolites and substrates leading to the generation of 
collinone (41), and the metabolite precollinone (58) is the predominant 
substrate produced in the absence of GrhO9. In this case many early tailoring 
enzymes would not act on specific substrates and oxygenation reactions of the 
early oxygenases would provide several products, which could be further 
processed by alternative oxygenation cascades on the multienzyme complex. 
This would also explain the numerous metabolites observed in the early 
tailoring steps leading to the compound precollinone (58). However, further 
functional investigation of these particular oxygenases is necessary to 
determine their substrate specificity and/or substrate range.  
At this point it would be necessary to mention a successful attempt of Kathrin 
Reinhardt to obtain a hybrid product, benarhodin A (78), of the polyketides 
griseorhodin A (5) and benastatin A (77) as described in Section 3.4.9 (Figure 
3.92) .125 For this combinatorial approach the minimal PKS of the grh cluster 
was replaced by the minimal PKS of benastatin A cluster. This experiment 
showed that the early oxygenases of grh cluster are able to perform tailoring 
reactions on the polyketide backbone produced by benastatin A minimal PKS. 
This indicates that the early tailoring enzymes might have a larger substrate 
range. 
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Another possible explanation for the oxidation at the aromatic core of KS-619-1 
(64) is that KS-619-1 (64) is a spontaneous oxidation product of an unstable 
pradimicin-type metabolite, such as (71). Excessive production of diverse 
pigments during fermentation described at Section 3.4.8 and 3.4.9 also suggests 
that the substrates of the early enzymes might undergo spontaneous reactions 
during fermentation, such as oxidation and polymerization. In this case the 
possibility of a preferred pathway leading to the generation of collinone (41) as 
postulated in Figure 3.102 could be expected. However, it is extremely difficult 
to identify intermediates for the biosynthetic steps up to the formation of the 
relatively stable compound precollinone (58) due to the unstable and diverse 
metabolites produced by the mutant strains. In addition, further investigation of 
the tailoring enzymes GrhU and GrhV, which could not be related to the 
biosynthetic steps yet, might reveal further insights into the early biosynthetic 
steps.  
The results presented in this thesis provide deeper understanding of the 
complex tailoring steps and enzymes taking part in the biosynthesis of 
griseorhodin A (5) and related rubromycin-type spiroketal compounds. These 
new insights to the griseorhodin A biosynthesis also contribute to the ongoing 
research in utilizing polyketide tailoring enzymes to create novel polyketide 
libraries to obtain new polyketide lead-structures via combinatorial 
biosynthesis. However, additional functional assays and combinatorial studies 
using genes with suspected cooperative activity need to be conducted to obtain 
further information about the individual mechanism and substrate specificities 
of these numerous interesting tailoring enzymes.  
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4 MATERIALS AND METHODS 
4.1 Molecular Biological Materials and Methods 
4.1.1  Solutions and Media 
The following ingredients were purchased for the preparation of broth and 
media; Tryptone (Becton Dickinson, Heidelberg), yeast extract (Becton 
Dickinson, Heidelberg), soja flour (Bacto Saitone, Becton Dickinson, Heidelberg), 
tryptic soy broth (Difco, USA), beef extract (Roth, Karlsruhe), acid casein 
hydrolysate (Roth, Karlsruhe) potato starch (Sigma-Aldrich, Seelze), agar-agar 
(Roth, Karlsruhe). 
4.1.1.1 LB - (Luria Bertani) Medium and Agar 
10 g NaCl, 10 g tryptone, 5 g yeast extract were dissolved in 1 L of distilled 
water. The pH of the LB medium was adjusted to 7 with 1 N NaOH solution. The 
mixture was autoclaved for 20 min at 120 C.  
To prepare LB agar, 1 L of LB medium was prepared, and 15 g agar-agar was 
added into it. The mixture for the agar was autoclaved 20 min at 120 C.  
To prepare both LB-Apr10 medium and agar containing the antibiotic 
apramycin, the mixtures for both the medium and agar were both autoclaved 
and cooled down to 50-60 C. 1 mL of the apramycin stock solution with a 
concentration 10 mg/mL was added both to a total volume of 1 L of LB medium 
and to agar. 
4.1.1.2 TSB Medium 
30 g Tryptic soy broth was dissolved in 1 L of distilled water. The mixture was 
autoclaved 20 min at 120 C. 
4.1.1.3 MS Agar 
For the preparetation of 1 L of MS agar, 20 g agar-agar, 20 g mannitol, 20 g soja 
flour (Bacto Saitone) were used, and distilled water was added to a total volume 
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of 1 L. 5 mL of a 2 M MgCl2 solution were added to the mixture and the mixture 
was autoclaved twice at 120 C for 15 min.  
To prepare both MS-Apr10 medium and agar containing the antibiotic 
apramycin, the mixtures for both the medium and agar were autoclaved and 
cooled down to 50-60 C. 1 mL of an apramycin stock solution with a 
concentration 10 mg/mL was added to the 1 L of the mixture. 
4.1.1.4 2CM Agar 
20 g agar-agar, 10 g soluble potato starch, 2 g tryptone, 1 g NaCl, 2 g (NH4)2SO4 , 
1 g K2HPO4, 2 g CaCO3, 2 g MgSO4.7H2O were used, and distilled water was 
added to achieve a total volume of 1 L. 1 mL Inorganic salt solution was added 
into the mixture and the mixture was autoclaved for 20 min at 120 C. For 
preparing 2CM -Apr10 agar containing the antibiotic apramycin, the mixtures for 
both the medium and agar were autoclaved and cooled down to 50-60 C. 1 mL 
of an apramycin stock solution with a concentration 10 mg/mL was added to 1 
L of the both mixtures. 
Ingredients for the inorganic solution needed to prepare 2CM agar  
1 g FeSO4.7H2O, 1g MgCl2.6H2O, 1g ZnSO4.7H2O were used and distilled water 
was added to achieve a total volume of 1 L. The mixture was autoclaved for 20 
min at 120 C. 
4.1.1.5 MM Agar (Müller Minton Agar) 
2 g Beef extract, 17.5 g acid casein hydrolysate, 1.5 g potato starch, 17 g agar 
were used, and distilled water was added to achieve a total volume of 1 L. The 
mixture was autoclaved for 20 min at 120 C. 
 
4.1.2 Methods for the Storage and Cultivation of the S. albus Strains 
4.1.2.1 Storage of Strains 
For long-term storage of S. albus strains, spores were suspended in a solution of 
20% (v/v) glycerol and stored at -80 C. For storage of the strains up to 3 
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months, strains were grown overnight in 200 mL of LB medium and the culture 
was transferred into 50 mL Falcon tubes to harvest the bacteria by centrifuging 
at 5000 rpm. Bacteria were washed twice with a sterile 10.3% (w/v) sucrose 
solution. Subsequently, bacteria were resuspended in 10 mL of the sucrose 
solution, transferred into 10 mL Falcon tubes and stored at -20 C. 
4.1.2.2 Cultivation on Agar Plate 
S. albus strains were plated on 2CM and MS agar plates. Also 2CM-Apr10 and MS-
Apr10 agar plates were used in cases where the cultures were contaminated 
with other bacteria. Sterile toothpicks were used to pick single colonies. To 
obtain a larger amount of bacteria for extractions, bacteria were plated with a 
sterile cotton bud on the agar plates, and depending on the growth and 
expression of the strain, plates were incubated up to 6 days. 
4.1.2.3 Cultivation and Fermentation of Mutant Strains in Liquid Medium 
S. albus strains were fermented in LB, TSB and MS media. For fermentation 
baffled flasks of volume up to 2 L were used. The medium occupies 20% of the 
flask volume to provide the bacteria enough oxygen supply needed during 
fermentation. For inoculation of the larger scale fermentations with several 
flasks, an overnight culture of the strain was used and distributed in equal 
amounts to the flasks containing the medium. 
4.1.2.4 Freeze-Drying for Storage and Extraction of Mycelium 
Bacteria obtained from fermentation were harvested by centrifugation. The 
obtained mycelia were resuspended in 100 mL of distilled water and were 
transferred into 1 L round flasks. The suspension was frozen with liquid 
nitrogen. The flasks were left to dry overnight in the freeze drier. Subsequently, 
flasks were filled with argon gas to avoid the decomposition of the compounds 
on the dry mycelia during their storage.  
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4.1.3 Methods for the Storage and Cultivation of the Strains Used for the 
Antibacterial Activity Assays 
Strains chosen for the tests are following: 
 Escherichia coli-DH5α (Gram-) 
 Staphylococcus carnosus-DSH 20501 (Gram+) 
 Bacillus amyloliquefaciens (Gram+) 
 Bacillus subtilis (Gram+) 
 Pseudomonas fluorescens-DSH 50090T (Gram-). 
 
4.1.3.1 Storage of Strains 
For the long-term storage of strains, 750 µL of overnight cultures in LB medium 
were mixed with a 750 µL of 30% (v/v) glycerol solution. The mixture was 
frozen with liquid nitrogen and was stored at -80 C.  
4.1.3.2 Cultivation of the Strains for the Antibacterial Assay 
For the antibacterial assay, strains were grown on MM agar and incubated at 37 
C over night. For the MIC assay, bacteria were grown on LB medium and 
incubated at 37 C at 220 rpm over night. 
 
4.1.4 Analytical and Chemical Materials and Methods 
4.1.4.1 Thin Layer Chromatography and Column Chromatography  
For the thin layer chromatography, silica gel 60 F254 20x20 cm plates (layer 
thickness 0.2 mm, Merck) were used. Dipping in a 2 M NaH2PO4 solution 
impregnated the plates as discriebed in Section 4.1.4.2. For the column 
chromatography, a silica gel 60, 40-63 m (Roth) material was used. For the 
impregnation of the silica plates, 2 M NaH2PO4 solution was used. The silica 
material, which was used for column chromatography was impregnated with a 
2 M NaH2PO4 solution as well.  
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4.1.4.2 Procedure for Impregnation 
200 mL of silica were stirred overnight in 400 mL of 2 M NaH2PO4 solution. The 
gel was poured into glass plates and left to dry in a dry oven at 100 C overnight. 
Impregnation of the silica gel was necessary for the chromatographic separation 
of polar phenolic compounds. Depending on the pKa value, these compounds 
become deprotonated and form strong interactions on silica materials. 
Impregnation of the silica plates results in full protonation and decrease of 
polarity of the analytes, thus improving chromatographic behaviour. For the 
chromatography, a mobile phase either chloroform:methanol (9:1) or 
chlorofom:ethyl acetate (4:1) was preferred. The NaH2PO4-impregnated silica 
material can be used for a mobile phase up to 25% of methanol. Higher 
percentages of methanol should be avoided because of the elution of salts 
during chromatography.  
4.1.4.3 Sephadex LH-20 Gel Chromatography 
Sephadex material (Sephadex LH-20, Bead size: 25-100 μm, Sigma) was used for 
gel chromatographic separation. Gel chromatographic separation takes plates 
according to the mechanism that the analytes with higher molecular weight 
elute slower than the analytes with smaller molecular weight. Sephadex LH-20 
powder purchased was made to swell overnight in methanol without stirring. 
The obtained Sephadex LH-20 gel was pured in glass columns and used for 
chromatographic separation of the compounds in the extracts. As a mobile 
phase methanol was used. 
4.1.4.4 Analytical and Semipreparative HPLC 
For the LC-HRMS measurements, a Jasco 2000 Plus series HPLC device with a 
Jasco pump PU-2080 and a Jasco autosampler AS2050 was used. For the 
analysis of the extracts, an PerfectChrom 100 C18 reverse-phase analytic 
column (250 mm × 4 mm, 5 µm) at a flow rate of 1 mL min-1 was used. As mobile 
phase, acetonitrile:water containing 0.1% TFA was used. For the purification of 
the substances, extracts were subjected on a PerfectChrom 100 C18 reverse-
phase semipreparative column (250 mm × 8 mm, 5 µm) at a flow rate of 6 mL 
min-1 and a mobile phase acetonitrile:water containing 0.1% TFA was used. The 
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compounds were detected with a Jasco MD-2015 PDA detector. The UV spectra 
was recorded between 220 and 600 nm. The unsaturated compounds were 
detected at 254 nm. As characteristic absorption maxima the wavelengths of 
360 nm was selected for detection of polyaromatic phenols, and the wavelangth 
of 488 nm for aromatic quinone compounds. The fact that aromatic compounds 
having a quinone structure in their scaffold have a specific absorption maximum 
at 488 nm helped to identify the compounds in the extracts, related to 
griseorhodin A (5). The gradients used for the separation are as described 
below.  
For the LC-HRMS measurements, an Agilent 1200 Series HPLC device and a 
Nucleodur 100-5 C18 column (100 mm × 4 mm, 5 µm) with a flow 0.4 mL/min 
were used. For the detection of the compounds a Bruker micrOTOF-Q time-of-
flight mass spectrometer and an Agilent 4000 UV spectrometer, which makes 
detection at the wavelength 254 nm, was used. LC Methods and solvents were 
the same as the methods used for the HPLC. The only difference was that the 
flow rate had to be reduced to adapt to the LC column. 
4.1.4.5 HPLC Methods 
 Analytical method 1: A 10-90 % to 95-5% AN:H2O + 0.1% TFA gradient was 
used over 20 min at a flow rate of 1.5 mL min-1. 
 Analytical method 2: A 10-90% to 95-5% MeOH:H2O gradient was used over 20 
min at a flow rate of 1 mL min-1. 
 Analytical method 3: A 20-80% to 100-0% AN:H2O + 0.1% TFA gradient was 
used over 15 min at a flow rate of 1 mL min-1. 
 Preparative method 1: A 25-75% to 100%-0% AN:H2O + 0.1% TFA gradient 
was used over 25 min at a flow rate of 6 mL min-1. 
 Preparative method 2: A 60-40% to 100%-0% MeOH:H2O gradient was used 
over 25 min at a flow rate of 4 mL min-1. 
 Preparative method 3: A 60-40% to AN:H2O + 0.1% TFA gradient was used over 
25 min at a flow rate of 6 mL min-1. 
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4.1.4.6 UV Spectrometry 
The compounds’ UV spectra were recorded with a Jasco MD-2015 PDA detector 
at the wavelengths ranging from 220 nm to 600 nm. 
4.1.4.7 IR Spectrometry 
The compounds’ IR spectra were recorded as a film on a Nicolet 380 FT-IR 
spectrometer (Thermo Scientific). Measured IR spectra are in Appendix 3. 
4.1.4.8 Optical Rotation 
Polarimetric measurements were performed with a Perkin-Elmer 340 
polarimeter at the wavelength of 589 nm at 20 C. 1 dm long cuvettes were used 
to measure the samples. A solution with a concentration up to 5x10-3 g/100 mL 
of the compounds with the solvent CHCl3 was used for the measurement.  
4.1.4.9 CD Spectrometry  
CD spectrometry of the compounds and the quantum chemical calculation of the 
spectral data were performed by the group of Prof. Bringmann at the University 
of Würzburg as described in the literature. 13 
4.1.4.10 Mass Spectrometry  
ESI-HRMS (Electrospray high-resolution mass spectra) and collision-induced 
dissociation (CID) MSn spectra were recorded on a Bruker micrOTOF-Q time-of-
flight mass spectrometer and a Bruker APEX IV Fourier-transform ion 
cyclotron-resonance (FT-ICR) mass spectrometer with a 7.05 T magnet. Both 
instruments were equipped with an Apollo electrospray ion source. Analyte 
solutions in acetonitrile were introduced into the ion source with a syringe 
pump (Cole-Parmers Instruments, Series 74900) at flow rates of 3 to 4 µL min-1 
or with an Agilent HPLC pump (1200 series) at a flow rate of 50 µL/min. Ion 
transfer into the first of three differential pump stages in the ion source 
occurred through a glass capillary with 0.5 mm inner diameter and nickel 
coatings at both ends. 
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For the (CID) MSn measurements, fragmentation of the compounds was 
achieved, in which the molecule ions were accelerated in an electrical potential 
and fragmented through collision with the utilized inert gas argon in the gas 
phase. The fragment ions were analyzed by a Bruker APEX IV Fourier-transform 
ion cyclotron-resonance (FT-ICR) mass spectrometer.  
ESI-MS/Tandem–MS (MS/MS)/MSn measurements were recorded on a Bruker 
micrOTOF-Q time-of-flight mass spectrometer (Bruker, Carlsruhe, Germany) 
For the ESI-MS/Tandem–MS (MS/MS)/MSn measurements, observation of the 
charged molecular ions and fragments are achieved, in which the compounds 
are dispersed by electrospray into an aerosol using acetonitrile and water, thus 
enabling ionization to positive or negative charged molecular ions depending on 
the properties of the compound. 
For the HR-LCMS measurements, an Agilent 1200 Series HPLC device and a 
Nucleodur 100-5 C18 column (100 mm × 4 mm, 5 µm) at a flow rate of 0.4 
mL/min were used. For the detection of the compounds a Bruker micrOTOF-Q 
time-of-flight mass spectrometer and an Agilent 4000 UV spectrometer at the 
wavelength of 254 nm were used. For the calibration, sodium formiate was used 
as an internal standard. 
LC methods applied to separate the compounds were adapted from the 
analytical HPLC methods in the section for HPLC analysis.  
4.1.4.11 NMR-Spectrometry  
1H-NMR and 13C-NMR, DEPT, HMBC, HMQC spectra were recorded on a Bruker 
ADVANCE DPX 400 and DRX 500 device at 400 MHz and 500 MHz, respectively, 
in either DMSO-d6 or CDCl3 (if not indicated otherwise) using the solvent signals 
as the reference. Measured IR spectra are in Appendix 2. 
NMR measurements for collinone (41), and the compounds less than 5 mg were 
carried out in a cooperation with Dr. Harald Gross at the Pharmaceutical 
Institute at University of Bonn on a Bruker device at 300 MHz. The temperature 
experiments were also done in the same facility. 
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LC-NMR measurement for the compound ZY1 (54) was performed at a Bruker 
ADVANCE DPX 400 device in cooperation with Michael Lalk at the University of 
Greifswald.  
 
4.1.5 Procedures for the Isolation  
4.1.5.1 Determination of the Growth and Production Curve of S. albus 
MP66  
1 liter of LB medium inoculated with S. albus MP66 was prepared and 
distributed into ten 250 mL baffled Erlenmeyer flasks so that each flask 
contained 100 mL of culture. The bacteria were incubated at 30 C in a shaker at 
220 rpm. During a period of five days, one of the Erlenmeyer flasks containing 
100 mL culture was taken out, and the time of incubation was noted two times a 
day, in the morning and in the afternoon. Bacteria and culture medium were 
separated by centrifugation at 10000 rpm for 10 minutes. To measure growth, 
the bacteria were freeze-dried and weighed in order to determine the changes 
of the biomass in each Erlenmeyer flasks. To measure secondary metabolite 
production, the absorption of the culture medium at 488 nm was used, since 
most produced metabolites have a characteristic absorption at 488 nm. 
4.1.5.2 Extraction of S. albus Strains for HPLC, HRMS and TLC Analysis  
To obtain an overview of the metabolites, strains were incubated 2-3 days at 30 
C on 2CM agar plates. The bacteria with pigments were scratched off, extracted 
eather with EtOAc:MeOH:AcOH (95:5:1) or acetonitrile with 0.1% TFA. An 
ultrasound bath was used to obtain better solubility and to destroy the bacterial 
wall. The bacterial residues were removed by centrifugation, and subsequently, 
the solvents were removed by a SpeedVac concentrator. The remaining crude 
extract was solved in 0.5 mL ethyl acetate to use for the TLC analysis.  
For the HPLC and LCMS analysis, the prepared cell extract was dissolved in 0.5 
mL of AN, and the HPLC method 1 (Section 4.1.4.5) was used. The molecular 
weight of the compounds were determined by LC-HRMS after the same bacterial 
extract was dissolved in MeOH or AN. ESI-HRMS and ESI-MS/Tandem-(MS/MS) 
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spectra were recorded on a Bruker microTOF-Q time of flight mass 
spectrometer. 
4.1.5.3 General Procedure for the Extraction of S. albus Liquid Cultures  
After the fermentation of the various strains in liquid medium, the mycelium 
and the liquid medium were separated by centrifugation, as described by 
Eckardt et al. for the isolation of griseorhodin A (5).85 The separated mycelium 
was extracted with a mixture of EtOAc:MeOH:AcOH (95:5:1). The solvent was 
removed. After acidification to pH 4 with 2 N HCl the separated medium was 
extracted with ethyl acetate. The organic phase was dried with Na2CO3. The 
solvent was removed at a rotary evaporator. 
4.1.5.4 General Procedure for the Chromatographic Analysis and 
Purification of the Liquid Culture Extracts of S. albus Strains  
For the TLC analysis of the prepared bacterial extracts, the crude extract was 
dissolved in the mobile phase CHCl3:MeOH (9:1). As stationary phase, 
impregnated silica plates with 2 M NaH2PO4 or KH2PO4 were used. It was 
advantageous to use impregnated plates since they simplified the separation of 
polar compounds. Impregnating the silica material before use prevents the 
polar aromatic phenolic compounds to attach on the material. Depending on the 
pKa value, these compounds become deprotonated and form strong interactions 
on silica materials. Impregnation of the silica plates results in full protonation 
and decrease of polarity of the analytes, thus improving chromatographic 
behaviour. The same principle also helps during flash chromatographic 
purification of the extracts containing phenolic aromatic compounds. The 
procedure of the impregnation is given in 4.1.4.2 in detail. 
4.1.5.5 General Procedure for the Isolation and Characterization of the 
Compounds  
For structure elucidation purposes, approximately 10 mg of compound was 
needed. Therefore, fermentation of the strains in liquid medium rather than on 
plates was performed to obtain this amount. The inoculates used for the 
fermentations were frozen stocks of strains kept in the -80 C freezer or frozen 
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cultures in 10.3% sucrose solution stored at -20 C. These procedures used for 
storing S. albus strains are given in the Section 4.1.2. The strains were tested for 
a suitable growth medium and fermented 4 to 6 days. The fermentation broth 
was centrifuged, and the mycelium was extracted separately from the 
fermentation broth. The aromatic pigments produced by the strains were 
usually accumulating on the surface of the bacterial cell wall so that most of the 
interesting compounds were isolated from mycelium extract. To increase the 
solubility of the compounds, the cells were acidified with an acidic solution of 
water to pH 3-4, left in ultrasound bath for 20 minutes and later extracted 
several times with ethyl acetate. The growth medium was also acidified to pH 3-
4 and extracted several times with ethyl acetate as well. After removing the 
solvent at a rotary evaporator, the crude extract was purified using flash silica 
and Sephadex LH-20 column chromatography depending on the characteristic 
of the extract. Final purification was performed with HPLC.  
4.1.5.6 Procedure for the Isolation of Griseorhodin A (5)  
For the isolation of griseorhodin A (5), S. albus MP31 spores were inoculated 
into 100 mL of LB medium and grown overnight. This seed culture was used to 
inoculate 9 L of LB medium, which was distributed to fifteen 1 L baffled flasks. 
Flasks were incubated at 220 rpm for 5 days at 30 °C. For compound isolation, 
the mycelia were harvested by centrifugation and suspended in 300 mL of H2O. 
The pH of the mixture was adjusted to 3-4 with TFA. After extraction with 200 
mL of EtOAc for 3 times, the combined extracts were fractionated by flash 
column chromatography on impregnated silica with a mobile phase 
CHCl3:MeOH (9:1). Further fractionation was done by Sephadex LH-20 gel 
filtration and the substances were eluted with methanol. Fractions containing 
griseorhodin A (5) were combined, dried, and further purified by 
semipreparative HPLC on a MN-Nucleodur-100 RP18 column with a gradient 
CH3CN:H2O +0.1% TFA (25:75) to CH3CN:H2O +0.1% TFA (90:10) in 25 min. The 
yield of the isolation was 17 mg. The identity of the compound was confirmed 
by both 1H-NMR analysis in DMSO-d6 and HRMS data. The molecular ion [M+H]+ 
of griseorhodin A (5) with the molecular formula C25H16O12 was detected in the 
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HRMS analysis at 509.0691 (509.072 is calculated [M+H]+). Spectral data found 
to be identical with the spectral data in the literature.14,112 
1H-NMR spectrum was recorded on a Bruker ADVANCE DPX 400 device. A Jasco 
MD-2015 PDA HPLC detector was used to obtained the UV spectrum of the 
compound. The IR spectrum was recorded as a film on a Micolet 380 FT-IR 
spectrometer. Polarimetric measurement of the compound was performed with 
a Perkin-Elmer 340 polarimeter at 589 nm at 20 ˚C. 
4.1.5.7 Procedure for the Isolation of Didesoxygriseorhodin C (46)  
For the isolation of the compound, S. albus KR7 spores were inoculated into 100 
mL of LB medium and grown overnight. The resulting seed culture was used to 
inoculate 6 L of LB medium, which was distributed to fifteen 1 L baffled flasks, 
so that each flask contained 400 mL culture. These were incubated at 220 rpm 
for 6 days at 30 °C. For the isolation, the mycelia were harvested by 
centrifugation and suspended in 300 mL of H2O. The pH of the mixture was 
adjusted to 3-4 with TFA. After extraction with 200 mL of EtOAc for 3 times, the 
combined extracts were fractionated by flash column chromatography on 
impregnated silica with a mobile phase CHCl3:MeOH (9:1). Fractions containing 
didesoxygriseorhodin C (46) were combined, dried, and further purified by 
semipreparative HPLC on a RP18 column with a gradient CH3CN:H2O+0.1%TFA 
(25:75) to CH3CN:H2O+0.1% TFA (90:10) in 25 min. This procedure yielded 16 
mg of pure compound. The molecular formula was deduced by ESI-HRMS 
analysis as C25H18O11 (494.089 measured [M+H]+, 494.085 calculated [M+H]+). 
The identity of the compound was confirmed by one- and two-dimensional NMR 
analysis in DMSO-d6. A literature survey showed that didesoxygriseorhodin C 
(46) was isolated formerly by Suetsuna et al. All spectral data were identical 
with the published data. 126-128 
1H-NMR, 13H-NMR, HMBC and HMQC spectra were recorded on a Bruker 
ADVANCE DPX 400 device. A Jasco MD-2015 PDA HPLC detector was used to 
obtain the UV spectrum of the compound. The IR spectrum was recorded as a 
film on a Micolet 380 FT-IR spectrometer. Polarimetric measurement of the 
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compound was performed with a Perkin-Elmer 340 polarimeter at 589 nm at 20 
˚C. 
4.1.5.8 Procedure for the Isolation of Collinone (41) 
For the isolation of collinone (41), S. albus KR8 spores were inoculated into 100 
mL of TSB medium and grown overnight. The resulting culture was used to 
inoculate 6 L of TSB medium, which was distributed to 500 mL Erlenmeyer 
flasks with a stainless steel spring, so that each flask contained 200 mL medium 
for production. Flasks were incubated in shaker for 4 days at 30 °C at 200 rpm. 
For the extraction of the compounds, the mycelia were harvested by 
centrifugation and the acidity was adjusted to pH 2 with a 2 N HCl solution. 
Afterwards, the mixture was extracted with ethyl acetate for 3 times. The 
combined extracts were fractionated by flash chromatography on NaH2PO4-
impregnated silica gel column eluted with a mobile phase CHCl3:MeOH (9:1). 
The compound was detected via TLC and HPLC in column fractions and 
fractions needed were combined and dried. Further purification was carried out 
by preparative HPLC using a PerfectChrom 100 C18 reverse-phase 
semipreparative column (250 mm x 8 mm, 5 µm) with UV detection at 254 nm 
and 488 nm using a Jasco MD-2015 PDA detector. A 25%-75% to 40%-60% 
CH3CN:H2O+0.1% TFA gradient was used over 22 min at a flow rate of 6 mL 
min-1. As a result 8 mg of pure collinone (41) was obtained. The identity of the 
compound was confirmed both by ESI-HRMS analysis (m/z: 557.067 [M+Na]+) 
and by one- and two-dimensional NMR analysis in CDCl3. All spectral data were 
found to be identical with published data. 137 
1H-NMR, 13H-NMR, HMBC and HMQC spectra were recorded on a Bruker DPX 
300 device. A Jasco MD-2015 PDA HPLC detector was used to obtain the UV 
spectrum of the compound. The IR spectrum was recorded as a film on a Micolet 
380 FT-IR spectrometer. Polarimetric measurement of the compound was 
performed with a Perkin-Elmer 340 polarimeter at 589 nm at 20 ˚C. 
4.1.5.9 Procedure for the Isolation of Lenticulone (53) 
For the isolation of the compound MP66a, which was later renamed as 
lenticulone (53), S. albus MP66 was grown in 12 L of LB medium which was 
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distributed to 1 L baffled flasks, so that each flask contained 400 mL culture. 
After incubation at 220 rpm for 4 days at 30 °C, the bacteria were harvested by 
centrifugation and suspended in 400 mL of H2O. The solution was acidified to 
pH 3-4 with TFA and extracted for 3 times with 300 mL of ethyl acetate. To 
prevent decomposition of the compound during solvent removal, most of the 
TFA was back extracted with H2O for 2 times. The crude extract was 
fractionated by flash column chromatography on impregnated silica with a 
mobile phase CHCl3:EtOAc (5:1). Fractions containing the compound were 
combined and dried, and further purification was carried out by preparative 
HPLC using a PerfectChrom 100 C18 reverse-phase semipreparative column 
(250 mm x 8 mm, 5 µm) with UV detection at 254 nm and 488 nm using a Jasco 
MD-2015 PDA detector. A 25%-75% to 100%-0% CH3CN:H2O+0.1% TFA 
gradient was used over 25 min at a flow rate of 6 mL min-1. The yield of the 
isolation was 20 mg of lenticulone (53). The identity of the compound was 
confirmed by both ESI-HRMS/MS analysis for the molecular ion [M+H]+ as 
C26H16O12 (m/z = 521.0714, calcd. 521.0720) and one- and two-dimensional 
NMR analysis in CDCl3.  
1H-NMR, 13H-NMR, HMBC and HMQC spectra were recorded on a Bruker 
ADVANCE DPX 400 device. A Jasco MD-2015 PDA HPLC detector was used to 
obtain the UV spectrum of the compound. The IR spectrum was recorded as a 
film on a Micolet 380 FT-IR spectrometer. Polarimetric measurement of the 
compound was performed with a Perkin-Elmer 340 polarimeter at 589 nm at 20 
˚C. 
4.1.5.10 Procedure for the Isolation of ZY1 (54) 
For the isolation of ZY1 (54), S. albus MP66 was grown in 12 L of LB medium, 
which was distributed to 500 mL flasks with stainless-steel springs, so that each 
flask contained 200 mL culture. Flasks were incubated at 200 rpm for 4 days at 
30 °C. Mycelia were harvested by centrifugation and suspended in 400 mL of 
H2O. After adjustment to pH 2 with 2 N HCl, the mixture was extracted with 300 
mL of EtOAc:MeOH:AcOH (95:5:1) for 3 times. The combined extracts were 
fractionated by flash column chromatography on impregnated silica with a 
mobile phase CHCl3:MeOH (9:1). Fractions containing the compound were 
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combined, dried, and further purification was carried out over Sephadex LH-20 
with MeOH as mobile phase. The solvent was removed on a rotary evaporator. 
The yield of the isolation for the compound ZY1 (54) was 6 mg. The molecular 
ion for the new compound was determined by ESI-HRMS as [M+H]+ of C15H12O9: 
m/z = 337.055, calcd. 337.056. One- and two-dimensional NMR analysis were 
carried out in AN-d3. 
1H-NMR, 13H-NMR, HMBC and HMQC spectra were recorded on a Bruker 
ADVANCE DPX 400 device in the LC-NMR facilities of the University Greifswald 
by Michael Lalk. A Jasco MD-2015 PDA HPLC detector was used to obtain the UV 
spectrum of the compound.  
4.1.5.11 Procedure for the Isolation of Precollinone (58) 
For the isolation of the compound, spores of S. albus KR53 were inoculated into 
100 mL of LB medium and grown overnight. The resultant seed culture was 
used to inoculate 9 L of LB medium, which was distributed to fifteen 1 L baffled 
flasks. Flasks were incubated at 220 rpm for 3 days at 30 °C. Subsequently, the 
mycelia were harvested by centrifugation and freeze-dried overnight. The 
biomass was suspended in 500 mL of MeOH. After filtering the cell residues, 
MeOH was removed by a rotary evaporator. 500 mL of water with 0.1% TFA 
was added to the brown-yellow crude extract. The mixture was stirred for 30 
min and extracted for 3 times with 200 mL of ethyl acetate. The combined 
extracts were filtered on C18-silica before being fractionated on Sephadex LH-
20 material with methanol as mobile phase. Fractions containing the compound 
were combined, dried, and further purification was carried out by preparative 
HPLC using a PerfectChrom 100 C18 reverse-phase semipreparative column 
(250 mm x 8 mm, 5 µm) with UV detection at 254 nm and 360 nm using a Jasco 
MD-2015 PDA detector. A 40-60% to 60-40% CH3CN:H2O+0.1% TFA gradient 
was used over 25 min at a flow rate of 6 mL min-1. The yield of the isolated new 
compound precollinone (58) was 18 mg. The identity of the new compound 
with the molecular formula C27H20O10 was confirmed by both ESI-HRMS 
analysis for the molecular ion m/z = 505,111 for [M+H]+, calcd. 505.116, and 
one- and two-dimensional NMR analysis in DMSO-d6.  
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1H-NMR, 13H-NMR, HMBC and HMQC spectra were recorded on a Bruker 
ADVANCE DPX 400 device. A Jasco MD-2015 PDA HPLC detector was used to 
obtain the UV spectrum of the compound. The IR spectrum was recorded as a 
film on a Micolet 380 FT-IR spectrometer. Polarimetric measurement of the 
compound was performed with a Perkin-Elmer 340 polarimeter at 589 nm at 20 
˚C. 
4.1.5.12 Procedure for the Extraction of KR5a 
For the extraction of the compound, S. albus KR5 spores were inoculated into 
100 mL of TSB medium and grown overnight. The resultant seed culture was 
used to inoculate 12 L of LB medium, which was distributed to fifteen 1 L 
baffled flasks. Flasks were incubated at 220 rpm for 4 days at 30 °C. For the 
isolation, the mycelia were harvested by centrifugation and freeze-dried 
overnight. The dry bacteria were suspended in 500 mL of H2O with TFA at pH 3. 
After 10 to 15 minutes, 500 mL of EtOAc was added and stirred overnight in RT. 
After filtering the solution the EtOAc phase was separated and dried with 
Na2CO3. After removal of solvent in vacuum, 500 mg brown crude extract was 
obtained from a total of 12 L of fermentation broth. 
4.1.5.13 Procedure for the Methylation of KR5a  
To a stirred suspension of 500 mg crude extract of S. albus KR5 and 10 g 
anhydrous K2CO3 (72.46 mmol) in 90 mL of dry acetone, 14 mL of dimethyl 
sulfate (DMS) (144.29 mmol) was added dropwise. The mixture was stirred at 
RT for an hour and then heated under reflux for 24 h at 40 °C. Afterwards the 
mixture was cooled down to room temperature and diluted with 100 mL of H2O. 
After stirring for further 30 min, the mixture was extracted with 300 mL of 
CHCl3. The organic phase was washed with water to remove the remaining salt. 
and the solvent was removed to obtain the dry extract. The combined extracts 
were fractionated by flash chromatography with a mobile phase of CHCl3:EtOAc 
(1:1). Fractions containing the compound were detected via TLC (Rf: 0.63) and 
HPLC. Further purification was carried out by preparative HPLC using a 
PerfectChrom 100 C18 reverse-phase semipreparative column (250 mm x 8 
mm, 5 µm) with UV detection at 254 nm and 488 nm using a Jasco MD-2015 
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PDA detector. A 60-40% to 100-0% CH3CN:H2O gradient was used over 25 min 
at a flow rate of 6 mL/min. Next, a second purification on preparative HPLC was 
carried out using methanol/water. A method with a 60-40% to 100-0% 
MeOH:H2O gradient was used over 25 min at a flow rate of 4 mL/min. The 
isolated yield of secocollinone-1 (59) was 13 mg. The molecular ion of the 
compound was determined by ESI-HRMS analysis (m/z: 635.222 [M+H]+). The 
structure was confirmed by one- and two dimensional NMR analysis in DMSO-
d6.  
1H-NMR, 13H-NMR, HMBC and HMQC spectra were recorded on a Bruker 
ADVANCE DPX 400 device. A Jasco MD-2015 PDA HPLC detector was used to 
obtain the UV spectrum of the compound. The IR spectrum was recorded as a 
film on a Micolet 380 FT-IR spectrometer. Polarimetric measurement of the 
compound was performed with a Perkin-Elmer 340 polarimeter at 589 nm at 20 
˚C. 
4.1.5.14 Procedure for the Isolation of KR41a 
For the isolation of the compound, spores of S. albus KR41 were inoculated in 19 
L of TSB medium, which was distributed to 1 L baffled flasks, so that each flask 
contained 400 mL culture. After incubation at 220 rpm for 4 days at 30 °C the 
bacteria were separated and removed by centrifugation. The medium was 
extracted with EtOAc . The aqueous phase was acidified to pH 3-4 with a 2 mL/L 
TFA solution and extracted 3 for times with 300 mL of EtOAc. To prevent the 
decomposition of the compounds during solvent removal at rotary evaporator, 
the organic phase was back extracted with 100 mL of H2O to remove remaining 
TFA. The crude extract was fractionated by flash column chromatography on 
impregnated silica with a mobile phase CHCl3:MeOH (9:1). The combined 
extracts were applied to a Sephadex LH-20 column with methanol as mobile 
phase. Further purification of the compounds KR41a was carried out by 
preparative HPLC using a PerfectChrom 100 C18 reverse-phase 
semipreparative column (250 mm x 8 mm, 5 µm) with UV detection at 254 nm 
and 475 nm using a Jasco MD-2015 PDA detector. A 60-40% to 100-0% 
CH3CN:H2O+0.1% TFA gradient was used over 25 min at a flow rate of 6 
mL/min. The isolated yield of KR41a was 17 mg. The molecular formula was 
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determined via ESI-HRMS analysis for the molecular ion [M+H]+ as C26H19O9: 
m/z = 475.100 calcd. 475.1029 . One- and two-dimensional NMR analysis of the 
compound were carried out in DMSO-d6.  
1H-NMR, 13H-NMR, HMBC and HMQC spectra were recorded on a Bruker 
ADVANCE DPX 400 device. A Jasco MD-2015 PDA HPLC detector was used to 
obtain the UV spectrum of the compound.  
4.1.5.15 Procedure for the Methylation of KR41a 
2 ml dimethyl sulfate (21.08 mmol) was added dropwise to a suspension of 17 
mg of KR41a and 2 g of anhydrous K2CO3 (14.47 mmol) in 15 mL of dry acetone. 
The mixture was stirred at room temperature for an hour and later heated 
under reflux for 15 h. The mixture was cooled down to room temperature and 
diluted with 100 mL of H2O. After stirring for further 30 min, the mixture was 
extracted with 100 mL of CHCl3. The organic phase was washed with water and 
the solvent was removed in vacuum. A yellow crude product was obtained. In 
the TLC analysis with a mobile phase of CHCl3:MeOH (9:1) at RT a spot was 
observed with an Rf value of 0.73. Further purification was carried out by 
preparative HPLC using a PerfectChrom 100 C18 reverse-phase 
semipreparative column (250 mm x 8 mm, 5 µm) with UV detection at 254 nm 
and 488 nm using a Jasco MD-2015 PDA detector. A 60-40% to 100-0% 
CH3CN/H2O gradient was used over 25 min at a flow rate of 6 mL/min. 
Subsequently a second purification was carried out on preparative HPLC using a 
60-40% to 100-0% MeOH/H2O gradient over 25 min at a flow rate of 4 mL/min. 
The yield of the compound, KS-619-3 (65), was 5 mg. The molecular formula of 
the compound was obtained by ESI-HRMS analysis for the molecular ion [M+H]+ 
as [C31H29O9]+: m/z =545.1969 [M+H]+ (calcd. 545.1812). The identity of the 
compound was confirmed by 1H-NMR and 13H-NMR analysis in CDCl3.  
1H-NMR and 13H-NMR spectra were recorded on a Bruker ADVANCE DPX 400 
device. A Jasco MD-2015 PDA HPLC detector was used to obtain the UV 
spectrum of the compound. The IR spectrum was recorded as a film on a Micolet 
380 FT-IR spectrometer. 
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4.1.5.16 Procedure for the Isolation of KR41c 
For the isolation of the compound, S. albus KR41 was grown in 19 L of TSB 
medium, which was distributed to 1 L baffled flasks, so that each flask contained 
400 mL culture. After incubation at 220 rpm for 4 days at 30 °C, the mycelium 
was harvested by centrifugation, suspended in 50 mL of H2O and freeze-dried. 
250 mL of MeOH was added to the dry mycelium to extract the metabolites, and 
after stirring for at least an hour, the bacterial residue was removed by 
filtration. Methanol was removed at a rotary evaporator. The crude extract was 
washed with CHCl3 and EtOAc to avoid the presence of non-polar lipids during 
further purification. The residue was acidified with water containing 3 mL/L 
TFA and extracted for 3 times with 300 mL of EtOAc. To prevent the 
decomposition of the compounds during solvent removal, TFA was back 
extracted with H2O from the organic phase, and the ethyl acetate was removed 
at the rotary evaporator. The mycelium extract contained mainly the 
compounds KR41c and KR41c’ with a characteristic UV absorption at 360 nm. 
The extract was dissolved in AN, filtered, and further purification was carried 
out by preparative HPLC using a PerfectChrom 100 C18 reverse-phase 
semipreparative column (250 mm x 8 mm, 5 µm) with UV detection at 254 nm 
and 360 nm using a Jasco MD-2015 PDA detector. The isolated yield of KR41c 
was 12 mg. The molecular formula was confirmed by the determined molecular 
ion by ESI-HRMS analysis for [M+H]+ as [C26H19O8]+: m/z = 459.1050 calcd. 
459.1074. One- and two-dimensional NMR analysis was carried out in AN-d3.  
1H-NMR, 13H-NMR, HMBC and HMQC spectra were recorded on a Bruker 
ADVANCE DPX 400 device. A Jasco MD-2015 PDA HPLC detector was used to 
obtain the UV spectrum of the compound.  
4.1.5.17 Procedure for the Methylation of KR41c 
Into a stirred suspension of 10 mg of KR41c and 2 g anhydrous K2CO3 (14.47 
mmol) in 15 mL of dry acetone, 2 mL dimethyl sulfate (21.08 mmol) was added 
dropwise. The mixture was stirred at room temperature for an hour, heated 
under reflux for 15 h, cooled down to room temperature and diluted with 100 
mL of H2O. After stirring further for 30 min, the mixture was extracted with 50 
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mL of CHCl3, washed with water and the solvent was remived. TLC analysis with 
a mobile phase of CHCl3:MeOH (9:1) and HPLC analysis of the product showed 
that the reaction did not yield sufficient amount of substance to carry out a 
characterization. 
4.1.5.18 Procedure for the Isolation of KR11a 
For the isolation of the compound KR11a, S. albus KR11 was grown in 18 L of 
TSB medium which was distributed to 1 L baffled flasks, so that each flask 
contained 400 mL culture. After incubation at 220 rpm for 4 days at 30 °C, the 
mycelia were harvested by centrifugation and suspended in 50 mL of H2O and 
freeze-dried for further investigation.  
The fermentation medium, which had been obtained after the centrifugation, 
was extracted with 300 ml of EtOAc and subsequently acidified to pH 3-4 with 
TFA. Next, the acidified mixture was extracted for 3 times with 300 mL of EtOAc. 
To prevent decomposition of the compounds during solvent removal, TFA was 
back extracted with H2O. The extract contained the yellow compound KR11a 
with an characteristic UV absorption maximum at 470 nm. The crude extract 
obtained from the medium was fractionated by flash column chromatography 
on impregnated silica with a mobile phase CHCl3:MeOH (9:1). Fractions 
containing the compound were combined and dried, and further purification 
was carried out by semipreparative HPLC with a gradient: 25% to 100% CH3CN 
in H2O+ 0.1% TFA over 25 min. The isolated yield of KR11a was 12 mg. The 
identity of the compound was confirmed by ESI-HRMS analysis for the 
molecular ion [M+H]+ as [C26H19O9]+: m/z = 475.1077 calcd. 475.1029 . One- and 
two-dimensional NMR analysis was carried out in DMSO-d6.  
1H-NMR, 13H-NMR, HMBC and HMQC spectra was measured on a Bruker 
ADVANCE DPX 400 device. A Jasco MD-2015 PDA HPLC detector was used to 
obtain the UV spectrum of the compound.  
4.1.5.19 Procedure for the Methylation of KR11a 
Into a stirred suspension of 12 mg of the yellow compound KR11a and 2 g 
anhydrous K2CO3 (14.47 mmol) in 15 mL of dry acetone, 2 mL dimethyl sulfate 
(21.08 mmol) was added dropwise. The mixture was stirred at room 
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temperature for an hour and then heated under reflux for 15 h, cooled down to 
room temperature and diluted with 100 mL of H2O. After stirring further for 30 
min, the mixture was extracted with 100 mL of CHCl3, washed with water and 
the solvent was removed. A yellow solid compound was obtained. By using TLC 
with a mobile phase of CHCl3:MeOH (9:1) at RT, a spot was detected at Rf : 0.7. 
Purification was carried out by preparative HPLC using a PerfectChrom 100 C18 
reverse-phase semipreparative column (250 mm x 8 mm, 5 µm) with UV 
detection at 254 nm and 470 nm using a Jasco MD-2015 PDA detector. A 60-
40% to 100-0% CH3CN:H2O gradient was used over 25 min at a flow rate of 6 
mL min-1. Subsequently a second purification on preparative HPLC was carried 
out using a 60-40% to 100-0% (MeOH:H2O) gradient over 25 min at a flow rate 
of 4 mL min-1. The yield of the isolated methylated compound was 3 mg. The 
identity of the compound was confirmed by ESI-HRMS analysis for the 
molecular ion [M+H]+ as [C31H29O9]+: m/z =545.1991 [M+H]+ calcd. 545.1812. 
4.1.5.20 Procedure for the Methylation of KR11b 
Into a stirred suspension of 1 g of the mycelia crude extract of the S. albus KR11 
and 10 g anhydrous K2CO3 (72.35 mmol) in 90 mL of dry acetone, 12 mL 
dimethyl sulfate (126.53 mmol) was added dropwise. The mixture was stirred 
at room temperature for an hour and then heated under reflux for 24 h, cooled 
down to room temperature and diluted with 100 mL of H2O. After stirring 
further for 30 min, the mixture was extracted with 150 mL of CHCl3, washed 
with water and the solvent was removed at a rotary evaporator. A green solid 
was obtained. Using a mixture of CHCl3:MeOH (9:1) as a mobile phase, TLC was 
made and an Rf value of 0.75 was determined for a green component. The 
product was further purified with column chromatography with the same 
solvent mixture, and applied on a Sephadex LH-20 column with a mobile phase 
of methanol. Further purification attempts on RPand Normal-phase HPLC 
columns with the solvents MeOH, AN and H2O did not yield any results. 
Experiments using less polar solvent mixtures with THF, ethanol, and 
isopropanol were not further pursued due to the technical problems caused by 
these solvents on the HPLC instrument. 1H-NMR of the partially purified 
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compound was performed in DMSO-d6. 10 mg of the green solid was used. The 
spectrum was not clean enough to use for structure elucidation. 
4.1.6 Assays for Determining In Vivo Activity of the Oxygenase GrhO6 
4.1.6.1 Procedure for Assay 1 
For the first assay, the reaction was performed in a 50 mL Falcon tube without 
lid at 30 C at 250 rpm. The reaction was carried out factor for a time period of 4 
hours in a total volume of 2 mL of 1 M Tris buffer at pH 6 with 1 mM NADPH and 
10 M FAD used as cofactor. Into 630 L of 0.32 mg/mL lenticulone (53), which 
was solved with an addition of 10 L DMSO-d6 in Tris buffer, 4 L of FAD 
solution (0.005 M), 100 L of NADPH solution (0.02 M) and 1116 L of Tris 
buffer were added. To the mixture 150 L enzyme with a concentration of 1 mM 
of the enzyme GrhO6 was added and every 30 min 400 L of the solution was 
removed into a 1mL Eppendorf tube. The compounds were extracted with 250 
L of ethyl acetate, centrifuged and the organic phase was transferred into 
another 1 mL Eppendorf tube. During the extraction, the formation of a white 
precipitate was observed, which made the extraction process more difficult due 
to the clinging of red pigments on this precipitate. The precipitation is predicted 
to be caused by the fact that the protein components are insoluble in organic 
solvents. The ethyl acetate from the extraction was removed on a SpeedVac. The 
extract was dissolved in 50 L of acetonitrile and subjected to MN-Nucleodur-
100 RP18 HPLC column with a gradient of 40-60% to 100-0% acetonitrile:water 
at a flow rate 1 mL/min. Simultaneously, a control mixture was incubated. This 
control mixture contained the identical reaction mixture with the substrate 
lenticulone (53) without the enzyme. The control reaction was incubated in 
order to see the degradation products of the compound during the assay. A 
second control mixture contained the identical reaction mixture with GrhO6 but 
not the assumed substrate lenticulone (53) was also incubated in order to tast 
the effects of components, such as cofactors, and to make sure that such 
components do not lead to a signal, which might be mistaken for a product of 
the enzyme reaction.  
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4.1.6.2 Procedure for Assay 2 
Assay 2 investigates the enzyme activity of GrhO6 in two different pH values. 
The assay fallows a procedure similar to assay 1 described above. The reaction 
was carried out in a 50 mL Falcon tube without lid at 30 C at 225 rpm. Assay 2a 
was carried out at a pH 6 in 1 M Tris buffer at pH 6 and assay 2b was carried out 
pH7 in 1 M Tris buffer at pH 7. 1 mM NADPH and 10 M FAD were used as co-
factor for a time period of 4 hours. The total volumes of both reactions were 
increased to 5 mL in order to enable better UV detection of the resulting 
compounds. Into 4490 L of Tris buffer, 10 L of the FAD solution in Tris buffer 
(0.005 M), 250 L of NADPH solution in Tris buffer (0.02 M) and 1 mg 
lenticulone (53), which was dissolved in 50 L DMSO, were added. To the 
mixture 200 L 1.5 mM enzyme was added. Every hour 1 mL of the solution was 
withdrawn from both mixtures and additional 100 L enzyme was added into 
the assay mixtures. The transferred 1 mL solutions were immediately extracted 
with 0.5 mL of ethyl acetate. Precipitates of the proteins were formed again, 
therefore ultrasound bath were used in order to get better solubility during 
extraction this time. The extraction mixture was centrifuged, the organic phase 
was transferred into an Eppendorf tube and ethyl acetate was removed on the 
SpeedVac. The extract was dissolved in 50 L of acetonitrile and subjected to 
MN-Nucleodur-100 RP18 HPLC column with a gradient of 40-60% to 100-0% 
acetonitrile:water at a flow rate 1 mL/min. Additionaly to this reaction, a 
control mixture without GrhO6 and another control mixture without lenticulone 
(53), were prepared as a control mixture and the procedure for the assay was 
applied. 
4.1.6.3 Procedure for Assay 3 
The optimal enzyme activity of a related enzyme MtmOIV was reported to take 
place at the pH 8.25, therefore the previous assay was repeated in 1 M Tris 
buffer at pH 7 and at pH 8.25. The assay 3a was performed at pH 7 and assay 3b 
was performed at pH 8.25. Assay 3 was carried out in a similar manner with 
assay 2. The reactions were performed in an 50 mL Falcon tube without lid at 
27 C at 225 rpm by addition of 1 mM NADPH and 10 M FAD as co-factor for a 
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total time period of 4 hours. Into 4490 L of Tris buffer, 10 L of FAD solution in 
Tris buffer (0.005 M), 250 L NADPH solution in Tris buffer (0.02 M) and 1 mg 
lenticulone (53), which was dissolved in 50 L DMSO, were added. To both 
mixtures 200 L of 1.5 mM enzyme was added. Every hour 1 mL of both 
solutions was withdrawn and a additional 100 L enzyme was added into assay 
mixture. The transferred 1 mL solutions were immediately extracted with 0.5 
mL of ethyl acetate. A precipitate of the proteins formed again therefore ultra 
sound bath was used in order to get better solubility during extractions. The 
only difference of the extraction procedure from the previous ones is that 1 mL 
solutions taken out every hour is required to be acidified before the extractions 
with 0.5 mL of ethyl acetate. This is because these compounds are not soluble in 
organic solvents without being acidified. Therefore the withdrawn samples at 
pH 7 were diluted with an equal amount of 0.025% TFA solution and then 
extracted. The withdrawn samples at pH 8.25 were diluted with 2 mL of the 
0.025 % TFA solution. The extraction mixtures were centrifuged and the 
organic phases were transferred into Eppendorf tubes. Afterwards, ethyl 
acetate was removed on the SpeedVac. The extracts were dissolved in 50 L of 
acetonitrile and subjected to MN-Nucleodur-100 RP18 HPLC column with a 
gradient 40-60% to 100-0% acetonitrile:water at a flow rate 1 mL/min. 
Additionaly to this reaction, a control mixture without GrhO6 and another 
control mixture without lenticulone (53), were prepared as a control mixture 
and the procedure for the assay was applied. 
 
4.1.7 Assays for the Determination of Antibacterial Activity 
The isolated compounds lenticulone (53), griseorhodin A (5), collinone (41), 
precollinone (58), didesoxygriseorhodin C (46) and the crude extracts of the 
mycelia from S. albus KR11 and S. albus KR5, and also the medium extract of S. 
albus KR11 were tested by the strains below. 
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4.1.7.1 Agar Diffusion Assay: 
Two Gram-positive and two Gram-negative bacterial strains were chosen to test 
the antibacterial activity of the compounds for this assay. The strains used for 
the assay are below: 
 Escherichia coli-DH5α (Gram-) 
 Staphylococcus carnosus-DSH 20501 (Gram+) 
 Bacillus amyloliquefaciens (Gram+) 
 Pseudomonas fluorescens-DSH 50090T (Gram-). 
 
 The strains were incubated overnight in TSB medium at 37 C and plated on 
MM agarplates (Müller Minton agar). A set of ethyl acetate solutions of the test 
compounds at the concentrations of 1 mg/mL, 0.5 mg/mL and 0.25 g/mL were 
prepared in Eppendorf tubes. For the assay with a crude extract, double amount 
of extract was used. Sterile 6 mm filter paper disks with radius 0.5 cm 
(Whatman filter paper; Whatman International Ltd.) were prepared and each 
was soaked with 20 L of each test solution. A disk was used as negative control 
by applying only 20 L of ethyl acetate. The disks were left to dry. Prepared 
disks with different concentrations and the control disk were placed on the 
prepared plates; 10 L of distilled water was dropped on the disc to increase 
the diffusion of the compounds into the agar plates. The plates with the bacteria 
and discs on them were incubated overnight at 37 C. On the next day, the discs 
with active compounds showed no signs of bacterial growth on the surface and 
on the borders. However, bacterial growth was observed on the surface and 
around the control disc without compound. Thus, it was concluded that these 
compounds inhibited the strains’ growth. Although the compounds inhibited the 
bacterial growth on and around the disk surface, no activity zone could be 
determined. The inhibition radius was not determined since activity zone was 
not observed as a symmetric area, in some cases not even as an area. The reason 
is predicted to be the low water solubility and poor diffusion property of the 
test substances. Eventhough colorful pigments were used as compounds, low 
compound concentration prevented the observation of the activity zone by 
color.  
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4.1.7.2 Minimum Inhibition Concentration (MIC-Assay) 
MIC value was determined for the compounds, which showed antibacterial 
activity with the two Gram+ strains at the agar diffusion assay explained above. 
The strains used for the assay are below: 
 Staphylococcus carnosus (Gram+) 
 Bacillus subtilis (Gram+) 
 
The assay was carried out in LB medium. The total volume of each test tube was 
2.5 mL. All initial solutions of the test compounds in LB medium were prepared 
in a Falcon tube with a total volume of 10 mL. Each solution had a carefully 
determined compound concentration in the range of 100 g/mL. For the 
preparation of the initial solutions, the test compounds were weighed in an 
Eppendorf tube and 20 L DMSO was added to solve these compounds. Next, 
they were transferred into 10 mL of LB medium. Each initial solution was 
distributed into two overnight culture tubes so that each tube contained 5 mL of 
the solution. These tubes were used to prepare two set of test tubes in a 
concentration row to test each strain. For the prepartion of each concentration 
row, 2.5 mL of the initial solution was transferred to from the first tube into the 
next tube. Afterwards, 2.5 mL of LB medium was added into this next tube to 
obtain a twofold dilution in a total volume of 5 mL. The next tube of the 
concentration row was prepared by transferring 2.5 mL of the twofold-diluted 
solution into it and by addition of 2.5 mL of LB medium so that again a total 
volume of 5 mL was obtained. The solution is a four-fold dilution of the initial 
solution. This procedure was repeated until there were 8 different 
concentrations in decreasing order. The final volume of the solutions in the 
tubes was 2.5 mL. 20 L DMSO was added to each tube to increase the solubility 
of the test compound. A control mixture containing only 20 L DMSO and LB 
medium without the test compound was also prepared. For the preparation of 
the strains a day before, bacterial strains were grown overnight at 37 C in LB 
medium and used on the following day to inoculate a new culture to achieve a 
growth maximum of the bacteria (OD600 between 0.08 and 0.1). 100 L of each 
bacterial cultures was used to inoculate the tubes in the concentration row and 
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the control tubes. Afterwards, the prepared tubes were incubated overnight at 
37 C in a shaker at 175 rpm. A second control tube without bacteria containing 
only LB Medium was also incubated to check for any contaminations that might 
be present in the test medium. On the next day the minimum inhibition 
concentrations could be determined by observing the tubes with bacterial 
growth. When the assay result showed no bacterial growth at any concentration 
another complimentary assay was carried out starting at the low concentration 
of 5 g/mL. The procedure of the complimentary assay described above in 
detail. 
 
4.1.8 Characterization of the Isolated Compounds 
4.1.8.1 Griseorhodin A (5) 
 
Figure 4.1. Structure of Griseorhodin A (5). 
Chemical formula: C25H16O12 
[]   
  = +54 (c=0.015 g/100 mL in CHCl3) 
ESI-(+)-HRMS=Measured m/z: 509.0691, calculated m/z: 509.0720 for [M+H]+. 
IR [cm-1]=3481, 1687,1649,1604, 1440, 1308, 1159, 1136, 1104, 1077, 1020, 
977, 936, 651, 586, 542, 451, 441.  
UV (in acetonitrile)  [nm]=224, 260, 308, 362, 488 nm. 
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1H-NMR (500 MHz, DMSOd6)= 2.23 (s, 3H, CH3-7), 3.92 (s, 3H, OCH3-7’), 4.30 
(d, 1Ha, J3 [Ha,b] =4 Hz, H-3), 4.40 (d, 1Hb, J3 [Hb,a] =4 Hz, H-4), 5.32 (s, 1H, H-3’), 
6.37 (bs, 1H, H-6’), 6.44 (s, 1H, H-6), 6.90 (s, OH, H-3’), 7.1 (s, 1H, H-5),10.80 (s, 
OH, OH-10), 11.76 (sb, OH, OH-9’), 13.22 (s, OH, OH-4’). 
 
4.1.8.2 Didesoxygriseorhodin C (46): 
 
Figure 4.2 Structure of didesoxygriseorhodin C (46). 
Chemical formula: C25H18O11 
[]   
  =+48 (c=0.015 g/100 mL in CHCl3) 
ESI-(+)-HRMS=Measured m/z: 495.0911, calculated m/z: 495.0927 for [M+H]+. 
IR [cm-1]=3509, 1687, 1650, 1604, 1439, 1320, 1284, 1195, 1157, 1081, 1041, 
121, 983, 929.  
UV (in acetonitrile)  [nm]=224, 254, 314, 356, 494 nm. 
1H-NMR (500 MHz, DMSO-d6)= 1.8 (3H, s, CH3-18), 2.20-2.22 (4H, m, CH2-7, 
CH2-8), 5.15 (s, 1H, H-6), 6.41,6.45 (bs, OH, OH-6), 6.49 (s, 1H, H-6), 6.85 (s, 1H, 
H-6), 10.78 (s, OH, OH-14), 11.84 (s, 1 OH, OH-17). 
13C-NMR (400 MHz, DMSO-d6)= 18.63 (s, C-18), 21.22 (s, C-7), 23.12 (s, C-8), 
56.97 (s,OCH3-2), 74.04 (s, C-6), 103.72 (s, C-10), 104.16 (s, C-6a), 106.35 (s, C-
4a), 110.14 (s, C-3), 113.12 (s, C-11), 114.01(s, C-17a), 114.86 (s, C-9), 124.02 (s, 
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C-8a), 130.18 (s, C-5a), 132.35 (s, C-13a), 137.69 (s, C-9a), 146.79 (s, C-14a), 
148.58 (s, C-16a), 152.14 (s, C-14), 153.96 (s, C-17), 157.14 (s, C-5), 160.18 (s, C-
2), 165.64 (s, C-13), 179.86 (s, C-1), 185.37 (s, C-4). 
 
4.1.8.3 Lenticulone (53): 
 
 
Figure 4.3 Structure of Lenticulone (53) 
Chemical formula: C26H16O12 
[]   
  =+28 (c=0.012 g/100 mL in CHCl3) 
ESI-(+)-HRMS=Measured m/z: 521.0714, calculated m/z: 521.0720 for [M+H]+. 
IR [ cm-1]=2923, 2853, 1686, 1650,1606, 1438, 1403, 1336, 1289, 1234, 1197, 
1145, 1069, 1053, 1006, 989, 932, 893, 857, 819, 799, 747, 697, 668, 585, 568, 
546, 519, 445, 421, 412 .  
UV (in acetonitrile)  [nm]=230, 355, 494 nm. 
1H-NMR (500 MHz, CDCl3)= 2.24(3H, s, CH3-19), 2.4-2.5(2H, m, CH2-7), 2.85-
3.25(2H, m, CH2-8), 4.01 (3H, s, OCH3-2), 6.17 (1H, s, H-10), 6.29 (1H, s, H-3), 
6.61 (1H, s, H-9), 10.98 (OH, s, OH-14), 12.74 (OH, s, OH -18), 13.37 (OH, s, OH -
18). 
13C-NMR (400 MHz, CDCl3)= 19.30 (s, C-19), 23.96 (s, C-7), 20.59 (s, C-8), 57.33 
(s, CH30-2), 99.08 (s, C-6a), 104.01 (s, C-10), 105.08 (s, C-11), 110.20 (s, C-3), 
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114.21 (s, C-9), 117.93 (s, C-4a), 118.26 (s, C-18a), 121.74 (s, C-17a), 127.7 (s, C-
5a), 131.387 (s, C-9a), 137.14 (s, C-14a), 132.09 (s, C-8a), 150.15 (s, C-14), 
152.85 (s, C-11), 153.61 (s, C-5), 155.88 (s, C-18), 158.28 (s, C-17), 161.15 (s, C-
2), 166.66 (s, C-13), 181.67 (s, C-1), 182.81 (s, C-6). 
 
4.1.8.4 ZY1 (54): 
 
Figure 4.4 Structure of ZY1 (54). 
Chemical formula: C15H12O9 
ESI-(+)-HRMS=Measured m/z: 337.055, calculated m/z: 337.056 for [M+H]+. 
UV (in acetonitrile)  [nm]:224, 272, 308, 356, 488 nm. 
1H-NMR (400 MHz, CNCD3)= 3.87 (6H, s, OCH3-9, OCH3-10), 3.93 (3H, s, OCH3-
10), 6.34 (H, s, H-5), 12.16 (OH, s, OH-2), 12.87 (OH, s, OH-7). 
13C-NMR (400 MHz, CNCD3)= 53.18, 53.82, 53.82, 130.77, 132.58, 111.53, 
114.52, 115.10, 132.58, 153.12, 154.06, 162.44, 164.76, 164.82, 184.35, 190.13. 
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4.1.8.5 Collinone (41): 
 
Figure 4.5 Structure of collinone (41). 
Chemical formula: C27H18O12 
[]   
  =+39 (c = 0.03 g/100 mL in CHCl3) 
ESI-(+)-HRMS= Measured m/z: 535.088, calculated m/z: 535.088 for [M+H]+. 
IR [cm-1]=3382, 2920, 2850, 1683, 1616, 1557, 1446, 1403, 1342, 1289, 1231, 
1167, 1085, 1013, 984.  
UV (in acetonitrile)  [nm]=236, 290, 338, 510 nm. 
1H-NMR (500 MHz, CDCl3)= 2.2 (3H, s, CH3-26), 2.2-2.5 (2H, m, CH2-19a), 3.1-
3.2 (2H, m, CH2-19b), 6.1 (1H, s, H-24), 6.2 (H, s, H-6), 6.6 (1H, s, H-22), 11.6 
(OH, s, OH-3). 
13C-NMR (400 MHz, CDCl3)= 19.45 (s, C-26), 26.10 (s, C-19a), 27.30 (s, C-20), 
78.99 (s, C-5), 80.80 (s, C-18), 103.481 (s, C-2), 104.090 (s, C-24), 110.78 (s, C-
12), 115.82 (s, C-22), 115.91 (s, C-14), 119.54 (s, C-4), 128.6 (s, C-16), 130.92 (s, 
C-7), 147.91 (s, C-21), 154.65 (s, C-8), 155.12 (s, C-25), 155.6 (s, C-15), 159.5 (s, 
C-3), 160.74 (s, C-11), 166.508 (s, C-1), 182.65 (s, C-10), 188.14 (s, C-13), 191 (s, 
C-17). 
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4.1.8.6 Precollinone (58): 
 
Figure 4.6 Structure of precollinone (58). 
Chemical formula: C27H20O10 
[]   
  =+48 (c=0.035 g/100 mL in CHCl3) 
ESI-(+)-HRMS=Measured m/z: 505.111, calculated m/z: 505.114 for [M+H]+.  
IR [cm-1]=2921, 2851, 1681, 1621, 1425, 1382, 1340, 1253, 1201, 1085, 1040, 
811, 755, 720, 668, 657, 569 .  
UV (in acetonitrile)  [nm]=236, 278, 344, 410 nm. 
1H-NMR (500 MHz, CDCl3)= 2.06 (3H, s, CH3-26), 2.46-2.26 (2H, m, CH2-19), 
3.12-3.08 (2H, m, CH2-20), 3.86 (3H, s, OCH3), 6.17 (1H, s, H-24), 6.57 (1H, s, H-
12), 6.61 (1H, s, H-22), 7.14 (1H, s, H-10), 7.75 (1H, s, H-8), 10.09 (OH, s, OH-15), 
11.36 (OH, s, OH-3), 14.17 (OH, s, OH-13). 
13C-NMR (400 MHz, CDCl3)= 19.15 (s, C-26), 23.76 (s, C-19), 28.05 (s, C-20), 
56.09 (s, C-11), 77.99 (s, C-5), 80.85 (s, C-18), 102.67 (s, C-10), 111.02 (s, C-16), 
116.10 (s, C-22), 103.03 (s, C-2), 103.88 (s, C-12), 104.06 (s, C-24), 106.92 (s, C-
14), 118.44 (s, C-8), 122.35 (s, C-4), 131.45 (s, C-7), 137.55 (s, C-23), 140.42 (s, 
C-9), 148.33 (s, C-21), 155.17 (s, C-25), 159.08 (s, C-3), 159.17 (s, C-15), 163.20 
(s, C-11), 164.40 (s, C-13), 166.71 (s, C-1), 197.71 (s, C-17), 198.96 (s, C-6). 
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4.1.8.7 Secocollinone-1 (59): 
 
Figure 4.7 Structure of secocollinone-1 (59). 
 Chemical formula: C34H34O12 
[]   
  =+62 (c=0.05 g/100 mL in CHCl3) 
ESI-(+)-HRMS=Measured m/z: 634.213, calculated m/z: 634.205 for [M+H]+.  
IR [cm-1]=2920, 1732,1589,1558, 1456,1404,1340, 1257,1209, 1109, 
1037,803, 750, 668, 418.  
UV (in acetonitrile)  [nm]=230, 260, 350, 362, 398 nm. 
1H-NMR (500 MHz, CDCl3)= 2.18 (3H, s, CH3-10), 2.80-2.85 (2H, m, CH2-11), 
2.90-2.95 (2H, m, CH2-12), 3.79 (3H, s, OCH3-21), 3.80 (3H, s, OCH3-26), 3.79 
(3H, s, OCH3-21), 3.81 (6H, s, OCH3-4, OCH3-25), 3.87 (3H, s, OCH3-3), 3.88 (3H, 
s, OCH3-18), 3.91 (3H, s, CH3-26), 3.97 (3H, s, CH3-20), 6.43 (H, s, CH-8), 7.02 (H, 
s, CH-19), 7.08 (H, s, CH-6). 
13C-NMR (400 MHz, CDCl3)= 19.69 (s, C-26), 26.02 (s, C-26), 31.52 (s, C-26), 
57.31 (s, C-26), 57.56 (s, C-26), 61.87 (s, C-26), 62.04 (s, C-26), 62.41 (s, C-26), 
62.45 (s, C-26), 63.51 (s, C-26), 103.14 (s, C-26), 103.63 (s, C-26), 112.97 (s, C-
26), 116.03 (s, C-26), 122.26 (s, C-26), 125.20 (s, C-26), 129.25 (s, C-26), 130.79 
(s, C-26), 135.79 (s, C-26), 136.19 (s, C-26), 140.80 (s, C-26), 144.81 (s, C-26), 
147.83 (s, C-26), 151.44 (s, C-26), 154.26 (s, C-26),154.30 (s, C-26), 156.63 (s, C-
26), 156.76 (s, C-26), 158.87 (s, C-26), 158.96 (s, C-26), 181.12 (s, C-26), 184.01. 
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4.1.8.8 KS-619-3 (65): 
 
Figure 4.8 Structure of KS-619 (65). 
Chemical formula: C31H28O9 
[]   
  =+23 (c=0.05 g/100 mL in CHCl3) 
ESI-(+)-HRMS=Measured m/z: 545.1969, calculated m/z: 545.181 for [M+H]+.  
IR [cm-1]=1720, 1661, 1594, 1578, 1460, 1429, 1369, 1304, 1214, 1158, 1134, 
1054, 1022, 999, 976, 947, 799, 665, 536, 481, 430.  
UV (in acetonitrile)  [nm]=230, 296, 404 nm. 
1H-NMR (500 MHz, CDCl3)= 2.19 (3H, s, CH3-26), 2.8-2.6 (2H, m, CH2), 2.9-3 
(2H, s, CH2), 3.64 (3H, s, OCH3-1), 3.72 (3H, s, OCH3-24), 3.92 (3H, s, OCH3-23), 
3.95 (3H, s, OCH3-15), 3.96 (3H, s, OCH3-13), 3.98 (3H, s, OCH3-9), 6.77 (H, s, H-
14), 6.92 (H, s, H-4), 7.42 (H, s, H-16), 8.96 (H, s,H-20). 
13C-NMR (400 MHz, CDCl3)= 21.89 (s, C-7), 29.29 (s, C-6), 30.08 (s, C-26), 48.71 
(s, C-24), 52.85 (s, COOCH3-23), 56.35 (s, OCH3-13), 56.99 (s, OCH3-15), 62.22 (s, 
OCH3-1), 62.43 (s, OCH3-9), 102.61 (s, C-16), 105.49 (s, C-14), 118.57 (s, C-12), 
118.81(s, C-10), 122.65 (s, C-20), 125.65 (s, C-19), 126.48 (s, C-22), 127.22 (s, C-
4), 128.62 (s, C-2), 133.19 (s, C-3), 134.37 (s, C-8), 137.72 (s, C-17), 140.58 (s, C-
21), 143.24 (s, C-5), 156.81 (s, C-1), 157.21 (s, C-9), 162.21 (s, C-13), 164.49 (s, 
C-15), 168.52 (s, C-23), 182.13 (s, C-11), 183.92 (s, C-18), 205.46 (s, C-25). 
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4.1.9 List of Chemicals and Materials  
All chemicals used were standard chemicals of analytical grade from following 
companies: Across, Fluka, Roth (Karlsruhe), Merck (Darmstadt) and Sigma 
(Seelze). HPLC grade solvents were purchased from Baker (Deventer,NL), 
Merck (Darmstadt) and Fischer Scientific (Schwerte). NMR solvents were from 
Sigma and Euriso-Top. 
Table 4.1 Table of Chemicals 
Chemicals Company, Location 
Acetic acid Merck, Darmstadt 
Acid casein hydrolysate Roth, Karlsruhe 
Agar-agar Roth, Karlsruhe 
Ammonium sulfate Applichem, Darmstadt 
Ampicillin-Sodium salt Roth, Karlsruhe 
Apramycin sulfate Sigma-Aldrich, Seelze 
Beef extract Roth, Karlsruhe 
Calcium carbonate Roth, Karlsruhe 
Calcium chloride KMF, Lohmar 
[D1] Chloroform (CDCl3) Euriso-Top, Gif sur Yvette (F) 
Dipotasium hydrogenphosphate-dihydrate Merck, Darmstadt 
Dimethyl sulfate (DMS) Roth, Karlsruhe 
Dimethyl sulfoxide (DMSO) Roth, Karlsruhe 
[D6] Dimethyl sulfoxide (DMSO-d6) Euriso-Top, Gif sur Yvette (F) 
Disodium hydrogenphosphate-dihydrate Fluka / Riedel-de-Haën, Seelze 
D(+)-Glucose monohydrate Fluka / Riedel-de-Haën, Seelze 
Glycerol Merck, Darmstadt 
Hydrocloric acid Fluka / Riedel-de-Haën, Seelze 
Iron(II)sulfate-heptahydrate Merck, Darmstadt 
Magnesiumchloride-hexahydrate Fluka / Riedel-de-Haën, Seelze 
Magnesiumsulfate-heptahydrate Roth, Karlsruhe 
Mannitol Roth, Karlsruhe 
Potassium carbonate AppliChem, Darmstadt 
Potassium chloride Acros Organics, Geel (B) 
Potassium dihydrogenphosphate  Merck, Darmstadt 
Potassium sulfate Grüssing, Filsum 
Potato starch, soluble Sigma-Aldrich, Seelze 
Sodium carbonate KMF, Lohmar 
Sodium chloride Grüssing, Filsum 
Sodium dihydrogenphosphate-dihydrate Roth, Karlsruhe 
Sodium hydroxide KMF, Lohmar 
Sulfric acid Fluka / Riedel-de-Haën, Seelze 
Soja flour (Bacto Saitone) Becton Dickinson, Heidelberg 
Trifluor acetic acid (TFA) Roth, Karlsruhe 
Tris-(hydroxymethyl)-amino methane (Tris) Roth, Karlsruhe 
Trimethyl silyl diazo methan Roth, Karlsruhe 
Tryptic Soy Broth (TSB) Difco, USA 
Tryptic Soy Broth (TSB) Becton Dickinson, Heidelberg 
Trypton Becton Dickinson, Heidelberg 
Yeast extract Becton Dickinson, Heidelberg 
Zinc chloride Acros Organics, Geel (B) 
Zinc sulfate Merck, Darmstadt 
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4.1.10 List of Equipments 
Table 4.2 Table of equipments 
Equipment Company, Location 
Autoklave V65 Systec, Wettenberg 
Balance CP225D Sartorius, Göttingen 
Balance 440-47N Kern, Balingen-Frommern 
Balance BP110 Sartorius, Göttingen 
Centrifuge Rotina 35R Hettich, Tittlingen 
Centrifuge Z513K Hermle, Wehingen 
Clean bench Biowizard Kojair, Vilppula (FIN) 
Freeze dryer Heto PowerDry LL3000 Thermo, Langenselbold 
HPLC-ColumnC18 Nucleodur 100, 125 x 2 mm, 5 µm Macherey-Nagel, Düren 
HPLC-ColumnC18 PerfectChrom 100, 250 x 4 mm, 5 µm Macherey-Nagel, Düren 
HPLC-ColumnC18 PerfectChrom 100, 250 × 8 mm, 5 µm Macherey-Nagel, Düren 
HPLC-Instrument  Jasco, Gross-Umstadt 
HPLC-Vials with Cap and Septum Bio-Rad, München 
Inkubator B12 Thermo, Langenselbold 
Membrane vakuum pumpe Vacuubrand, Wertheim 
Microcuvettes UltraVette (70-850 µL) Roth, Karlsruhe 
Microwave Lifetec Medion, Essen 
Microcentrifuge Mikro200 Hettich, Tuttlingen 
Photometer BioMate 3 Thermo Electron, Cambridge  
Pipettes Gilson, Middleton (USA) 
Poly-Prep Column  Bio-Rad, München 
Rotation evaporator VV2000 Heidolph, Kelheim 
Silica gel 60 (0,040- 0,063 mm) Merck, Darmstadt 
Speedvac / Concentrator 5301 Eppendorf, Hamburg 
TLC-Plates silica gel 60 F254 Merck, Darmstadt 
TLC-Plates Alugram RP-18 W/UV254 Macherey-Nagel, Düren 
Ultrasound homogenisator Sonopuls HD2070 Bandelin, Berlin 
Vakuum pump RZ6 Vacuubrand, Wertheim 
Vortex-Mixer VTX-3000L LMS, Tokio (J) 
Water bath GFL, Burgwedel 
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5 SUMMARY 
Griseorhodin A (5) is a member of the rubromycins, a group of aromatic 
polyketides with unique structures. Members of this group such as γ-
rubromycin (37) and heliquinomycin (39) inhibit HIV reverse transcriptase 
and human telomerase. Both pharmacological activities depend on the presence 
of a highly unusual spiroketal moiety, but how the bacteria achieve the 
biosynthesis of this pharmacophore has not been understood completely. 
In previous work, the griseorhodin A (5) biosynthetic gene cluster (Fig. 1.24) 
was isolated and sequenced and a heterologous expression system was created 
to study griseorhodin A biosynthesis 17 mutant strains lacking biosynthetic 
genes were prepared by Kathrin Reinhardt for her PhD work. The aim of this 
PhD study was the development of cultivation procedures, the chemical 
investigation, and the characterization of the metabolites and shunt products 
from the griseorhodin A pathway, focusing on the function of the 11 
griseorhodin A (5) tailoring enzymes performing the post-PKS steps and the 
function as-yet undetermined genes.  
 Heterologous expression and metabolic analysis of the strains enabled the 
assignment of most genes to various stages of griseorhodin A biosynthesis, the 
identification of tailoring enzymes and the study of the pharmacophore 
generation process. In addition to griseorhodin A (5), seven metabolites, 
didesoxygriseorhodin C (46), collinone (41), ZY1 (54), lenticulone (53), 
precollinone (58), KS-619-3 (65) and secocollinone-1 (59), were isolated, 
which are present in the extracts of fourteen producing mutant strains. With the 
data obtained from the HR-LCMS experiments and structure elucidation, a new 
biosynthetic pathway for griseorhodin A (5) was postulated. (Section 3.7) 
Among the substances isolated for the biosynthesis studies, the structures of the 
compounds ZY1 (54), lenticulone (53), precollinone (58), KS-619-3 (65) and 
secocollinone-1 (59) were identified as new. In addition to biosynthesis studies, 
an in vito enzyme activity assay for the oxygenase GrhO6 with the isolated 
metabolite lenticulone (53) was conducted to stud biosynthesis. 
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It was also tested, how the degree of oxidative modification during griseorhodin 
A biosynthesis affects bioactivity. The compounds griseorhodin A (5), 
didesoxygriseorhodin C (46), collinone (41), precollinone (58) and lenticulone 
(53) showed antibacterial activity to Gram-positive bacteria Staphylococcus 
carnosus, Bacillus amyloliquefaciens und Bacillus subtilis. The MIC values for the 
inhibitory activity were determined. collinone (41) and griseorhodin A (5) 
showed the highest antibacterial activity. 
Serine protease-inhibiting activity for the compounds and extracts were tested 
in the group of Prof. Michael Gütschow, at the University of Bonn. For 
griseorhodin A (5), didesoxygriseorhodin C (46), collinone (41), and 
lenticulone (53) a considerable inhibiting activity to human leukocyte elastase 
(HLE) was determined. The highest HLE-inhibiting activity is displayed by 
didesoxygriseorhodin C (46). (IC50=3.10±0.83 µg mL-1) The results impliy that 
the griseorhodin-type compounds could represent a new class of candidates for 
HLE inhibitors.  
Cytotoxic and antiproliferative activities of griseorhodin A (5), 
didesoxygriseorhodin C (46), collinone (41), and lenticulone (53) were 
determined in the group of Hans-Martin Dahse in HKI, Jena. In general, the 
activities of all of these compounds were moderate and in the same range. 
In addition, the absolute configuration of griseorhodin A (5), collinone (41) and 
precollinone (58) was determined by quantum chemical circular dichroism 
(CD) calculations in combination with experimental CD measurements in the 
group of Prof. Gerhard Bringmann, at the University of Würzburg.  
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6 ZUSAMMENFASSUNG 
Griseorhodin A (5) ist ein Vertreter der Rubromycin-Familie der aromatischen 
Polyketide. Die Vertreter wie das γ-Rubromycin (37) und das Heliquinomycin 
(39) inhibieren HIV reverse Transkriptase und die menschliche Telomerase. 
Beide pharmakologischen Aktivitäten sind abhängig von der Spiroketal-Einheit 
der Substanzen. Bislang konnte nicht vollständig aufgeklärt werden, wie die 
Bakterien dieses Pharmacophore erzeugen.  
In früheren Arbeiten wurde der Griseorhodin-Gencluster aus Streptomyces sp. 
JP95 isoliert und ein heterologes Expressionssystem erzeugt. Um die 
Griseorhodin A Biosynthese zu studieren, wurde von Kathrin Reinhardt in ihrer 
Dissertation 17 Mutantenstämme generiert, denen Biosynthesegene fehlen. Die 
Zielsetzung dieser Arbeit ist die Entwicklung effizienter Kultivierung-
Protokolle, die chemisch-analytische Untersuchung und Strukturaufklärung der 
Metaboliten der Mutantenstämme mit Fokus auf der Funktion der 11 Post-PKS 
Oxygenasen sowie der Enzyme, deren Rollen in der Biosynthese bislang nicht 
aufgeklärt werden konnte.  
Anhand der Ergebnisse war die Zuordnung der meisten Polyketid 
modifizierenden Enzyme und die Aufklärung der wesentlichen Schritte in der 
Pharmakophorebiosynthese möglich. Zusätzlich zum Metabolit Griseorhodin A 
(5) wurden Didesoxygriseorhodin C (46), Collinon (41), ZY1 (54), Lenticulon 
(53), Precollinon (58), KS-619-3 (65) und Secocollinon-1 (59) isoliert und 
strukturell characterisiert. Anhand der Ergebnisse der HR-LCMS-Analysen und 
der aufgeklärten Strukturen konnte ein Verlauf der Biosynthese von 
Griseorhodin A (5) postuliert werden. (Abschnitt 3.7) Unter den Metaboliten, 
konnten als neue Naturstoffe die Strukturen von ZY1 (54), Lenticulon (53), 
Precollinon (58), KS-619-3 (65) und Secocollinon-1 (59) identifiziert werden. 
Zusätzlich zu den Biosynthesestudien wurde eine Untersuchung der in vitro 
Enzymaktivität für die Oxygenase GrhO6 durchgeführt.  
In Bioaktivitätsstudien haben Griseorhodin A (5), Didesoxygriseorhodin C (46), 
Collinon (41), Precollinon (58) und Lenticulon (53) antibakterielle Aktivitäten 
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gegen die Gram-positiven Stämme Staphylococcus carnosus, Bacillus 
amyloliquefaciens und Bacillus subtilis gezeigt. Die MIC-Werte wurden bestimmt. 
Collinone (41) und Griseorhodin A (5) haben die höchsten antibakteriellen 
Aktivitäten gezeigt.  
Die Serine-Protease-inhibierende Wirkung der Substanzen und Mutant-extrakte 
wurde in der Gruppe von Prof. Michael Gütschow am Pharmazeutischen Institut 
der Universität Bonn untersucht. Griseorhodin A (5), Didesoxygriseorhodin C 
(46), Collinon (41), und Lenticulon (53) besitzen eine hohe hemmende 
Wirkung gegen die menschliche Leucocyten Elastase (HLE). Die stärkste HLE-
Hemmung wurde für Didesoxygriseorhodin C (46) nachgewiesen 
(IC50=3.10±0.83 µg mL-1). Aufgrund dieser Ergebnisse Substanzen der 
Griseorhodintyps gute Kandidaten für eine neue Klasse von HLE-Inhibitoren 
sein.  
Zytotoxizitäten und antiproliferative Wirkungen der isolierten Substanzen 
wurden von Hans-Martin Dahse am HKI, Jena, bestimmt. Bei den Substanzen 
Griseorhodin A (5), Didesoxygriseorhodin C (46), Collinon (41), und Lenticulon 
(53) wurden moderate Zytotoxizitäten und antiproliferative Wirkungen 
ermittelt.  
Auβerdem wurde in einer weiteren kooperation die vollständige 
Strukturaufklärung die absoluten Konfigurationen von Griseorhodin A (5), 
Collinon (41) und Precollinon (58) durch quantenchemische 
Circulardichroismus-Kalkulationen in Kombination mit experimentellen 
Circulardichroismus-Werten in der Gruppe von Prof. Gerhardt Bringmann an 
der Universität Würzburg bestimmt. 
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7.1 APPENDIX 1: MS Data 
 
Figure 1.1 EI-MS data of secocollinone-1 (59). 
 
 
Figure 1.2 ESI-MS/MS of secocollinone-1 (59). 
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Figure 1.3 ESI-MS/MS of lentıculone (53). 
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7.2 APPENDIX 2: NMR Spectra 
 
 
 
 
 
Figure 2.1 1H-NMR spectrum of didesoxygriseorhodin C (46), in DMSO-d6, 500 MHz 
Figure 2.2 1H-NMR spectrum of didesoxygriseorhodin C (46), in DMSO-d6, 500 MHz. 
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Figure 2.3 13C-NMR spectrum of didesoxygriseorhodin C (46), in DMSO-d6, 500 MHz. 
Figure 2.4 LC-1H-NMR spectrum of didesoxygriseorhodin C (46), in AN-d3, 500 MHz. 
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Figure 2.5 LC-HH-COSY-NMR spectrum of didesoxygriseorhodin C (46), in AN-d3, 500 MHz. 
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Figure 2.6 LC-HMBC-NMR spectrum of didesoxygriseorhodin C (46), in AN-d3, 500 MHz. 
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Figure 2.7 1H-NMR spectrum of collinone (41), in CDCl3, 400 MHz. 
 
 
 
 
 
Figure 2.8 1H-NMR spectrum of collinone (41), in CDCl3, 400 MHz. 
                                                                                                                                   7 APPENDIX 
____________________________________________________________________________________________ 
 251 
 
 
 
 
 
 
Figure 2.9 13C-NMR spectrum of collinone (41), in CDCl3, 400 MHz. 
Figure 2.10 DEPT spectrum of collinone (41), in CDCl3, 400 MHz. 
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Figure 2.11 HMBC spectrum of collinone (41), in CDCl3, 400 MHz 
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Figure 2.12 LC-1H-NMR spectrum of ZY1 (54), in AN-d3, 500 MHz 
Figure 2.13 LC-13C-NMR spectrum of ZY1 (54), in AN-d3, 500 MHz 
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Figure 2.14 LC-DEPT spectrum of ZY1 (54), in AN-d3, 500 MHz 
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Figure 2.15 LC-COSY spectrum of ZY1 (54), in AN-d3, 500 MHz 
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Figure 2.16 LC-HMBC spectrum of ZY1 (54), in AN-d3, 500 MHz 
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Figure 2.18 1H-NMR spectrum of lenticulone (53), in CDCl3, 500 MHz. 
 
Figure 2.17 1H-NMR spectrum of lenticulone (53), in CDCl3, 500 MHz. 
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Figure 2.19 13C-NMR spectrum of lenticulone (53), in CDCl3, 400 MHz. 
Figure 2.20 DEPT spectrum of lenticulone (53), in CDCl3, 400 MHz. 
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Figure 2.21 HMBC spectrum of lenticulone (53), in CDCl3, 500 MHz. 
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Figure 2.22 H-H-Cosy spectrum of lenticulone (53), in CDCl3, 500 MHz. 
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Figure 2.23 HMQC spectrum of lenticulone (53), in CDCl3, 500 MHz. 
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Figure 2.24 1H-NMR spectrum of precollinone (58), in DMSO-d6, 500 MHz. 
 
 
Figure 2.25 1H-NMR spectrum of precollinone (58), in DMSO-d6, 500 MHz. 
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Figure 2.26 13C-NMR spectrum of precollinone (58), in DMSO-d6, 400 MHz. 
 
 
Figure 2.27 DEPT spectrum of precollinone (58), in DMSO-d6, 400 MHz. 
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Figure 2.28 HMBC spectrum of precollinone (57), in DMSO-d6, 500 MHz. 
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Figure 2.29 HMQC spectrum of precollinone (57), in DMSO-d6, 500 MHz. 
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Figure 2.31 1H-NMR spectrum of secocollinone-1 (59), in DMSO-d6, 500 MHz. 
 
  
Figure 2.30 1H-NMR spectrum of secocollinone-1 (59), in DMSO-d6, 500 MHz. 
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Figure 2.32 13C-NMR spectrum of secocollinone-1 (59), in DMSO-d6, 400 MHz. 
 
 
 
 
Figure 2.33 DEPT spectrum of secocollinone-1 (59), in DMSO-d6, 400 MHz. 
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Figure 2.34 DEPT spectrum of secocollinone-1 (59), in DMSO-d6, 400 MHz. 
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Figure 2.35 HMBC spectrum of secocollinone-1 (59), in DMSO-d6, 500 MHz. 
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Figure 2.36 Predicted 1H-NMR spectrum of secocollinone-1 (59), in DMSO-d6, 500 MHz 
 
Figure 2.37 Predicted 13C-NMR spectrum of secocollinone-1 (59), in DMSO-d6. 
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Figure 2.38 Predicted 1H-NMR spectrum of secocollinone (59b), in DMSO-d6. 
 
 
 
Figure 2.39 Predicted 1H-NMR spectrum of secocollinone (59b), in DMSO-d6. 
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Figure 2.40 1H-NMR spectrum of KR41c, in AN-d3, 500 MHz. 
Figure 2.41 13C-NMR spectrum of KR41c, in AN-d3, 400 MHz. 
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Figure 2.42 HMQC spectrum of KR41c, in AN-d3, 500 MHz. 
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Figure 2.43 HMBC spectrum of KR41c, in AN-d3, 500 MHz. 
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Figure 2.44 1H-NMR spectrum of KR41a-partial (6c), in DMSO-d6, 500 MHz. 
 
 
Figure 2.45 13C-NMR spectrum of KR41a-partial (6c), in DMSO-d6, 400 MHz. 
 
7 APPENDIX 
____________________________________________________________________________________________ 
276 
 
 
Figure 2.46 DEPT spectrum of KR41a-partial (6c), in DMSO-d6, 400 MHz. 
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Figure 2.47 HMQC spectrum of KR41a-partial (6c), in AN-d3, 500 MHz. 
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Figure 2.48 HMBC spectrum of KR41a-partial (6c), in AN-d3, 500 MHz. 
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Figure 2.49 1H-NMR spectra of KR41a-partial (6c), in DMSO-d6, 400 MHz. 
Experiment at temperatures 20 ˚C, 30 ˚C, 40 ˚C, 50 ˚C and 60 ˚C. 
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Figure 2.50 1H-NMR spectrum of KS-619-3 (65), in CDCl3, 500 MHz. 
 
 
Figure 2.51 1H-NMR spectrum of KS-619-3 (65), in CDCl3, 500 MHz. 
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Figure 2.52 1H-NMR spectrum of KS-619-3 (65), in CDCl3, 500 MHz. 
 
Figure 2.53 13C-NMR spectrum of KS-619-3 (65), in CDCl3, 400 MHz. 
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Figure 2.54 DEPT spectrum of KS-619-3 (65), in CDCl3, 400 MHz. 
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7.3 APPENDIX 3: IR Spectra 
 
Figure 3.1 IR spectrum of griseorhodin A (5). 
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Figure 3.2 IR spectrum of didesoxygriseorhodin C (46). 
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Figure 3.3 IR spectrum of collinone (41). 
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Figure 3.4 IR spectrum of precollinone (58). 
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Figure 3.5 IR spectrum of lenticulone (53). 
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Figure 3.6 IR spectrum of secocollinone-1 (59). 
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Figure 3.7 IR spectrum of KS-619-1 (64). 
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Figure 3.8  IR spectrum of KS-619-3 (65). 
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